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preFace
Malaria is responsible for 250 million cases and nearly 1 million deaths per 
year, imposing an enormous burden of suffering on too many lives in tropi-
cal regions of the world. The Global Malaria Eradication Program (1955–1969) 
achieved considerable success in removing the threat of malaria from about 
a billion people but, for much-discussed reasons, the program could not be 
sustained and stopped well short of its goal. We are again encouraged by recent 
and significant progress in “shrinking the malaria map,” with many countries 
dedicating resources and making great efforts toward releasing their nations 
from the threat of malaria. This evolution has been linked in part to a substan-
tial increase in investment in tackling malaria globally, leading to develop-
ment of much-improved means of treatment and control and in the ability to 
make these available where they are most needed.
An overarching strategy has been developed to exploit this major new initia-
tive. The new strategy, defined in the Roll Back Malaria Global Malaria Action 
Plan, has three parts to it:
1. To strengthen the aggressive control of malaria in its heartland  
This should happen in the 61 highly endemic countries where the 
most deaths and disease occur. This is the part of the overall strategy 
on which most investment must continue to be focused.
2. To shrink the malaria map from the endemic margins inward  
By achieving elimination, countries will, in addition to gaining the 
intrinsic benefits of that success, continue the global strategy that 
has occurred de facto since the early 20th century — spatially progres-
sive elimination.
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3. To continue researching and developing new tools  New tools, 
such as improved drugs, diagnostics, insecticides, and eventually a 
vaccine, are essential to the success of ongoing and future elimina-
tion efforts. Looking forward, and using the lessons from malaria 
history of the past 50 years, many of the interventions that work at 
present will need to be replaced because they will inevitably become 
less effective over time.
In order for the ultimate goal of eradication to be achieved, all three compo-
nents of this strategy must proceed simultaneously.
The Malaria Elimination Group (MEG) was convened in late 2007 by the 
Global Health Group at the University of California, San Francisco, to support 
the relatively neglected second part of the strategy. The MEG plays a supportive 
role to countries that are embarked on the path to elimination of malaria or are 
considering whether or not elimination is a viable option for them.
The MEG is an international multidisciplinary group that has taken on the 
task of identifying and providing informed discussion on the substantial ques-
tions of whether, when, and how to eliminate malaria. Strategic planning and 
feasibility, the operational and technical challenges of reducing transmission 
to zero, importation risk, outbreak risk, and cross-border transmission — all of 
these considerations and risks, as well as others, need to be carefully evaluated 
by countries pursuing or contemplating elimination.
A Prospectus on Malaria Elimination aims to provide practical advice that 
can guide countries in thinking through their decisions on whether, when, 
and how to eliminate malaria. It is prepared for key stakeholders who work on 
the front lines of elimination, and for those who provide technical insight to 
governments, donors, and potential investors. The Prospectus is not prescrip-
tive, because the specific decisions surrounding the direction that the malaria 
program should follow must be made in each country, with the context care-
fully taken into consideration. The Prospectus does, however, outline a strategic 
vision and serves to inform the decision-making process by providing a range 
of considerations that a country must evaluate in context before, during, and 
after the elimination decision. A companion document to the Prospectus has 
also been published by the Global Health Group at the University of California, 
San Francisco: A Guide on Malaria Elimination for Policy Makers, written by Sir 
Richard Feachem and the Malaria Elimination Group. 
The majority of the authors of the Prospectus are members of the MEG. 
Authors of specific chapters were chosen for their expertise in particular areas 
relevant to an elimination program; some outside expertise was drawn from 
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as needed. Authors collaborated as small working groups, reflecting upon the 
rich history of malaria elimination and eradication while brainstorming new 
ideas based on their knowledge of opportunities presented and challenges to 
be expected. As a group, the MEG discussed and debated the first draft of the 
Prospectus in October 2008 and reviewed the final draft remotely.
The Prospectus is a living document and will undergo periodic updates and 
supplements. The Prospectus is available on the Web (www.malariaelimination 
group.org) and in hard copy. It is the first part of a much larger MEG agenda 
that will provide more extensive data and updates on the progress of elimina-
tion, accomplished by using new data or through dialogue with countries as 
they plan to carry out their elimination progams. Case studies on countries 
that have achieved elimination or are implementing an elimination strategy 
are in progress, and these will help inform the elimination agenda and will 
lead to additional improvements and updates to the Prospectus. We encourage 
all those working on the front lines of elimination to comment on and con-
tribute to this evolving work through a forum available on the MEG Web site 
(www.malariaeliminationgroup.org).
Richard G.A. Feachem San Francisco 
Allison A. Phillips April 2009 
Geoffrey A. Targett
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executive SuMMary
Thirty-nine countries across the world are making progress toward malaria 
elimination. Some are committed to nationwide elimination, while others are 
pursuing spatially progressive elimination within their borders. Influential 
donor and multilateral organizations are supporting their goals of achieving 
malaria-free status.
With elimination back on the global agenda, countries face a myriad of 
questions. Should they change their programs to eliminate rather than control 
malaria? What tools are available? What policies need to be put into place? 
How will they benefit from elimination? Unfortunately, answers to these ques-
tions, and resources for agencies and country program managers considering or 
pursuing elimination, are scarce.
The 39 eliminating countries are all positioned along the endemic margins 
of the disease, yet they naturally experience a variety of country characteris-
tics and epidemiologies that make their malaria situations different from one 
another. The Malaria Elimination Group (MEG) and this Prospectus recognize 
that there is no single solution, strategy, or time line that will be appropriate for 
every country, and each is encouraged to initiate a comprehensive evaluation 
of its readiness and strategy for elimination. The Prospectus is designed to guide 
countries in conducting these assessments.
The Prospectus provides detailed and informed discussion on the practical 
means of achieving and sustaining zero transmission. It is designed as a road 
map, providing direction and options from which to choose an appropriate 
path. As on all maps, the destination is clearly marked, but the possible routes 
to reach it are numerous.
The Prospectus is divided into two sections:
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Section 1 Eliminating Malaria, comprises four chapters covering the 
strategic components important to the periods before, during, and after 
an elimination program.
Section 2 Tools for the Job, comprises six chapters that outline basic 
information about how interventions in an elimination program will 
be different from those in a control setting.
Chapter 1, Making the Decision, evaluates the issues that a country should 
consider when deciding whether or not to eliminate malaria. The chapter 
begins with a discussion about the quantitative and qualitative benefits that a 
country could expect from eliminating malaria and then recommends a thor-
ough feasibility assessment. The feasibility assessment is based on three major 
components: operational, technical, and financial feasibility. Cross-border and 
regional collaboration is a key subject in this chapter.
Chapter 2, Getting to Zero, describes changes that programs must consider 
when moving from sustained control to an elimination goal. The key stra-
tegic issues that must be addressed are considered, including supply chains, 
surveillance systems, intersectoral collaboration, political will, and legislative 
framework. Cross-border collaboration is again a key component in Getting to 
Zero.
Chapter 3, Holding the Line, provides recommendations on how to conduct 
an assessment of two key factors that will affect preventing the reemergence of 
malaria once transmission is interrupted: outbreak risk and importation risk. 
The chapter emphasizes the need for a strong surveillance system in order to 
prevent and, if necessary, respond to imported cases.
Chapter 4, Financing Elimination, reviews the cost-effectiveness of elimi-
nation as compared with sustained control and then presents the costs of 
selected elimination programs as examples. It evaluates four innovative financ-
ing mechanisms that must support elimination, emphasizing the need for pre-
dictable and stable financing. Case studies from Swaziland and two provinces 
in China are provided.
Chapter 5, Understanding Malaria, considers malaria from the point of 
view of elimination and provides a concise overview of the current burden of 
the disease, malaria transmission, and the available interventions that can be 
used in an elimination program.
Chapter 6, Learning from History, extracts important lessons from the 
Global Malaria Eradication Program and analyzes some elimination efforts 
that were successful and some that were unsuccessful. The chapter also reviews 
how the malaria map has been shrinking since 1900.
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Chapter 7, Measuring Malaria for Elimination, provides a precise language 
for discussing malaria and gives the elimination discussion a quantitative 
structure. The chapter also describes the role of epidemiological theory and 
mathematical modeling in defining and updating an elimination agenda for 
malaria.
Chapter 8, Killing the Parasite, outlines the importance of case detection 
and management in an elimination setting. Options for diagnosis, the hidden 
challenge of Plasmodium vivax in an elimination setting, and the impact of 
immunity are all discussed.
Chapter 9, Suppressing the Vector, explores vector control, a necessary ele-
ment of any malaria program. It considers optimal methods available to inter-
rupt transmission and discusses potential changes, such as insecticide resis-
tance, that may affect elimination efforts.
Chapter 10, Identifying the Gaps — What We Need to Know, reviews the 
gaps in our understanding of what is required for elimination. The chapter 
outlines a short-term research agenda with a focus on the operational needs 
that countries are facing today.
The Prospectus reviews the operational, technical, and financial feasibility 
for those working on the front lines and considers whether, when, and how 
to eliminate malaria. A companion document, A Guide on Malaria Elimination 
for Policy Makers, is provided for those countries or agencies whose responsi-
bility is primarily to make the policy decisions on whether to pursue or sup-
port a malaria elimination strategy. The Guide is available at www.malaria 
 eliminationgroup.org.
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key deFinitionS
Malaria elimination is:
The interruption of local mosquito-borne malaria transmission in a defined 
geographical area, creating a zero incidence of locally contracted cases. Imported 
cases will continue to occur and continued intervention measures are required.
Malaria eradication is:
The permanent reduction to zero of the worldwide incidence of malaria infection.
DeFInIT IOnS BY THe WOrLD He ALTH OrGAnIz ATIOn
importation risk (also known as vulnerability) is:
The probability of malaria reintroduction based on an area’s proximity to other 
malarious areas and the movement of infected humans or infected Anopheles 
mosquitoes.
outbreak risk (also known as receptivity) is:
A measure of the potential of an area or focus to allow transmission to occur, or 
once elimination has been achieved, the propensity for reintroduced malaria to 
give rise to malaria outbreaks. 
DeFInIT IOnS BY THe MAL ArIA eL IMInATIOn GrOUP
UCSF-Prospectus-revs.indd   15 4/22/2009   12:01:55 PM
 xv i   A PrOSPeC TUS On MAL ArIA eL IMInATIOn
UCSF-Prospectus-revs.indd   16 4/22/2009   12:01:55 PM
   1
1 |  Making the deciSion
Bruno Moonen,a Scott Barrett,b Jim Tulloch,c  
and Dean T. Jamisond
1.1 | introduction
Malaria elimination, according to the WHO definition, is “the interruption 
of local mosquito-borne malaria transmission in a defined geographical area,” 
which implies that imported cases may occur and that continued interven-
tions will be required after elimination has been achieved.1 For the MEG, a 
“defined geographical area” does not necessarily imply national boundaries, as 
the epidemiological zones where malaria elimination might be feasible from a 
technical perspective do not always follow administrative borders.
The MEG global strategy for malaria elimination, as set out in this Prospectus, 
encourages countries at the current global boundaries of malaria transmission, 
and countries that benefit from other geographical characteristics that favor 
elimination (for example islands), to explore the option of pursuing an elimi-
nation strategy.2 Depending on the malaria epidemiology within the country 
or region, countries may want to target specific zones at the subnational level 
or participate in wider regional initiatives, including cross-border collabora-
tions toward elimination. This chapter identifies considerations that countries 
may wish to take into account as they address the elimination decision.
the eliMination unit
As shown in Figure 1.1, there are currently 39 countries that are either planning 
for elimination or already in the pre-elimination or elimination phase.3-10 These 
aClinton Foundation, Nairobi, Kenya; bSchool of Advanced International Studies, 
Johns Hopkins University, Washington, DC, USA; cAustralian Agency for International 
Development, Canberra, Australia; dInstitute for Health Metrics and Evaluation, 
University of Washington, Seattle, USA
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Box 1.1  Main Messages
The Malaria elimination Group (MeG) makes the following recommendations:
•	 All countries unsure about the appropriateness and timing of moving to an 
elimination program should conduct a rigorous and structured feasibility 
assessment, taking into account technical, operational, and financial feasibility.
•	 Mathematical modeling of outbreak risk and importation risk is an integral 
part of the methodology to assess technical feasibility. When both are esti-
mated to be low, countries should seriously consider elimination. From a 
technical point of view, elimination should not only be assessed on a regional 
or country level but, rather, be based on ecological zones and their malaria 
epidemiological contexts.
•	 The assessment of operational feasibility takes into account the commitments 
a government can or is willing to make to fulfill the necessary programmatic 
requirements and to create an enabling environment to facilitate the elimina-
tion process.
•	 Donors and governments interested in elimination need to rethink financing 
and probably adopt new financial mechanisms. Financial feasibility requires 
institutional change as well as long-term and reliable monetary resources.
•	 Countries should pursue a multinational elimination target based on epi-
demiological factors rather than arbitrary national borders. regional and/
or international bodies should not only provide the institutional structure to 
encourage and assist in achieving this goal but also financially reward coun-
tries that adopt and contribute to achieving regional and global targets.
•	 The importance of benefits such as expected reduction in morbidity and 
mortality, a better climate for foreign direct investment, satisfaction resulting 
from a national accomplishment, and the fact that elimination is potentially a 
cost-reducing investment should be factored into the overall judgment about 
whether to commence explicit elimination efforts.
The MeG, while supporting ambitious future strategic thinking, also places 
high value on honest feasibility assessments and rigorous operational planning. 
These key elements, in combination with novel approaches to guarantee sustain-
able financing, will determine the success of any elimination effort. The MeG also 
strongly supports the idea that broad regional targets and collaborations are often 
the most effective approach to cross-border challenges.
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countries — for example, Algeria, Botswana, and Mexico — lie on the fringes of 
areas of malaria transmission. Over time, when such fringe countries have 
achieved elimination, neighboring countries — including in this example Niger, 
Zambia, and Guatemala, respectively — will find themselves on the boundaries 
of areas of transmission, and they will de facto be faced with the decision of 
whether or not to pursue the same goal, either for their border areas or for the 
whole country. Figure 1.1 shows that countries in large parts of Eurasia, Asia, 
and South America, as well as island countries from the Caribbean, Africa, and 
Oceania, have made the decision to go for elimination.
While it is countries that typically embark on malaria elimination and are 
eventually certified by WHO as malaria free, there are important subnational 
and supranational components to this effort. Countries can choose to pursue 
malaria elimination in limited areas pending a move toward a nationwide 
effort to eliminate. For example, a country composed of many islands, such 
as Vanuatu or the Solomon Islands, may undertake spatially progressive elim-
ination by pursuing elimination island by island. Similarly, large countries, 
such as China, India, and Indonesia, may focus initially on malaria elimina-
tion in certain states and provinces before launching national elimination 
efforts.
Seychelles Comoros
Zanzibar
Mauritius
Reunion 
Cape Verde
Maldives
Sao Tome & Principe 
Solomon Islands
Vanuatu
No malaria transmission
Eliminating malaria, nationally or subnationally
Controlling malaria
F i g u r e  1 .1   Malaria freedom, elimination, and control, by country, 2009
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the eliMination deciSion
The decision to begin the elimination process is complex and should not be 
made lightly, as the consequences of failure can be discouraging and costly. A 
premature elimination target can lead to false expectations and may be fol-
lowed by resurgence of malaria, damaged credibility because of the failure to 
achieve expected results, and consequent erosion of national and international 
support. At the same time, excessively conservative control targets can carry 
similar risks in that populations, governments, and donors may eventually 
tire of ongoing activity despite low disease risk. For some countries, politi-
cal interest in and consensus on the feasibility of achieving and sustaining 
zero transmission will be strong enough initially so that the decision can be 
made with little analysis. This has been the case with some countries that 
have adopted elimination in recent years. With other countries, a more rigor-
ous and evidence-based decision-making process will be needed. In line with 
previous and current WHO guidelines, the MEG recommends that countries 
unsure about an elimination program (subnational, national, or regional) 
should undertake a rigorous and structured study. The appropriateness and 
timing and the technical, operational, and financial feasibility of moving 
toward or participating in a program should be considered. Before a discussion 
of these issues takes place, some background is provided here on the potential 
economic (and other) benefits to a country of moving from a high degree of 
control to elimination.
1.2 | potential Benefits of elimination
Successful, sustained elimination can yield substantial benefits for a country. 
These benefits range from the reduced burden of malaria and its sequelae, such 
as anemia, to the corresponding increase in educational attainment11 and pro-
ductivity among the population, to the potential stimulation of the tourist 
industry and greater foreign direct investment.
Eliminating malaria from a country requires current investment; the 
returns are realized later. These returns can come in one or both of two forms. 
First, elimination may simply be less costly than sustained control in the 
long run. Second, even if the long-term costs of elimination exceed those 
of sustained control, the ultimate benefits may still exceed the costs. A brief 
history of the economic consequences of attempts to eliminate other diseases 
may provide insight before the benefits and costs of malaria elimination are 
considered.
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econoMic conSequenceS oF eliMinating other diSeaSeS
A review of the economic effects of disease elimination naturally begins with 
smallpox, which was globally eradicated in 1979. This is compared with the 
very different situation with measles. Table 1.1 addresses smallpox and mea-
sles, as well as the ongoing elimination/eradication programs for polio, Guinea 
worm, and river blindness.
Before the smallpox eradication campaign began, many countries had 
already unilaterally eliminated smallpox within their borders. Elimination by 
individual countries served as an indicator that eradication might be feasible. 
Eradication yielded specific dividends — removing the need to vaccinate, as well 
as the absence of risk of any future infections. This expectation of high benefits 
was met by the extremely high benefit-cost ratios, which were estimated later. 
It was possibly the greatest single public investment the world had ever made.12 
The key to the success of this investment was that smallpox eradication ben-
efited the world, as well as every country. Yet, the effort almost did not succeed; 
its greatest challenge was international financing.12
The economics of malaria eradication differs from that of smallpox because 
in the latter case, every country had to vaccinate to a critical and even level 
everywhere (80%). Malaria has an ecological basis, and because of this the 
steps needed to eliminate malaria vary substantially from country to country. 
In this way, feasibility is inherently different between the two diseases, suggest-
ing the desirability of the MEG’s strategy to eliminate first in less-challenging 
countries on the endemic margins of malaria.
Measles has recently been eliminated in the Americas and in Asia; in other 
places, the number of cases has declined dramatically because of increased con-
trol. The benefit-cost ratio shown in Table 1.1 is small compared with smallpox 
eradication, partly because measles has a low mortality rate in resource-rich 
countries. It is also because, as yet, there is no dividend analogous to the cessa-
tion of vaccination that followed smallpox eradication. Because measles is highly 
infectious, sustaining elimination in the face of a substantial risk of reintroduc-
tion requires that countries maintain very high levels of immunization cover-
age. As we shall see, in countries technically well positioned for an elimination 
effort for malaria, there may be more economic similarity to smallpox eradica-
tion than to measles elimination, despite the differences outlined above.
eliMination aS a coSt-reducing inveStMent
Before we conduct an analysis of malaria elimination relative to sustained con-
trol in a country, we need cost and epidemiological data, including estimates of 
UCSF-Prospectus-revs.indd   5 4/22/2009   12:01:57 PM
 6  A PrOSPeC TUS On MAL ArIA eL IMInATIOn
the inherent potential within a country to spread malaria (outbreak risk) and 
its risk of new infections from abroad (importation risk). If epidemiological 
and cost assessments are sufficiently favorable, elimination may prove to be a 
cost-reducing investment.
On the cost side, we first need to obtain the baseline costs of sustained con-
trol. Next, we need information about the most efficient combination of inter-
ventions that can eliminate malaria and about what that combination will 
cost. Ideally, we will have not just a point estimate but also an understanding 
of how costs vary with the level of control. The costs of approaching elimina-
tion are likely to be high in countries with a high importation risk or high 
outbreak risk. Elimination may not be economical in these countries, even if it 
is deemed technically feasible.
Finally, we need data on the costs of sustaining elimination after it has 
been achieved. As noted previously, for measles the marginal costs of achiev-
ing and sustaining elimination are the same. In both elimination and preven-
tion of reintroduction, population immunity must be kept at the critical level 
through continued immunization. For malaria, it is possible that the measures 
needed to sustain elimination will be different from the measures that were 
used to achieve elimination. If the costs of sustaining elimination are lower 
than the costs of sustaining control, there will be an investment dimension to 
elimination.
The first step in an economic analysis of malaria elimination is to explore 
whether elimination could be a cost-reducing investment. Current historical 
information is highly limited for all three types of cost — sustaining control, 
pushing toward elimination, and sustaining elimination. Careful empirical 
case studies would provide much firmer guidance than is now possible about 
the circumstances that are likely to make elimination ultimately cost reducing. 
That said, cost analyses have been undertaken for a number of regions contem-
plating elimination, and these studies give an idea of the range of costs that 
might be expected. To take one example (which Chapter 4 further discusses, 
along with several others), our analyses suggest that Hainan Island, China, is 
now spending about $2.9 million per year to sustain a high level of control. The 
estimated cost of a push to elimination would be about twice as high annually 
for approximately 5 years. After transmission interruption, the estimated cost 
of holding the line would be about $1.6 million a year — substantially less than 
is now being spent. The 5-year investment period ultimately yields cost sav-
ings. For Swaziland, however, planning estimates point to the likelihood that 
sustaining elimination is likely to result in a permanent increase in costs. This 
increase can be justified by the benefits if their magnitude is sufficient.
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other BeneFitS oF Mal aria eliMination
Beyond the potential for cost reduction, there are other benefits of elimination 
efforts, notably, marked reductions in morbidity and mortality, an improved 
climate for tourism and foreign direct investment, and the satisfaction of a 
national accomplishment. These benefits may sometimes be of quantitative 
significance, but others are likely to prove difficult to measure. Even so, a judg-
ment concerning their importance should be factored into the overall decision 
about whether to commence explicit elimination efforts.
In addition to the benefits within the country of achieving elimination, 
table 1.1 | economic studies of the elimination of selected diseases
disease target Status economics
Smallpox The goal of eradication 
was declared by the World 
Health Assembly (WHA) in 
1959.
The last endemic case 
was in 1977; smallpox was 
declared eradicated in 
1979.
The benefits-costs ratio 
for global expenditure was 
159:1; for international 
financing, 483:1.13
Measles WHO Americas agreed to 
eliminate by 2000; WHO 
europe by 2007; WHO 
eastern Mediterranean by 
2010.
It was eliminated in the 
United States in 2000 and 
in the Americas in 2002. 
Imports occur regularly.
Pelletier et al.14 show that, 
for Canada, moving from 
a one-dose to a two-dose 
immunization program to 
eliminate measles yields 
a benefits-costs ratio 
between 2.6 and 4.3.
guinea worm 
(dracunculiasis)
The goal of eradication 
was established by the 
Centers for Disease 
Control in 1980 and later 
reinforced by several WHA 
resolutions.
It was eliminated from 11 
countries, including all of 
South Asia. It remained 
endemic in 9 sub-Saharan 
African countries at the 
end of 2006.
Kim et al. estimate a 
positive net present 
value,15 implying benefits 
> costs; but see Miller 
et al.16
poliomyelitis The goal of eradication 
was declared by the WHA 
in 1988.
Wild poliovirus type 2 has 
not been detected since 
1999. The other two wild 
viruses are endemic in 4 
countries (Afghanistan, 
India, nigeria, and 
Pakistan), down from 125.
Barrett and Hoel12 showed 
that benefits > costs.17 
However, these analyses 
assume that eradication 
is certain to occur and 
that vaccination can cease 
post-eradication.
river blindness 
(onchocerciasis)
Two regional programs 
(OCP and APOC) control 
in sub-Saharan Africa. 
WHO Americas pledged to 
eliminate onchocerciasis by 
2007.
As of 2007, no new 
cases of blindness in the 
Americas have been due 
to onchocerciasis. Control 
efforts are successful in 
sub-Saharan Africa, but 
elimination has not been 
achieved.
Analysis shows benefits > 
costs for the OCP18 and 
APOC.19
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there are international effects that may be important. Neighboring countries 
will no longer need to worry about importing cases from the eliminating coun-
try. The world as a whole will have taken a step toward the global public good 
of eradication, and many will have learned something from each country’s 
experience. And, finally, the country will no longer be a source of potential 
resistance to antimalarial drugs, which will benefit all countries.
equity iMpact
Every member of a country remaining at risk of malaria will benefit from 
malaria elimination. One consideration relevant to the decision of whether to 
eliminate is the equity consideration: will disadvantaged members of society 
share fully in the benefits of the program? Economists and others regularly 
conduct “benefit-incidence” analyses to ascertain which portions of a popula-
tion benefit from a particular public sector program. Typically, but far from 
uniformly, programs favor the better-off. In the Philippines in 1998, for exam-
ple, immunization coverage was about 75% overall, but in the poorest quin-
tile, coverage was only about 50%. Given this starting situation, moving from 
75% to universal coverage would differentially benefit the poor. It is plausibly 
similar with malaria elimination: because control efforts are likely to have first 
reached the better off and more engaged populations, elimination programs 
will, by reaching remaining segments of the population, almost surely will 
prove to be equity enhancing.
In conclusion, our analyses point to the importance of considering the 
investment potential when elimination’s initial costs are counterbalanced by a 
situation in which maintaining elimination is less costly than sustaining high 
levels of control. The possibility of such a situation is suggested by our analy-
ses for Hainan Island; a country’s actual importation and outbreak risks will 
determine the reality. Additionally, but harder to measure, elimination will 
improve a country’s environment for tourism and foreign direct investment. 
The experience of malaria elimination in the United States and polio elimina-
tion in South America suggests that, if properly undertaken, these programs 
can contribute to overall health system strengthening. Finally, there is strong 
reason to believe that malaria elimination programs will enhance equity by 
principally serving disadvantaged subpopulations. These conclusions must be 
viewed with the caveat that the evidence available at this time is limited. It is 
important that malaria elimination efforts gather data as they progress so the 
economics of elmination can be reassessed on an ongoing basis.
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1.3 | the Feasibility assessment
technical FeaSiBility
According to WHO, elimination is technically feasible if it has been demon-
strated in a similar eco-epidemiological setting in the recent past.1 For the 
moment, this excludes, de facto, the whole of sub-Saharan Africa, where elimi-
nation has not been achieved recently. Pampana (1969) defined technical feasi-
bility as “evidence that conditions in a country are such that a particular tech-
nique . . . will succeed in an acceptable period of time and that, once obtained, 
absence of transmission could be maintained.”20 The MEG further defines tech-
nical feasibility as the probability that malaria transmission can be reduced to 
zero in a given area using the currently available tools and that elimination 
can be maintained in that area. Achieving elimination thus depends on the 
effectiveness of the control tools used, which is influenced by the strength of 
transmission in a given area. Maintaining zero not only depends on the local 
strength of transmission but also on the probability that an infected person or 
mosquito does not reintroduce malaria into the area. The technical feasibility 
of maintaining elimination in a given area depends on the following:
•	 the malaria transmission potential of that area, or outbreak risk 
(receptivity)
•	 the likelihood that malaria will be reintroduced once elimination 
has been achieved, or importation risk (vulnerability)
Recent efforts to quantify both outbreak and importation risks are discussed 
in Chapter 7. Although there are no definite criteria for establishing the exact 
levels for both variables,1 mathematical modeling should be an integral part of 
the methodology used to assess technical feasibility.
Modeling of outbreak risk is important for the elimination decision because 
the actual transmission levels at which countries should begin elimination 
efforts may vary significantly. Zanzibar, before 2000, was considered to be 
moderately to highly endemic and therefore not a country that, according to 
WHO guidelines, should aim for elimination. However, it achieved such levels 
of control that it recently decided to assess the feasibility of malaria elimi-
nation on the islands. Even though they had not reached the recommended 
WHO milestone of a slide positivity rate (SPR) of less than 5%,1 the model-
ing of their outbreak risk demonstrated that elimination would be technically 
feasible in the next 6 to 10 years (David Smith, University of Florida, personal 
communication, February 2009).
Mathematical modeling of importation risk not only will quantify the risk of 
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reintroduction but also might identify specific groups that need to be targeted 
with surveillance to avoid reintroduction of malaria. It will also provide the 
necessary arguments to convince governments, regional bodies, and donors 
of the importance of cross-border operations such as the Lubombo Spatial 
Development Initiative (LSDI) in Mozambique, South Africa, and Swaziland. 
Modeling outbreak and importation risks provides a more quantitative basis 
on which to determine technical feasibility, to complement WHO’s qualitative 
definition of “proof in a similar eco-epidemiological setting.”1
The decision to eliminate malaria is ultimately determined by its techni-
cal feasibility. If assessment of this feasibility concludes that technically it is 
unlikely that malaria can be eliminated, further evaluations of operational and 
financial feasibility become unnecessary. As illustrated in Figure 1.2, the con-
cepts of outbreak and importation risk can help countries to grasp the techni-
cal feasibility even before rigorous evaluations are finalized.
When both factors are deemed to be high, as in Nigeria, the elimination 
decision should most probably be postponed. Instead, countries with high 
importation risk and high outbreak risk should scale up their malaria control 
for impact, both to reduce burden and to make it possible for themselves and 
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their neighbors to eventually move toward elimination. If the importation 
risk is low but outbreak risk high, as in certain island settings, feasibility will 
mainly depend on the country’s ability to maintain high levels of control, 
reduce the vector capacity, provide prompt and effective treatment, and rapidly 
respond to detected cases. If a country’s outbreak risk is considered to be low 
but importation risk is high because of population movements from endemic 
countries, elimination will only be possible if a near-perfect surveillance system 
detects all imported cases immediately. An example is in Bhutan, where 77% 
of all malaria cases originate from three districts located on its southern bor-
der with India.21 Thailand provides a similar example of a country with high 
importation risk, where a vast majority of cases are imported from neighboring 
countries that do not have as strong malaria control measures. Both examples 
demonstrate that malaria is a regional issue. When both outbreak and importa-
tion risks are low, countries should seriously consider elimination.
oper ational FeaSiBility
Historically, operational feasibility was subdivided into administrative and 
practical feasibility. Administrative feasibility was defined as “the possibility 
to create a national organization that can carry out a malaria elimination pro-
gram with a strong long-term governmental commitment, a conducive legal 
environment for malaria elimination control activities especially spraying and 
surveillance, and the availability of sufficient funds.” Practical feasibility meant 
“countrywide access for personnel and materials, sufficient human resources 
for the malaria control program and the health facilities, and cooperation of 
the general public.”22 Given the importance of financial feasibility, the MEG 
proposes that it should be considered separately, and operational feasibility 
should focus on requirements related to the implementation of all activities 
needed to achieve and maintain elimination. The operational feasibility com-
ponent thus tries to answer the questions around if and how the interven-
tions needed to achieve and sustain elimination can be implemented given 
the capacity of the national malaria program and the health system. Unlike 
technical feasibility, which is defined by the malaria epidemiology in a given 
area that does not necessarily follow administrative borders, operational (and 
financial) feasibility can only be addressed using defined regional, national, or 
subnational units. While technical feasibility is paramount in the decision to 
go for elimination or not, operational feasibility is much more dependent on 
whether a government can or is willing to meet the necessary programmatic 
requirements and to create an enabling environment to facilitate the elimina-
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tion process. If elimination is deemed technically feasible and the financial 
means and political will are available, almost anything can be done.
It is prudent to note that a variety of operational shortcomings were an 
important part of the failure of the Global Malaria Eradication Program, even 
when political commitment and financial means were available.20 Key opera-
tional issues related to “getting to zero” and “holding the line” are therefore 
discussed in detail in the later chapters. When assessing the different aspects of 
operational feasibility, it is important to keep two main questions in mind:
1. What activities are essential, and for how long, to achieve and main-
tain elimination?
2. How are these activities different from “sustained control”?
Operational feasibility is extremely context dependent, but the following 
operational requirements can be considered universal components for any 
malaria elimination program:
•	 A health system that is capable of providing near-universal access 
to high-quality diagnosis and treatment — access and quality are 
important in order to guarantee sufficient coverage and specificity 
for passive case detection. This can be achieved through both the 
private and public sector and, as discussed in the following chapter, 
might be possible even when the health system is not yet fully 
developed. In addition, this will require sufficient capacity, both 
managerial and technical, at the central or district levels.
•	 The capacity to implement a near-perfect surveillance system; to 
design and run an effective information, education, and com-
munication program; and to establish a monitoring and evaluation 
(M&E) system for measuring elimination-specific targets — the 
delivery of these key interventions is discussed in detail in the two 
following chapters. They are not unique to an elimination program 
but require either a higher level of perfection in their execution or a 
shift in focus or methods, which necessitates a careful evaluation of 
the operational implications.
•	 An enabling environment with political stability, genuine political 
buy-in and support, a legal framework adapted to the operational 
needs of elimination, good collaboration between the different 
sectors involved (e.g., immigration, education, and agriculture), 
community participation, and cross-border collaboration — all are 
important, but political stability can be considered an absolute. 
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Political support has to reach beyond high-level, politically 
motivated declarations, and it requires direct involvement of 
political leaders to make elimination a matter of national priority 
and pride. In addition, it is important that malaria elimination be 
treated as a regional and global public good, with regional initiatives 
complementing national decision-making. In many ways, the 
ideal approach for most countries would be to join the pursuit of 
a multinational elimination target, which defines the scope of a 
program based on epidemiological factors rather than arbitrary 
national borders. As such, the MEG supports the idea of broad sub-
regional or multi-country targets and collaborations as being the 
most effective approach to cross-border challenges.
Financial FeaSiBility
The efficient administration of any health program requires long-term stabil-
ity. Providers need to learn their jobs within the system, and patients need to 
learn when and where to seek care. Stability, in turn, requires adequate levels 
and continuity of financing. Malaria elimination is no exception. Where then 
will the required financing come from? The annual amounts involved may rea-
sonably be in the order of $0.25 to $25.00 per person in the population at risk 
(with the higher end ($25) being substantially more in difficult-to-reach loca-
tions [see Chapter 4 for more detail]). For middle-income and upper-income 
countries (9 of the 39 elimination countries in Table 1.2), domestic public 
financing can suffice. For the 11 low-income countries and for many of the 19 
lower-middle-income countries, external assistance will be required and must 
be assured. (Low-income countries spend only $6 to $8 per person per year on 
health through the public sector.)
Beyond the concern for adequacy of financing, malaria elimination requires 
two additional elements of financial design. First, the country must sustain 
financing after the disease has ceased to exist in the population and has there-
fore lost political salience. Second, cross-border transmission will often call for 
international financing. The magnitude of the need for cross-border financial 
arrangements will increase with the country’s importation risk. Chapter 4 pro-
poses mechanisms to sustain financing after transmission in a country has 
ceased. These mechanisms include long-term loans or grants, earmarked taxes, 
and where feasible, creation of endowments. International financing can come 
from a relatively rich eliminating country to a poorer, malarious neighboring 
country. More typically, international financing will involve support by bilat-
UCSF-Prospectus-revs.indd   13 4/22/2009   12:01:58 PM
 14  A PrOSPeC TUS On MAL ArIA eL IMInATIOn
taBle 1.2   demographic, economic, health, and aid characteristics of the 
39  elimination countries1
country po
p
u
la
ti
o
n
 
(m
ill
io
n
s)
li
fe
 e
xp
ec
ta
n
cy
  
at
 b
ir
th
 (
ye
ar
s)
g
n
i p
er
 c
ap
it
a 
(u
.S
. $
)2
h
ea
lt
h
 
ex
p
en
d
it
u
re
 p
er
 
ca
p
it
a 
(u
.S
. $
)2
pr
iv
at
e 
h
ea
lt
h
 
ex
p
en
d
it
u
re
 (
%
 
o
f 
to
ta
l h
ea
lt
h
 
ex
p
en
d
it
u
re
)
g
Fa
t
M
3  
r
9 
m
al
ar
ia
 e
lig
ib
ili
ty
 
(y
/n
)
pM
i4
 s
el
ec
te
d
 
(y
/n
)
w
o
rl
d
 B
an
k 
id
a
5  
el
ig
ib
le
 (
y/
n
)
low- incoMe econoMieS
comoros 0.6 65 650 14 47 Y n Y
haiti 9.6 61 420 28 69 Y n Y
korea (north) 23.7 66 — 14 14 Y n n
kyrgyz republic 5.2 66 450 29 60 Y n Y
Madagascar 19.7 59 290 9 38 Y Y Y
Sao tome and 
principe 0.2 61 800 49 15 Y Y6 Y
Solomon islands 0.5 67 630 28 8 Y n Y
tajikistan 6.7 64 330 18 77 Y n Y
uzbekistan 26.9 68 530 26 52 Y n Y
yemen 22.4 61 650 39 58 Y n Y
Zanzibar7 1.0 43 340 178 438 Y Y Y
lower-Middle- incoMe econoMieS
algeria 33.9 71 2,720 108 25 Y n n
armenia 3.0 69 1,470 88 67 Y n Y
azerbaijan 8.6 64 1,260 62 75 Y n Y
Bhutan 0.7 64 1,270 52 29 Y n Y
cape verde 0.5 70 1,980 114 18 Y n Y
china 1,320.0 73 1,740 81 61 Y n n
dominican republic 9.8 70 2,310 197 67 Y n n
egypt 75.5 68 1,270 78 62 Y n n
el Salvador 6.9 71 2,530 177 53 Y n n
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iraq 28.5 56 — — 26 Y n n
namibia 2.1 61 2,950 165 35 Y n n
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Sri lanka 19.9 72 1,170 51 54 Y n Y
Swaziland 1.1 42 2,210 146 36 Y n n
turkmenistan 5.0 63 1,234 156 33 Y n n
vanuatu 0.2 69 1,580 67 35 Y n Y
upper-Middle- incoMe econoMieS
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high- incoMe econoMieS
korea (South) 48.0 79 15,880 973 47 n n n
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total countries 39 
total population 2,173,020,000 
1. All data are from standard Web sources provided by the World Bank; World Health Organization; British Broadcasting 
Corporation; Central Intelligence Agency; the Global Fund to Fight AIDS, Tuberculosis and Malaria; and the Government of 
Tanzania. Data are from the most recent year available, mostly 2005-2008.
2. Atlas method (U.S. dollars): The Atlas Conversion Factor is used by the World Bank in order to facilitate cross-country 
comparisons of national income and health expenditure. The method uses the 3-year average of the local currency exchange 
rate to U.S. dollars, adjusting for inflation.
3. GFATM is the Global Fund to Fight AIDS, Tuberculosis and Malaria. r9 refers to applicant eligibility for round 9 in 2009.
4. PMI is the President’s Malaria Initiative of the U.S. Government.
5. World Bank IDA is the International Development Association.
6. Sao Tome and Principe is not among the PMI 15 focus countries but is receiving support from from the governments of Brazil 
and the USA for its elimination program.
7. Throughout this document we treat zanzibar as if it were a country, because its malaria situation and intentions are different 
from those of mainland Tanzania.
8. These data include both Tanzania and zanzibar.
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Solomon islands 0.5 67 630 28 8 Y n Y
tajikistan 6.7 64 330 18 77 Y n Y
uzbekistan 26.9 68 530 26 52 Y n Y
yemen 22.4 61 650 39 58 Y n Y
Zanzibar7 1.0 43 340 178 438 Y Y Y
lower-Middle- incoMe econoMieS
algeria 33.9 71 2,720 108 25 Y n n
armenia 3.0 69 1,470 88 67 Y n Y
azerbaijan 8.6 64 1,260 62 75 Y n Y
Bhutan 0.7 64 1,270 52 29 Y n Y
cape verde 0.5 70 1,980 114 18 Y n Y
china 1,320.0 73 1,740 81 61 Y n n
dominican republic 9.8 70 2,310 197 67 Y n n
egypt 75.5 68 1,270 78 62 Y n n
el Salvador 6.9 71 2,530 177 53 Y n n
georgia 4.4 70 1,300 123 80 Y n Y
iran 71.0 71 2,580 212 44 Y n n
iraq 28.5 56 — — 26 Y n n
namibia 2.1 61 2,950 165 35 Y n n
paraguay 6.1 75 1,230 92 64 Y n n
philippines 87.9 68 1,270 37 63 Y n n
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eral or multilateral development assistance agencies for regional cross-border 
elimination projects. 
The dynamics of malaria elimination point to the critical need for mecha-
nisms to achieve sustainable international financing. In particular, the follow-
ing considerations are important:
•	 After individuals are no longer exposed to the malaria parasite, they 
progressively lose what immunity they have acquired. The harm to a 
newly infected infant will be the same pre- and post-elimination. But 
for an adult who had acquired immunity through repeated exposure, 
and then lost it during elimination, the risk will be larger should 
malaria be reintroduced years after elimination. This biological feature 
of malaria increases the adverse consequences of reintroduction. 
Therefore, programs to eliminate malaria should ensure they maintain 
the highest levels of vigilance and the ability to respond.
•	 Elimination may have implications for drug resistance. According 
to the Global Malaria Action Plan, “sustained control increases the 
chances of resistance spreading; achieving elimination removes the 
risk of resistance.”8 Moving to elimination clearly has a potential role 
to play in containing resistance, and this has important implications 
for financial design. If drug resistance is particularly likely to occur 
in some regions (e.g., Southeast Asia), there is an important global 
public good associated with elimination. Containing resistance will 
not only place demands on sustained financing but also require 
development of appropriate international financial mechanisms.
•	 Malaria elimination is likely to shift the structures of costs and 
finances from those of a relatively independent control program to 
those of a program more fully integrated within a health system. In 
particular, it is natural to envisage shifts toward integrated vector 
control activities, multi-disease surveillance programs, and improved 
clinical management of imported malaria through generally 
strengthened clinical services. Sustaining the malaria component 
of these integrated activities may best be done by maintaining 
separate malaria elimination financing in the context of integrated 
operations.
In essence, transition to an elimination effort requires rethinking financ-
ing and, probably, adoption of new financial mechanisms. Financial feasibility 
requires institutional change as well as monetary resources. Regional or inter-
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national bodies should provide the institutional structure not only to encour-
age and assist countries in achieving elimination but also to financially reward 
countries that pursue regional targets.
1.4 | conclusion
The decision to eliminate malaria is complex and should not be made lightly, 
as the consequences of an ill-informed or wrongly motivated decision can be 
serious. In the end, it is the role of each government, with local and interna-
tional guidance as appropriate, to select and weigh the final set of factors that 
are relevant to its decision. The MEG strongly encourages countries to assess 
the technical, operational, and financial feasibility of elimination so that pol-
icy makers can make an informed choice on whether or not to pursue malaria 
elimination. Technical feasibility is a prerequisite for elimination, but certain 
aspects of operational feasibility, such as political stability, are equally impor-
tant. Financial sustainability for activities aimed at a disease that will become 
increasingly rare will be a major challenge, and many malaria-endemic coun-
tries will most probably need long-term international financial support. 
Donors and governments alike therefore need to be informed about the 
potential substantial benefits that successful and sustained elimination dis-
cussed earlier can yield. In that regard, it will be important to consider the 
investment potential of having elimination’s initial costs counterbalanced by 
a situation in which maintenance of elimination is less costly than sustaining 
high levels of control. 
It is important that malaria elimination be treated as a regional and global 
public good, with regional initiatives complementing national decision-mak-
ing. In many ways, the ideal approach for most countries would be to join the 
pursuit of a multinational elimination target, and the MEG supports the idea of 
broad regional targets and collaborations as being the most effective approach 
to cross-border challenges. The MEG encourages countries and regions to be 
ambitious in their strategic thinking but believes that honest feasibility assess-
ments followed by rigorous operational planning, in combination with novel 
approaches that guarantee sustainable financing, are key factors that will deter-
mine the success of any elimination effort.
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2 |  getting to Zero
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2.1 | introduction
This chapter considers the actions that must be taken to attain the required 
level of coverage of a range of essential interventions that are needed to inter-
rupt malaria transmission. Goals that may seem straightforward in the abstract 
often involve immense logistical and operational challenges when attempted 
among the complex realities of an elimination program. As such, this chapter 
is fundamentally about the backbone of successful elimination programs — 
sound management and strong systems. The experience of the Global Malaria 
Eradication Program (GMEP) underscores the central role of management 
and systems in getting to zero. Emilio Pampana, one of the architects of the 
1955-1978 eradication program, recognized this need in the principal man-
ual of that era: “In malaria eradication we must prevent the very last case of 
malaria. There is no such thing as a partial success. . . . Consequently no other 
public health program needs such a careful and complete planning and such 
an efficient and smooth running administration.”1
An examination of the GMEP reveals that it was the inability to meet the 
onerous management criteria that hindered many programs and was the main 
aClinton Foundation, Boston, USA; bAustralian Agency for International Development, 
Canberra, Australia; cOffice of the United Nations Secretary General’s Special Envoy for 
Malaria, New York, USA; dJohns Hopkins University Bloomberg School of Public Health, 
Department of Health, Behavior and Society, Baltimore, USA; eThe Global Health Group, 
University of California, San Francisco, and Clinton Foundation, Pretoria, South Africa; 
fClinton Foundation, Nairobi, Kenya
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Box 2 .1 | Main Messages
•	 Malaria elimination initiatives should be planned and executed in a spa-
tially progressive manner, considering goals at the subnational, national, 
regional, and supranational levels where appropriate.
•	 Countries should assess and plan activities and a sound strategy for inter-
rupting transmission and preventing reintroduction prior to embarking 
on an elimination program.
•	 Transitions between phases of the malaria program continuum from con-
trol to elimination should be based on a range of factors, including politi-
cal, economic, and epidemiological, not just on epidemiological measures.
•	 Interventions in malaria elimination programs should be carefully tar-
geted based on identification and analysis of transmission foci.
•	 Universal diagnosis is critical to elimination and can be effectively 
achieved through appropriate use of rapid diagnostic tests (rDTs) and 
microscopy as well as DnA PCr.
•	 robust passive case detection is essential to elimination. This should 
be incorporated into the basic health system as soon as appropriately 
possible.
•	 elimination initiatives should only employ large-scale active case 
detection interventions after careful analysis of feasibility and cost-
effectiveness.
•	 Cross-border collaboration and regional initiatives should be vigorously 
pursued. Where cross-border initiatives are developed, there should be 
clearly defined funding and coordinated implementation.
•	 Countries should develop a comprehensive strategy for ensuring the 
sustained commitment and engagement of key stakeholders prior to 
transitioning to an elimination program.
•	 elimination can and should be pursued even if the public health system 
is not capable of conducting all interventions, if there are other entities 
able and willing to fulfill those responsibilities.
•	 Central malaria units should be incorporated into the broader health 
structure gradually, as opposed to rapid dissolution, after the achieve-
ment of elimination, in order to prevent reintroduction.
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reason that the program failed to reach its ultimate goal of eradication. In Latin 
America, for example, stalled progress in the early 1970s was most frequently 
attributed to “serious administrative and/or operational problems,” the code 
at the time for poor leadership and management, in addition to weak systems 
and logistics.2
While Chapter 1 explores the necessary forethought that contributes to the 
decision of whether or not it is reasonable to set the goal of eliminating malaria, 
this chapter evaluates the transition that is required for a program to achieve 
that goal. We explore a number of essential components and considerations 
to ensure successful implementation, including the interface with the basic 
health system and robust surveillance. Last, we discuss the imperative of cross-
border collaboration and regional initiatives for both achieving and sustaining 
malaria elimination in mainland countries.
It is important to keep in mind that the recommendations in this chapter 
are not fixed or static. What works for one country may not work for another; 
there is no “one size fits all” approach that will work universally. The GMEP’s 
greatest flaw was attempting to apply a single approach — extensive DDT spray-
ing — across immensely diverse eco-epidemiological, socioeconomic, cultural, 
and political settings. While lessons can and should be learned from other 
countries, each program must be designed to fit the unique characteristics of 
the local environment, tailoring available tools to the specific epidemiological 
and systems settings. Recommendations in this chapter are intended to guide 
an elimination program’s decision-making process and contribute to their 
strategy to interrupt transmission.
2.2 | From control to elimination
Once a decision to pursue elimination has been made, the program must begin 
to plan and execute appropriate changes to its strategies and interventions. 
There is no defined moment when a malaria effort ceases to be a control pro-
gram and becomes an elimination program. The program continues to pursue 
many of the same activities, including vector control, case management, and 
monitoring and evaluation, and the changes in interventions are subtle, with 
shifts in the emphasis, intensity, and targeting of certain key interventions.
WHO has provided a guideline (Figure 2.1) to assist countries in defin-
ing and planning the sequence of changes in the transition from control to 
elimination.3 As shown, it recommends that countries engage first in a “pre-
elimination” phase, in which initial shifts in emphasis and capacity are made, 
before pursuing complete interruption of transmission. The decision to engage 
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in the first two transitions (the last occurs automatically when elimination is 
achieved) should be based on a range of political, economic, and epidemiologi-
cal factors (Chapter 1).
For some countries, the prevention of reintroduction will be the most chal-
lenging phase (Chapter 3). Substantial interventions may have to be sustained 
for decades in the face of constant reintroduction of parasites and public fatigue, 
and significant advance planning for this phase is an integral component of 
the elimination program. The MEG therefore strongly recommends that when 
preparing to interrupt transmission, all countries carefully assess and plan the 
measures that will be used to prevent resurgence before making the decision to 
embark on an elimination program.
All core malaria interventions must be adapted in some way in the transi-
tion from control to elimination. For some interventions, these changes will 
be relatively minor. For example, some countries may decide to initiate limited 
larviciding as part of their vector control strategies for an elimination program.4 
For other interventions, a fundamental shift in the approach or intensity of 
implementation is required. Table 2.1 summarizes those interventions and/or 
program components that must undergo the most significant change and the 
general approach required in each program phase. This list is not exhaustive 
and does not include all interventions that can be used for elimination.
Spatial targeting oF progr aMS
Malaria, like most health issues, is typically financed and controlled at the 
national level. In many areas, however, there is a strong rationale for sub-
national (e.g., a low-endemic province), supranational, or regional (e.g., an epi-
demiological zone shared among several countries) malaria elimination targets 
and programs. While WHO will only certify an entire country as malaria free, 
this should not deter countries from pursuing elimination in more-limited 
Control Pre-elimination Elimination Prevention of
reintroduction
1st program
reorientation 
2nd program
reorientation 
F i g u r e  2 .1   Major intervention transitions by program phase
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national areas or regionally. The MEG recommends that national, subnational, 
and supranational elimination targets be established as appropriate given the 
epidemiological, political, and economic realities.
One of the greatest distinctions between control and elimination efforts is 
the geographical focus of key interventions. While there may be some varia-
tion between epidemiological zones, most interventions are uniformly applied 
to the target areas during the control phase. As the caseload approaches zero, 
however, remaining transmission is increasingly restricted to specific areas, 
and more precision in the application of interventions is needed. These “foci” 
are the primary targets of the elimination program, as continued heavy invest-
ment in areas where transmission has been interrupted is not cost-effective, 
nor always necessary.5
taBle 2 .1  Major interventions needed as program phases change
activity control elimination prevention of reintroduction
intervention 
target
entire or broad areas 
of country
residual and potential 
transmission foci
Potential transmission foci and 
individual imported cases
diagnosis High reliance on 
clinical diagnosis*; 
limited quality 
assurance
All cases confirmed with 
microscopy and/or rDTs; 
robust quality assurance
All cases confirmed with 
microscopy and/or rDTs; robust 
quality assurance
private sector Diagnosis and 
treatment provided 
in private sector 
(with support from 
public sector in some 
settings)
no diagnosis or treatment 
in informal private sector; 
formal private facilities 
fully integrated into 
surveillance system
no diagnosis or treatment in 
informal private sector; formal 
private facilities fully integrated 
into surveillance system
program 
management 
and legislation
Often limited central 
capacity, including 
M&e; limited or 
no cross-sectoral 
collaboration and 
enabling legislation
Strong central capacity 
with extensive analytical 
and technical capacity; 
substantial cross-sectoral 
collaboration and relevant 
legislation
reduced or reoriented, targeted 
central capacity; potential 
additional legislation (e.g., border 
screening)
Surveillance Limited reporting 
and analysis of cases 
through passive 
system
All new cases rapidly 
reported and analyzed 
through both passive and 
active systems
Sustained, comprehensive, and 
rapid detection of new cases 
through passive system
Border measures Limited or no cross-
border initiatives
Initiatives pursued to 
dramatically reduce 
transmission in key 
neighboring areas; 
prophylaxis for travelers 
to endemic areas
Cross-border initiatives and provi-
sion of prophylaxis maintained; 
potential border screening of 
travelers from endemic areas; 
potential screening and treatment 
of migrant workers and refugees
*Clinical diagnosis should also be phased out as soon as possible in order to improve control programs. 
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Interventions should be appropriately targeted based on the characteristics 
of the foci identified. To be able to determine and target the most effective 
interventions, a program must be capable of identifying foci, which requires 
the following:
•	 accurate universal diagnosis
•	 prompt reporting of new cases
•	 active case investigation
•	 entomological surveillance
•	 detailed spatial analysis
tr aining and retr aining
The transition from control to elimination is crucially dependent on countries 
giving a high priority to a full range of malaria program and allied-staff train-
ing. These will be required for different categories, including senior and junior 
Box 2 .2 |  attacking remaining Malaria Foci in Morocco4
In the decade between 1963 and 1973, Morocco reduced the number of annual new indigenous 
malaria cases from more than 30,000 to several dozen. Local transmission of Plasmodium falciparum 
was eliminated, and continuing P. vivax transmission was contained to limited areas of the country. 
While P. vivax resurged modestly in some areas in the ensuing decades, the government of Morocco 
committed in 1999 to fully eliminating malaria from the country by 2002. To do so, it developed a 
new strategy to target and interrupt the remaining sources of transmission and limit the introduc-
tion of new cases from abroad.
The heart of the new strategy is the classification of different transmission foci throughout the 
country and the tailoring of interventions to effectively address each. Two foci with continuing trans-
mission were targeted with indoor residual spraying (IrS) and larval control, robust surveillance, 
and case management. Areas where transmission had been interrupted recently were targeted with 
a slightly less-aggressive approach to vector control (larval control only) and surveillance (once- 
instead of twice-monthly home visits). The areas where transmission has been historically present 
but where indigenous cases have not been detected in more than 15 years receive limited vector 
control and surveillance targeted only at locations with high importation risk. In this way, Morocco 
has prioritized its resources to achieve elimination. no locally transmitted case of malaria has been 
recorded in Morocco since 2004. In 2008, after more than 3 years of zero transmission, the country 
applied to WHO for certification of malaria-free status.6
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health care professionals and other program-related staff. Many countries have 
far too few people trained in the essential skills as the capacity required for 
successful elimination is developed.
Program planning from inception through to prevention of reintroduction 
requires detailed training, retraining, and supervision. The extent of this train-
ing will reflect the requirements of the whole elimination strategy and thus 
needs to be comprehensive. For training, each country would use a standard 
operational manual that would be updated as evidence and experience accrued. 
Training must be locally relevant but should be based on a model elimination 
syllabus that is then adapted by each country or region.
diagnoSiS
Effective diagnosis of all cases will require some of the most challenging changes 
for many programs. While pursuing control, most countries, even those with 
low transmission, confirm only a minority of suspected malaria cases; clinical 
diagnosis is still prevalent among health workers.7 This is not acceptable in 
an elimination program: as transmission approaches zero, all new cases must 
be confirmed and treated so that remaining transmission may be monitored. 
Achieving this will require a comprehensive set of measures across the health 
system, most of which are not in place in many countries. They include the 
following:
•	 education and communication campaigns to increase the awareness 
of signs and symptoms of malaria, the prompt seeking of treatment 
at formal health facilities, and the acceptance of diagnosis results by 
patients and health care workers
•	 provision of diagnosis and treatment free of all charges (including 
consultation fees) to all malaria patients, including those attending 
the formal private sector
•	 sufficient trained and motivated staff in primary health facilities to 
conduct diagnostic tests (either RDT or blood slide)
•	 consistent supply of high-quality diagnostics and treatment at all 
levels of the health system
•	 well-equipped laboratories with trained and motivated staff and 
adequate transport for efficient transfer of tests and results between 
facilities and labs
•	 a strong central reference laboratory and a robust quality control 
system for diagnosis conducted at all levels of the system
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•	 a solid reporting structure in place to ensure that all positive 
diagnoses are reported to the central level with requisite speed
private Sector
In many countries, a significant proportion of malaria patients seek treatment 
outside the public sector.9 In a control program, the priority is to endeavor 
to ensure that such patients will be given access to effective treatment. Some 
countries are actively supporting this through subsidies and/or other interven-
tions. In an elimination program, only the public sector and the accredited 
premium private hospitals and clinics can provide the high-quality diagnostic 
facilities required as the basis of treatment. In most cases, the often-prevalent 
informal and unaccredited sources of treatment, including small drug shops, 
cannot be expected to provide quality diagnosis and treatment or appropri-
ately report new cases to the central level.
Box 2 .3 | Selecting diagnosis tools and Strategies
Full coverage with microscopy is not feasible in some settings,8 and other 
approaches, such as use of rDTs with appropriate quality control, should be 
adopted instead. Moreover, replacement of clinical diagnosis is important, 
particularly as endemicity goes down, to avoid overestimation of malaria 
cases and wastage of drugs.
each country should carefully tailor its diagnosis strategy to the local con-
text, taking into account operational realities within the health system and 
malaria epidemiology. Potential alternative strategies to the traditional exclu-
sive focus on microscopy might include the following:
•	 microscopy used at health facilities to diagnose and confirm cases with a 
robust quality control system based on DnA PCr at national or regional 
reference laboratories
•	 rDTs used at health facilities for primary diagnosis and case management 
with microscopy at regional and national level for verification and quality 
control
•	 rDTs used at health facilities for primary diagnosis and case management 
with DnA PCr at national reference laboratories used for verification and 
quality control
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Countries that are ready to pursue elimination and that have a strong infor-
mal network of providers will need to implement a comprehensive and inno-
vative approach to incorporate these facilities into the elimination program. 
Strategies should include incentives, training, and patient-behavior change 
approaches, as well as increased regulation, accreditation, and a reliable report-
ing system to ensure that informal private activity enables the elimination 
effort rather than undermining it.
progr aM capacity
The level and intensity of interventions used in an elimination program 
require a corresponding increase in the capacity of the national program. New 
technical staff in areas such as surveillance and data management will need 
to be added, as well as more general program staff, to closely oversee and sup-
port the implementation of key interventions. It will be necessary to enroll 
Box 2 .4 | the legal Framework for elimination
Some of the key activities of an elimination program may require changes in national legislation. 
Some countries have adopted a number of legislative measures to facilitate elimination, including 
mandatory acceptance of IrS.1 The recommended specific measures that countries should consider 
fall into four broad categories, including the following:
1. mandatory implementation of certain activities by health workers and authorities, for example, 
prompt notification of cases
2. mandatory acceptance by households and private businesses of elimination measures, for 
example, vector control
3. increased regulation of private sector health providers, including potential removal of over-the-
counter antimalarial medicines
4. border control measures such as mandatory screening at ports of entry and case follow-up
Given the personal privacy and human rights implications of some of these measures, the appro-
priate legislation will have to be carefully designed and adapted to each country, taking into account 
international conventions and local legal code. In some countries, enforcing these legislative mea-
sures will be challenging. However, even if they are not fully enforceable, adopting these measures 
establishes societal norms, creates awareness, and contributes to behavior changes that will benefit 
elimination programs.
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staff at all levels of the elimination program in regular training and retraining 
programs in order for them to learn new techniques and refresh their skills. 
Performance throughout the program and the health system will also need 
to be monitored and enforced to achieve elimination. In Oman, for example, 
there is a clear performance framework in which members of the program 
are held accountable for the appropriate management of new cases and other 
outcomes.10
Much more so than in the control phase, there is also a need for the national 
program to coordinate activities with other units within the government. For 
example, the ministry of defense must ensure that interventions are appropri-
ately implemented for all military locations and personnel, while the ministry 
of immigration may need to take measures to limit the introduction of new 
cases.
2.3 | knowing the enemy: Building Strong Surveillance
Surveillance is perhaps the most important component of an elimination pro-
gram. As will be further discussed in Chapter 3, a program must be able to 
detect, investigate, and respond rapidly to every individual case of malaria in 
order to achieve and sustain zero transmission. This enables it to treat remain-
ing cases appropriately, identify and address transmission foci, and eventually 
confirm and receive certification for the achievement of elimination.11 As a 
program moves to elimination, it must invest heavily in its surveillance system 
to ensure that it meets a high standard of speed and sensitivity. A surveillance 
system is composed of three core phases:
1. collection of case data through active and passive detection methods
2. analysis and interpretation of data, including case investigation
3. appropriate response, including radical treatment and targeting 
of foci
paSSive caSe detection
A robust passive case detection system, which includes reporting of cases cap-
tured through normal patient visits to health facilities to a central team that 
carefully analyzes and tracks patterns, is the cornerstone of any approach to 
surveillance — if new malaria cases identified at health facilities are not being 
adequately reported and followed up, elimination will not be achieved. In most 
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elimination programs, the passive case detection system will have to be sub-
stantially improved to ensure that all new cases are reported to the central 
level with the requisite speed (e.g., within 24 hours, once at or near zero local 
transmission). In addition, many countries will need to strengthen their cen-
tral units that record, analyze, and mobilize responses to reported cases, which 
can involve improving skills and obtaining appropriate technology.
Key considerations for elimination programs related to the passive case 
detection system include the following:
•	 Strengthening the system will require significant and sustained 
investment in equipment, personnel, training, and communication.
•	 In some countries, it may be necessary to create a malaria-specific 
reporting system that is distinct from the core health management 
information system. However, parallel reporting systems are not 
desirable, should be used only if elimination will not be achieved 
otherwise, and should be incorporated into the basic system as soon 
as responsibly possible.
•	 While some countries have extended their passive case detection 
beyond the formal health system to community health workers, this 
approach is not recommended for elimination programs.12
active caSe detection
Prior to implementing an elimination program, most countries will be unable 
to identify a sufficient number of new cases through the health system to 
interrupt transmission and will accordingly need to employ some form of 
active case detection, or the proactive screening of certain segments of the 
population for malaria parasites. Active detection provides the distinct benefit 
of enabling treatment of asymptomatic parasite carriers, who are often a major 
source of continued transmission. Many different approaches to active detec-
tion have been used.13 Figure 2.2 shows a spectrum of active case detection 
methods that have been employed from least to most complex and resource 
intensive.14 There is currently no evidence to suggest that the approaches on 
the right end of the spectrum (i.e., mass screening) are more effective and/
or cost-effective than the more-limited measures. The MEG therefore recom-
mends that countries only adopt these measures following detailed analysis of 
feasibility and cost-effectiveness.
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analySiS and reSponSe
The surveillance system is only as useful as the response it elicits. As described 
above, strong surveillance enables the program to identify and target its inter-
ventions at residual and potential foci. To do so, the program must first under-
stand and interpret the often complex data gathered by the system. This is 
done through the following:
•	 active investigation of all new cases to determine parasite species, 
source of infection, and history and duration of illness (e.g., for 
potential P. vivax relapse)
•	 collection of relevant entomological data in targeted areas (Chapter 9)
•	 prompt analysis of both epidemiological and entomological data 
in a central elimination database, ideally with a strong geographic 
information system component
Given the constant risk of resurgence, countries will need to maintain suf-
ficient emergency stocks of key commodities, such as insecticide and medica-
tions, to rapidly respond to emerging epidemics (“epidemic preparedness and 
response”). In addition, the requisite systems must be in place nationally and 
at district level to ensure that provision of the commodities can be guaranteed 
as needed.
Intensity of implementation and resources
Brazil, Morocco,
Philippines, Taiwan
Mpumalanga
Province,
South Africa
Swaziland
(proposed)
Screening family
members and
neighbors of
new cases
Periodic (perhaps 
monthly) screening of
targeted communities
where residual 
transmission and
continuing cases
are reported 
Screening targeted
individuals near
(perhaps within 1 km)
new cases
Approach:
Examples:
F i g u r e  2 . 2   Approaches to active case detection
UCSF-Prospectus-revs.indd   30 4/22/2009   12:02:02 PM
  Getting to Zero  31
2.4 | the imperative of cross-Border collaboration
As discussed in Chapter 1, all countries that will pursue national elimina-
tion in the coming years will have to face the challenge of continued malaria 
transmission in neighboring countries. This is particularly the case for coun-
tries that share lengthy land borders, but also applies to island countries with 
multiple entry points or areas pursuing subnational elimination. Borders are 
typically porous with increasingly high levels of human traffic, not only due 
to migrant laborers but also as a consequence of social and political unrest. 
As such, unless eliminating countries can ensure a significant and sustained 
reduction in transmission in the border areas of neighboring countries, it is 
unlikely that they will be able to achieve zero local transmission.
A number of different approaches to cross-border initiatives have been pur-
sued in the past, including the following:
•	 An eliminating country, which has greater capacity and resources, 
directly implements or provides detailed support for interventions 
in the neighboring country. This approach has been followed in the 
Lubombo Spatial Development Initiative (LSDI), a highly successful 
collaboration between Mozambique, South Africa, and Swaziland 
that has reduced malaria prevalence in targeted areas by more than 
90%.15
•	 The eliminating country provides limited or remote technical and 
financial assistance to the targeted areas. An example of this is an 
intermittent collaboration between Saudi Arabia and Yemen, where 
the principal activities have included training of Yemeni staff in 
Saudi facilities.16
•	 Participating countries engage only in targeted coordination of 
policies and increased communication between their programs.17 
This is the de facto approach used by most regional initiatives.
The MEG recommends that, as much as possible, countries develop regional 
initiatives that employ the first two of these approaches.
There are substantial challenges to developing and executing successful 
cross-border initiatives. Many initiatives have been conceived and planned, 
but few have had notable impact. Drawing on lessons learned from the LSDI, 
there are a number of apparent success factors for cross-border efforts:
Political and administrative support The negotiation of cross-border 
arrangements typically needs to occur at levels above the respective 
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malaria program managers, and a clear mandate from ministers 
of health or other political leaders can greatly facilitate regional or 
cross-border operational arrangements.
Technical leadership Strong alignment of approaches and guidance on 
technical issues across the participating countries is essential to any 
cross-border initiative. For example, the LSDI is led by a regional 
malaria control commission of technical and operational experts 
from the region, which designed the initiative and guides its ongoing 
work.14
Significant and independent funding As will be discussed more in Chapter 
4, innovative financing mechanisms are required to facilitate 
regional or cross-border programs. Cross-border initiatives typically 
require substantial additional funding, and in most areas, it is 
unlikely that governments alone will devote adequate national 
resources to controlling malaria in neighboring countries. The LSDI 
has been largely financed by private sector donors, South Africa, and 
the Global Fund to Fight AIDS, Tuberculosis and Malaria.
Strong centralized management In the LSDI, the Medical Research 
Council in South Africa (MRC) has established a robust management 
structure and closely monitors and manages performance across the 
initiative in line with the accountability standards and reporting 
requirements set by its donors.
2.5 | Sustaining national political will
Although recent experience has reconfirmed that dramatic reductions in 
malaria incidence can be achieved in a short time, fully eliminating local 
transmission is a war of attrition in most settings. Finding and clearing the last 
cases and foci, particularly of P. vivax, often requires five or more years of effort, 
even in relatively conducive settings such as in Europe and the Middle East.18 
As history has consistently shown, attention, resources, and diligence cannot 
waver during this time or malaria will resurge and the gains of the preceding 
years will be lost.
Fatigue among key stakeholders, ranging from local communities and 
implementers to national politicians, is one of the greatest threats to a malaria 
elimination program. It is challenging to convince individuals to engage in 
elimination-conducive behavior, such as sleeping under insecticide-treated 
nets (ITNs), and to convince politicians from endemic countries and donors 
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to commit funds and attention once malaria is no longer a major threat. The 
MEG therefore recommends that each country develop a comprehensive strat-
egy for ensuring the sustained engagement of key actors before it launches its 
full elimination program.
Key components of the strategy to maintain national and political will 
include the following:
Secure sustained, high-level political support The highest levels of the 
government must view elimination not just as a short-term political 
benefit but as a long-term investment in the development of the 
country or region. This can be fostered through incorporation of 
elimination goals and activities into broad development strategies 
and medium-term budgets as well as consistent, well-designed 
advocacy campaigns, ideally supported by high-profile champions 
from within the government.
Build community engagement Programs will greatly benefit if com-
munities fully understand and take ownership of the elimination 
goal.19 While there has been increased attention to community-led 
malaria-control initiatives in recent years, there is little evidence 
of the impact of these approaches on a large-scale.20, 21 Appropriate 
approaches must be developed within each country and adapted to 
local community structures and cultural practices.
Target vulnerable populations In many countries, special attention will 
need to be paid to particular subgroups within the population. The 
last sources of transmission are often found among groups such 
as cultural and ethnic minorities, nomadic or forest populations, 
and/or migrant workers, which often have less contact with the 
formal health system. Ensuring the necessary participation of these 
groups in elimination interventions will often require adaptation of 
approaches to unique social, cultural, and political dynamics. The 
failure of the first elimination campaign in Mexico, for example, has 
been partly attributed to resistance among indigenous populations in 
the south of the country.19
Set expectations and promote vigilance It is important that advocacy 
efforts set appropriate expectations of the duration and benefits 
of elimination with politicians and communities. Overselling the 
program will quickly lead to disappointment and reversals.22 In 
addition, once cases begin to near zero, it is critical that the program 
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taBle 2 .2  Framework for an elimination advocacy campaign by stakeholder group1 
Stakeholder outcome Message information needs
national leaders  
(e.g., heads of state)
Commitment to 
long-term support for 
elimination
elimination will bring 
great benefits to your 
country and your 
neighbors.
Health and economic 
impact estimates; 
elimination commitments 
by neighbors
Ministry of finance Significant and long-term 
financial support
Malaria elimination 
is good for economic 
development and is 
cost-effective.
economic impact and 
cost-effectiveness 
estimates
Ministry of health Leadership of elimination 
program; appropriate 
investment in and 
management of the 
health system
eliminating malaria 
will reduce the burden 
on the health system. 
Maintaining elimination 
requires constant 
vigilance.
Detailed analysis of health 
system needs to achieve 
and sustain elimination 
local government 
leaders
effective sustained 
management of 
activities; commitment 
of local resources and 
leadership
elimination is a national 
priority that will greatly 
benefit communities 
in your area. Activities 
need to be sustained, 
or dangerous epidemics 
will occur.
Commitments by national 
and regional leaders; local 
budget and management 
needs for effective 
implementation
Business leaders In-kind and financial 
contribution to 
elimination activities
Malaria elimination is 
good for business (e.g., 
greater productivity 
and more tourism and 
investment).
economic impact 
estimates; mapping of 
opportunities for business 
contribution
donors Substantial and sustained 
funding for elimination 
program
elimination will 
contribute to health and 
economic development 
goals. elimination 
funding must be long-
term and predictable.
Inclusion of elimination 
in national development 
strategies; analysis of 
long-term financing needs 
and mechanisms for 
predictability
ngos Active participation 
in malaria elimination 
activities
elimination will save 
many lives and benefit 
communities. nGOs 
have an important role 
to play.
Mapping of opportunities 
and needs for nGO 
engagement
public Sustained engagement 
in elimination activities 
and appropriate health 
behavior
Malaria remains a 
deadly threat even once 
it has been eliminated. 
Simple examples of malaria 
resurgence from other 
countries
1. Courtesy of Dr. Matthew Lynch, Johns Hopkins Center for Communications Program 
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consistently reinforce the continued threat of resurgence and need 
for sustained investment vigilance. This can be done through 
advocacy and education campaigns (e.g., through schools), as well 
as by promoting national unity and pride in the achievement of 
elimination.
Develop robust financial arguments Many stakeholders, including 
ministries of finance and international donors, will question 
whether malaria elimination is the best use of limited resources. 
It is thus imperative that the economic case for elimination also 
be well presented. When this is done, the indirect impact of 
elimination on the health system (strengthening systems and 
reducing patient burden), foreign direct investment, and tourism 
should be considered, as should the strong arguments for considering 
elimination a regional public good (see Chapter 1).
Well-targeted and sustained advocacy and communications campaigns will 
be critical to executing strategies and achieving the objectives outlined above. 
An example of a comprehensive elimination advocacy campaign is outlined 
in Table 2.2. In most cases, it will be important for organizations other than 
the National Malaria Control Program (NMCP) to implement aspects of such 
a campaign (e.g., targeting national leaders and ministers). As such, it will be 
important for the NMCP to form strategic partnerships with NGOs and other 
organizations that can fill this important role.
2.6 |  Malaria elimination and constructive engagement 
with the health System
The strength of the basic health system is integral to elimination, and most 
countries will have to strengthen that system to achieve and sustain zero trans-
mission. However, that is not to say that a health system must be perfect for 
elimination to be achieved. Rather, the MEG recommends a careful examina-
tion of which components of an elimination program must be pursued through 
a strengthened health system and which can employ alternative approaches.
The health system is often equated with the formal, government-led public 
health infrastructure in the country. However, there is often a range of other 
organizations and facilities that provide health care and other essential ser-
vices related to malaria elimination, including private, nongovernmental, and 
faith-based organizations. In fact, elimination will only be achievable in some 
countries if these organizations play a substantial role. However, there are a 
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number of areas where government health system priorities and coordination 
are vital. These include the following:
Case management Appropriate diagnosis and treatment of patients 
presenting with fever at health facilities is essential to elimination. 
It is not feasible or effective to develop an infrastructure of human 
resources solely for primary malaria care. The health system must 
be strong enough to provide sufficient coverage and quality of case 
management, including the consistent supply of drugs and other 
commodities to the health facilities.
Surveillance and monitoring Health facilities will also be responsible for 
reporting the majority of new malaria cases to the central level. 
While a malaria-specific system may be adopted, it will need to 
build on the infrastructure of the general information system. If 
that system is weak, it is likely that malaria surveillance will also not 
reach sufficient levels of speed and accuracy, jeopardizing a rapid 
response.
Planning and coordination As already described, an elimination program 
faces significant risk of fatigue among policy makers and consequent 
financial volatility. If elimination efforts are planned and budgeted 
for “off-budget” or as isolated activities, the risks of uneven resource 
flows increase. It is therefore imperative that elimination be 
incorporated into all core planning and budgeting activities, and in 
decentralized systems, it must be part of district health plans to help 
to ensure sustainability.
Beyond these areas, it is possible, and in some cases advisable, for the pro-
gram to employ approaches that are complementary to the basic health system. 
It may be necessary, for example, to complement a weak surveillance system 
with periodic surveys, which could be conducted by a health research institu-
tion. Distribution of long-lasting insecticide-treated nets (LLINs) may be more 
efficiently achieved through the private sector or a faith-based organization. 
Opportunities for using elimination resources to build the capacity of the basic 
system should be pursued as long as they do not detract from the elimination 
goal. They can include expanding initially malaria-specific systems to support 
other diseases, as has been done with polio surveillance in some countries, 
and additional broad performance incentives for general health professionals, 
among others.23
Although the government must lead and typically implement the majority 
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of the elimination effort, the nongovernmental sectors can, as we have indi-
cated, contribute substantially in a number of key areas. These include, but are 
not limited to, the following:
Direct provision of services Some NGOs and private organizations are also 
well positioned to provide diagnosis, treatment, case management, 
and other services, particularly in remote communities. In addition, 
major businesses (e.g., tourism) with a stake in elimination can 
be used to provide services to their employees and surrounding 
communities.
Outsourcing of key functions Nongovernmental groups may be able 
to implement certain elements of an elimination program where 
government capacity or competency is weak. It may be efficient 
to outsource the implementation of complex technical functions, 
such as behavior-change communication, commodity procurement, 
and mass distribution campaigns, to private organizations that are 
particularly suited for logistically intensive functions.
Systems strengthening Others can play an important role in building 
and supporting the government’s capacity to achieve elimination, 
including by contributing additional skilled staff or implementing 
key training programs. Some organizations can also assist in essential 
advocacy and resource mobilization. However, the integration of all 
actors, private as well as public, into district planning is vital to a 
strong system.
It is typically understood that once elimination is achieved, the national 
malaria program will be disbanded and any ongoing malaria activities will 
be incorporated into the general health services.1 We question this assump-
tion. The premature dismantling of eradication programs during the 1970s 
and 1980s created many challenges for subsequent malaria control, including 
significant loss of technical staff at all levels, and contributed to resurgence 
during that period.24 Other elimination efforts, such as for Guinea worm, have 
faced similar challenges when integration has been pursued prematurely and 
resources and attention diverted away from essential activities.23 Therefore the 
eventual integration of malaria elimination activities should occur gradually 
and be carefully managed to prevent erosion of the capacity to intervene, thus 
protecting against possible resurgence of infection. For this reason, in some 
settings it may be advisable to maintain a robust, distinct national program for 
some time after transmission is initially interrupted, as was done on Taiwan.25
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3 | holding the line
Justin M. Cohen,a David L. Smith,b Andrew Vallely,c 
George Taleo,d George Malefoasi,e and Oliver Sabota
3.1 | introduction
Once elimination is achieved, the constant threats of reintroduction and 
reemergence, and thus severe morbidity and mortality, make some malaria 
control activities necessary. Prevention of transmission reemergence is an inte-
gral component of any elimination campaign and must be planned carefully 
before elimination is attempted. The risk of reintroduction after elimination is 
highly dependent upon two components:
1. the intrinsic potential for malaria transmission in the region, as 
determined by its vectors, geography, environment, and social 
factors
2. the rate at which new sources of malaria infection enter the region 
from other countries or regions where elimination has not yet been 
achieved
Even in regions with high intrinsic malaria risk, well-developed health sys-
tems and effective interventions can reduce the risk from this baseline preva-
lence, while measures such as targeted screening of immigrants can permit 
early identification and treatment. To “hold the line,” the MEG recommends 
aClinton Foundation, Boston, USA; bDepartment of Zoology and Emerging Pathogens 
Institute, University of Florida, Gainesville, USA; cPacific Malaria Initiative Support 
Centre, University of Queensland, Brisbane, Australia; dMalaria and Other Vector Borne 
Diseases, Ministry of Health, Port Vila,Vanuatu; eMinistry of Health, Honiara, Solomon 
Islands
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Box 3.1 | Main Messages
•	 Countries or regions considering elimination must make detailed assessments 
of the factors listed below to ensure the feasibility of preventing malaria 
reemergence:
1. importation risk, in terms of the number of infected individuals entering the 
country each year, in order to determine screening requirements
2. outbreak risk, in terms of the intrinsic potential for reintroduced malaria 
transmission
3. surveillance system capacity, in terms of its ability to identify, report, and 
respond to imported individual malaria cases and outbreaks
•	 Governments must commit to maintaining resources and encouraging com-
munity support for sustainable antimalarial interventions long after malaria has 
been eliminated.
•	 It may be appropriate to maintain a central unit with responsibility focused on 
malaria even after cessation of transmission, to ensure epidemic containment 
and effective case response, but these activities should be carefully integrated 
with the health system.
•	 each country needs to assess its own needs for the ongoing activities required 
to deal with outbreaks, and the potential for importation, according to the 
overall risks to which it is exposed.
•	 A coordinated multicountry regional approach to elimination will greatly reduce 
importation and outbreak risks and should strongly be considered before, dur-
ing, and after an elimination program.
•	 Screening high-risk individuals at ports of entry may help to reduce importation 
risk, but implementation and cost-effectiveness are important considerations. 
Key factors that determine whether port screening is likely to be cost-effective 
include the expected prevalence of infection in these individuals; the volume of 
travelers; and the importation risk, surveillance, and case response capabilities 
of the country to prevent missed cases from developing into epidemics.
•	 eliminating vectors is generally not recommended as a strategy for preventing 
reemergence of malaria, although controlling receptivity through sustained, 
targeted indoor residual spraying (IrS), or net use may be appropriate.
•	 Maintaining a strong surveillance and outbreak response system is essential for 
containing infections before they can spark epidemics.
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interventions tailored to the specifics of a region or 
country, which should include guarding against the 
introduction of malaria parasites (to lower the importa-
tion risk) and preventing the spread of such parasites 
should they be introduced (to lower outbreak risk). The 
ability to identify and respond quickly to introduced 
cases must be maintained through strong surveillance 
and outbreak response capacity.
Many countries have successfully eliminated malaria 
and have instituted sound surveillance programs and 
policies that hold the line, and they have been able to 
respond effectively to limited reintroduction. By con-
trast, as funding for the Global Malaria Eradication 
Program (GMEP) began to wane, malaria reemerged in 
other countries that had come close to zero but had not 
adequately prepared for surveillance and sustained vigi-
lance.1 Examples of the occurrence of epidemics include, 
in diverse settings, Sri Lanka (1968-1969),2 Madagascar 
(1986-1988),3 and more recently, Azerbaijan, Tajikistan, 
and Turkey.4 After insecticide spraying stopped or 
was scaled back in these areas, the vector populations 
recovered, resulting in high rates of transmission and 
thus severe malaria and mortality due to the waning of 
immunity.
Reaching zero is not the end of malaria; countries 
or regions must shift focus from eliminating internal 
transmission to preventing reemergence from external 
sources, whether from bordering nations or neighbor-
ing regions in which malaria is still endemic. In other 
words, planning for malaria elimination must consider 
not only how to get to zero but the equally challenging 
task of staying there; tactics for prevention of reemer-
gence should be treated as integral components of the 
overall elimination strategy, and many of the same 
approaches adopted to reach zero may successfully be 
maintained to hold the line.
Planning for elimination is based, in part, on the 
quantitative concepts of outbreak risk and importation 
risk (Chapter 1). After elimination is achieved, these 
kazakhstan
achieved elimination: 1980s
Malaria recurred: 1991-1996
contributing cause: Weakened 
health system; increased  migration 
(e.g., of soldiers from endemic areas)
South korea
achieved elimination: 1979
Malaria recurred: 1993
contributing cause: Introduction 
of parasites and vectors from north 
Korea
Mauritius
achieved elimination: 1973
Malaria recurred: 1975–1976
contributing cause: Increased 
migrant labor from endemic areas
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concepts remain highly relevant. The WHO certification of malaria elimina-
tion is awarded after 3 years of continued absence of locally acquired cases, 
but malaria can still return years later. Preventing reemergence of malaria will 
rely upon a combination of keeping outbreak risk low through maintenance of 
good health systems, minimizing importation risk, and maintaining a strong 
surveillance system to monitor and catch cases that do appear. The combina-
tion of a region’s outbreak risk and importation risk produces a measure called 
the malariogenic potential, which can be considered an indication of the over-
all risk that malaria will return.
Despite the widely recognized importance of malariogenic potential, there 
are no standardized measures for defining levels of outbreak risk or importation 
risk in any given geographical setting.7 In the future, mathematical models will 
play an important role in helping to define quantitative thresholds of accept-
ability (Box 3.2). Any model will require detailed data on the epidemiologi-
cal and entomological situation in a given country; collecting specific metrics, 
including age-specific parasite prevalence, vector density, human biting rate, 
Box 3.2 | Modeling outbreak risk
Initial efforts to define outbreak risk semi-quantitatively have been described in Italy5 and more 
recently in southern France (below)6 using detailed entomological transmission risk maps based 
on meteorological data. Such methods may be useful in assessing risk in places where malaria has 
already been eliminated and in monitoring and evaluating malariogenic potential in countries con-
sidering elimination.
0
0 - 0.01
0.01 - 0.1
0.1 - 1
>=1
0 10 20 Kilometers
N
F i g u r e  3 .1   Spatial variations 
in P. falciparum transmission risk 
estimate (ranging from 0 to greater 
than 1) in August in the Camargue. 
Corresponding calculations for P. vivax 
showed a much higher risk of outbreaks 
occurring at this time of year (from 
Ponçon et al.6).
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entomological inoculation rates, and other parameters at geo-referenced loca-
tions, will help in defining malaria risk. This information can then be used to 
make maps to inform operations, to identify ongoing transmission foci or hot 
spots, and to focus elimination efforts.
Collection of this information is something some countries could undertake 
now. Even without these data, planning for elimination can still proceed while 
the capacity to obtain detailed risk information is gradually improving.
In the example cited in Box 3.2, the outbreak risk is quite high in certain 
regions of the Camargue during August; however, the overall malariogenic 
potential will remain low if there is little importation risk occurring in those 
areas where outbreak risk is high. In this situation, and also when importation 
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F i g u r e  3 . 2   An example of how the measures required to prevent reintroduction will vary according to 
relative levels of outbreak risk and importation risk. Specific interventions must be appropriate to country 
contexts.
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risk is high but outbreak risk low, it is possible to hold the line (Figure 3.2). In 
places with high importation risk and high outbreak risk, multiple sustained 
approaches and interventions will be required if malaria reintroduction is to be 
avoided. To hold the line, countries must reduce their malariogenic potential 
to a level that ensures a low risk of reintroduction. Again, there are no absolute 
standards for defining a low level of risk.
The MEG recommends careful analysis of the outbreak risk and importation 
risk of a particular region to help determine the relative emphasis that must be 
placed on different sorts of post-elimination interventions.
3.2 | Management and implementation
Holding the line, like the campaign to get to zero, will necessitate a combination 
of strong commitment and effective management and leadership. Additionally, 
the national or regional health system will need to be sufficiently robust to per-
mit timely identification and treatment of all new malaria cases to prevent an 
outbreak. Maintaining sufficient political will and capacity to sustain interven-
tion against an invisible opponent will be a difficult task. Historical examples 
of countries that nearly eliminated malaria, only to suffer severe resurgences 
when control activities were stopped, illustrate the hazard in not maintaining 
disease-specific efforts after successful gains have been made.
The MEG recommends that countries attempting to hold the line consider 
maintaining a central malaria program in some form, integrated into the health 
system, to ensure sustainability of outbreak risk and importation risk-lowering 
interventions, as well as rapid and effective case management and epidemic 
containment (see Chapter 2).
Proactive planning is necessary to ensure that national commitment to 
malaria elimination does not end with achievement of zero transmission. 
Getting to zero requires an intensive campaign with defined resources, while 
holding the line needs an unbounded commitment to continue malaria pre-
vention activities until malaria is completely eradicated. As a result, it is impor-
tant to note that considerable financial resources may be required to maintain 
antimalarial operations even after elimination has been achieved (Chapter 4).
The MEG recommends that governments must commit to maintaining 
resources and encouraging community support for sustainable antimalarial 
interventions, even long after malaria has been eliminated.
As long as malaria remains endemic elsewhere, preventing its reintroduction 
requires strong political commitment, active community support, and in many 
cases, untiring interventions for reducing outbreak risk and importation risk.
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Approaches that may help maintain such steadfastness include:
•	 community awareness campaigns, such as periodic “malaria 
day” reminders of the great economic and health advantages of 
preventing the potentially devastating reintroduction of malaria
•	 maintenance of small malaria-specific programs, or a multipurpose 
program with specific malaria expertise, to ensure vigilance in areas 
Box 3.3 | the importance of Maintaining interventions
In the central highlands of Madagascar, a combination of DDT spraying, IrS, and case detection 
and treatment successfully prevented reemergence of malaria from 1960 until cessation of control 
activities in 1980. At that time, the government halted spraying in the highlands, since the lack of 
malaria seemed to indicate that such activities were no longer necessary. With the discontinuation 
of spraying, Anopheles funestus gradually became firmly reestablished in rice field breeding habitats, 
and this, coupled with the migration of gametocyte-positive individuals from malaria-endemic low-
land areas, resulted in an explosive malaria epidemic among a then-nonimmune highlands popula-
tion in the late 1980s, causing an estimated 40,000 deaths over 5 years.3 Although this example 
is of resurgence in a country that had not yet achieved elimination, it emphasizes that holding the 
line against reintroduction within a country is often deeply challenging and requires aggressive and 
sustained intervention.
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with high malariogenic potential or weak health systems, even years 
after the perception of a threat from malaria has vanished
•	 establishment of innovative financing schemes to ensure that 
domestic and international resources are set aside for post-
elimination antimalarial vigilance
Because a country’s or region’s importation risk and outbreak risk may change 
over time, assessments of these indicators must also be dynamic. Such a need 
Box 3.4 | Sociopolitical upheaval can Spark reemergence
In Tajikistan, malaria transmission had been reduced to very low levels by the 1980s, although occa-
sional seasonal cases still occurred. The situation deteriorated in the 1990s. What changed? Altered 
agricultural practices associated with the introduction of rice crop irrigation significantly increased 
outbreak risk by creating favorable breeding habitats for local competent malaria vectors (A. superpic-
tus, A. pulcherrimus, and A. maculipennis).9 At the same time, armed conflict, civil unrest, and adverse 
economic conditions led to large population movements across the border with Afghanistan, where 
2 to 3 million people are thought to have been infected in epidemics during the mid-1990s. Finally, 
malaria control in Tajikistan was disrupted during the 1992-1997 civil war. Although this example is 
of resurgence in a country that had not yet achieved elimination, it illustrates a central challenge that 
some eliminating countries will face as they attempt to hold the line.
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is especially important when development, agriculture, or conflict may cause 
significant changes in vector habitat or the risk of imported malaria. In areas 
undergoing major sociopolitical upheaval, rapid and simultaneous changes in 
importation risk and outbreak risk can result in resurgent malaria that quickly 
overwhelms available resources. For example, several countries of the former 
Soviet Union, notably Azerbaijan and Tajikistan, have experienced significant 
epidemics since indigenous transmission was reestablished in the 1990s.4,11,12
3.3 | importation risk
As discussed in Chapter 1, importation risk, also known as vulnerability, mea-
sures the rate at which infected and infectious mosquitoes or humans come 
into a region each year. Importation risk can be conceived of on a national 
scale, but it is also a useful concept for malaria elimination within parts of 
countries, such as the Philippines, where spatially progressive malaria elimina-
tion is occurring province by province.
Malaria is constantly being imported and exported around the globe, a fact 
that was brought into sharp relief after eastern Africa imported chloroquine-
resistant parasites from Southeast Asia, and as chloroquine resistance spread 
throughout the world from a few focal points of origin.13 In areas with high 
levels of transmission, importing malaria is a minor public health concern, 
except, as in eastern Africa, when the imported parasites are much more dif-
ficult to treat. As local transmission is reduced, imported malaria becomes a 
higher priority, and after malaria has been eliminated from a region, importa-
tion risk increases to the point where it is of utmost concern. Movement of 
parasites is facilitated by migration of their mosquito and human hosts, and we 
consider each of these cases separately.
Mosquitoes typically fly only short distances, but they occasionally travel or 
get blown much farther, and they can be transported accidentally in the cargo 
holds of airplanes or in containers on ships. The risk of importing malaria over 
long distances is real, but a second issue is that countries can import a new 
vector species and dramatically increase their importation risk. Brazil imported 
the efficient African vector A. arabiensis in 1930, sparking a severe outbreak. 
In that case, the epidemic was stopped by eliminating the vector, albeit with 
great difficulty, but malaria persisted. The geographical spread of sub – Saharan 
African vectors north of the Sahara and the spread of efficient vectors to neigh-
boring countries are important concerns, especially when those countries have 
eliminated malaria. These risks highlight the need for vector vigilance.
In almost all cases, human introduction of parasites, rather than acciden-
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tal transportation of mosquito species, is chiefly to blame in countries where 
malaria has resurged. Asymptomatic malaria infections in humans can last 
months, and humans can fly around the world in a few days and cross national 
borders in an afternoon. Given the numbers of people who move across bor-
ders, human movement is the most important component of importation 
risk. Malaria can be introduced by soldiers, journalists, diplomats, or others 
who are returning home from foreign service; tourists who have recently vis-
ited malaria-endemic areas; migrant labor populations; nomadic populations 
migrating across borders; people with ethnic or tribal affiliations across arbi-
trarily drawn political borders; or refugees escaping political instability in their 
home countries. Quantifying all of these rates is a daunting task.
Certain travelers, however, are likely to be at much higher risk of transporting 
parasites than others. Poor migrant workers traveling overland from endemic 
countries are substantially more likely to harbor parasites than wealthy tour-
ists on prophylaxis or business travelers arriving from nonendemic regions by 
plane and residing primarily in air-conditioned hotels. As a result, the magni-
tude of importation risk will be affected greatly by the endemicity in regions 
surrounding the borders of a country, as well as the socioeconomic status of 
the people in those regions. Elimination may be a tenuous, short-term victory 
for a nation bordering a poor, highly endemic country, especially if substantial 
migration occurs across porous borders.
One part of importation risk can be estimated by taking the product of the 
immigration rate and malaria endemicity in the immigrants’ country of origin. 
This multiplication provides a first-order approximation that can be built upon 
for planning or comparison purposes. Other more comprehensive assessments 
of importation risk can be made by sectors of the government that are not typi-
cally included in malaria planning, such as the department of immigration.
The MEG recommends a comprehensive evaluation of migration into the 
region in which malaria is to be eliminated, in order to estimate overall vulner-
ability and to identify groups at particularly high risk.
Important considerations include the following:
•	 the magnitude of immigration rates
•	 the likelihood that migrants carry malaria
•	 the parasite species carried (e.g., P. vivax may be more difficult to 
detect and uproot)
•	 where migrants settle (e.g., many immigrants arrive in urban areas, 
where malaria transmission rates tend to be low, though this is not 
always so in poor and expanding peri-urban areas)
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Although risk of reintroduction of malaria transmission will be driven by 
gametocyte carriers from malaria-endemic areas, in many cases the events 
necessary to spark a malaria outbreak will not occur despite the entry of an 
infected individual — that person may not be bitten by an anopheline mos-
quito during his or her time in the malaria-free country, or that mosquito may 
not survive long enough to transmit again. However, each additional case of 
imported malaria introduces the risk that all of these events will happen and 
that transmission will occur. There is, then, an urgent need to locate and treat 
the primary and secondary cases in order to stop the development of an out-
break. Knowing the rate of migration by potentially infected individuals from 
endemic regions allows a possibility to reduce importation risk. Two principal 
means of reducing importation risk should be evaluated:
1. Identify infected individuals and treat them promptly, ideally before 
entry, before they can infect competent local vectors and lead to 
secondary cases and sustained foci of indigenous transmission.5, 12
2. Address the source of infection directly by reducing transmission in 
the regions that are the primary sources of infected travelers.
identiFying inFected individualS and treating 
theM proMptly
Screening with malaria RDTs or microscopy at port of entry and/or point of 
departure and providing follow-up treatment of infected individuals may play 
an important role in reducing the number of imported cases and outbreaks. 
For example, all individuals entering the island of Aneityum in Vanuatu have 
a blood smear at the point of entry with same-day testing and treatment, as 
Box 3.5 | Screening travelers to Mauritius
In Mauritius, which has had no indigenous malaria transmission for a decade 
despite still having competent vectors, all visitors arriving from endemic 
countries are registered at the port of entry, and their names and addresses 
are recorded for follow-up by health surveillance officers. These officers may 
take a blood sample for screening, and private-sector doctors are also encour-
aged to take blood smears from those with suspected malaria cases. These 
measures have identified between 35 and 63 imported cases of malaria each 
year since 2000.
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appropriate. When migration rates are high, efforts should focus on screen-
ing high-risk groups, such as migrant laborers from endemic regions. Large 
influxes of laborers for agriculture or mining are a well-known source of 
imported malaria. As demonstrated in Table 3.1, targeted screening and treat-
ing of high-risk populations has been an effective tool for decreasing vulner-
ability in certain regions.
Countries generally adopt different border-entry procedures for their own 
citizens; in developed countries, citizens returning from malaria-endemic 
countries represent a dominant source of imported malaria. Citizens who plan 
to visit malaria-endemic countries should be encouraged to take prophylaxis 
while traveling and continue prophylaxis to control early-stage infections that 
appear after returning home. As malaria disappears from a country, doctors 
will tend to overlook malaria, so it is worth reminding doctors that they, too, 
need to remain vigilant and to ask patients whether they have been traveling 
and, if so, where.
Establishing effective internal border control measures to reduce the move-
ment of malaria within a country is a particular challenge when planning to 
stage spatially progressive elimination (e.g., province by province). Legal and 
ethical acceptability must be considered carefully. In addition, screening inter-
nal migration may be an enormous burden for a country already fully engaged 
with preventing introduction of malaria parasites from external sources; for 
example, uncontrolled internal migration was a major factor in the resurgence 
of malaria within Indian states, such as Kerala, during the GMEP. However, 
when geographically feasible, countries pursuing spatially progressive elimina-
tion should monitor movement within their own borders just as if they were 
reducing reimportation from a neighboring country. Generally, the problems 
of staged progressive elimination are more difficult for large contiguous coun-
tries like India than for multi-island nations like the Philippines, where inter-
nal migration is more easily screened.
table 3.1 | Some examples of key populations that could be screened
Source region Migrant group destination region
Mozambique Migrant sugar laborers Swaziland
Malaria-endemic regions of Burundi refugees from civil war violence Highlands region of Burundi
Colombian nonendemic regions nonimmune agricultural 
workers
Colombia’s malaria-endemic 
naya basin
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In resource-poor settings, it is unclear how much countries should rely on 
malaria screening at international ports of entry. Border screening can be costly 
and can entail direct monetary requirements, such as paying for RDT procure-
ment and the human resources needed to conduct the tests, and nonmonetary 
costs, including the inconvenience to the individuals being screened. Some of 
these costs can be passed on to immigrants, but such charges will also increase 
the incentives to bypass official border crossings.
The MEG recommends that countries conduct effectiveness and cost-
 effectiveness analyses to determine whether and where screening measures 
should be implemented.
Total costs must be weighed against the potential benefits to determine 
the cost-effectiveness of screening programs. The following points should be 
considered:
1. Screening groups of travelers at very low risk of malaria infection 
will prove inefficient because a large number of individuals will need 
to be tested to find a single positive case.
2. Border screening is unlikely to be cost-effective in settings with 
high immigration rates but low importation risk, as large numbers 
of malaria-free individuals will have to be screened to find the few 
cases, as in the first point.
3. For a test with a given sensitivity and specificity, positive predictive 
value (PV+, which indicates the probability that infection is truly 
present) will be lower if the population being screened has a low 
prevalence of infection (Figure 3.5).
4. The specificity of the screening test should be considered to ensure 
an acceptable rate of false negative results. In some cases, combining 
two tests — one highly specific and the other highly sensitive — may 
be appropriate.
5. The costs of screening can be reduced by focusing on high-risk 
groups, with calculations depending upon existing levels of out-
break risk and the capabilities for strong surveillance and outbreak 
response.
It is important to balance screening with other measures. For example, in 
the case of overland migration across a porous border, countries should increase 
the level of vigilance at the clinics in regions where migrants are likely to settle. 
The farms, mines, or other regions drawing migrant workers from endemic 
countries, for example, should be closely scrutinized for imported cases. If 
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screening is inherently inefficient, it may be more effective to focus resources 
on surveillance and outbreak risk reduction measures. There is no hard and fast 
rule for determining how valuable screening will be, but as a rule of thumb, 
the higher the malariogenic potential, the greater the need for all measures, 
including screening.
reducing tr anSMiSSion in Source regionS
Risk of infection for a given migrant is dependent upon the endemicity of 
malaria in the region from which he or she travels. Oman, for example, 
reported importing less malaria after Zanzibar, a source of many travelers, 
controlled malaria with artemisinin-based combination therapy (ACT) and 
IRS and therefore greatly decreased transmission rates. Similarly, the burden 
of malaria in South Africa was reduced after Mozambique improved control of 
malaria. In resource-poor areas that share a border with endemic regions, zero 
transmission is unlikely to be sustainable without significant investment in 
cross-border initiatives. In addition, importation risk will increase if malaria 
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and specificity) increases as prevalence of infection increases in the population. At 
lower prevalence, a smaller fraction of positive test results is actually due to infections. 
Among groups of people crossing borders, overall prevalence rates may be low, so 
assessment of particularly high-prevalence subgroups will facilitate a more specific 
and cost-effective screening program.
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interventions falter or weaken in countries connected by national borders or 
immigration routes, emphasizing that countries have an interest in not only 
achieving control in neighboring countries but also sustaining it.
Importation risk is thus, to some extent, a factor that can be modified by 
coordinating national and international malaria control programs. Regional 
benefits of malaria control through transnational initiatives are what justify 
spatially progressive approaches to elimination.
The MEG recommends working with neighboring countries and those from 
which migrants originate whenever possible, to reduce importation risk.
Working with neighbors to reduce malaria in a multi-country region will 
increase the sustainability of malaria elimination. Because malaria control has 
regional implications for the public good, it should be incorporated into the 
international financing of malaria control (Chapter 4). Contributing resources 
to ensure sustained reductions in malaria in neighboring countries may prove 
to be a cost-effective investment toward preventing reintroduction following 
elimination.
3.4 | outbreak risk
Outbreak risk, also known as receptivity, is essentially a measure of potential 
transmissibility that takes into account the two components described below:
1. the intrinsic potential for malaria transmission, as determined by 
the vectors and by geographic, environmental, and social factors 
(Chapter 7)
2. the interventions that reduce potential transmission from this 
baseline, including IRS, long-lasting insecticide-treated nets (LLINs), 
and well-developed health systems that treat malaria promptly with 
effective antimalarial drugs such as ACTs
The MEG recommends assessing intrinsic potential for malaria transmission 
to determine the need for maintaining interventions that lower outbreak risk.
Assessing potential transmission is important because many places in the 
world have suitable vectors and a history of malaria transmission. Some long-
term changes in the intrinsic potential for transmission come about naturally 
as a consequence of socioeconomic growth, environmental modification, and 
climate change (Table 3.2).
The effect on malaria transmission of interventions to achieve elimination is 
discussed in Chapter 7. In planning for elimination, it is important to evaluate 
whether it will be necessary to sustain high coverage levels of nets and spraying 
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even after reaching zero. Given that such operations will likely have been vital 
to the success of interrupting transmission, maintaining them should create an 
environment hostile to reemergence.
In countries where baseline outbreak risk is low, it will not be necessary to 
continue specific interventions to reduce outbreak risk further. The decision 
to maintain intervention coverage will depend upon the overall malariogenic 
potential: if baseline suitability for transmission or importation risk (or both) is 
high, reducing outbreak risk will be necessary to diminish reemergence risk to 
an acceptable level (Figure 3.2). At present, it is difficult to prescribe precisely 
what level of outbreak risk is “acceptable.”
Outbreak-risk-reducing activities in a post-elimination region may involve 
regular and targeted vector control in previously persistent transmission foci 
identified during the elimination campaign:
•	 Regions in which final cases persisted before elimination are very 
likely to be the same regions in which risk of resurgent malaria is 
highest.
•	 New transmission foci may be identified by factors such as the 
influx of a large population of migrant workers or changes in the 
environment and geography.
In some cases, distribution of insecticide-treated nets (ITNs) may be war-
ranted to ensure that outbreak risk does not return to baseline levels, while in 
other cases, larviciding and/or environmental management may be appropri-
ate to control key vector breeding sites (Chapter 9).
In cases where analysis of outbreak risk and importation risk indicate the 
need to continue activities that lower outbreak risk, the MEG recommends that 
table 3.2 | Factors affecting outbreak risk
Factors increasing outbreak risk Factors decreasing outbreak risk
evolution of vector resistance to insecticides or parasite 
resistance to antimalarial drugs
economic development
Increased poverty and deteriorating living conditions High-quality housing, screened windows
Increased agriculture or other land-cover/land-use 
changes (which may also decrease potential)
Paved streets, with gutters to improve drainage
Civil strife Increased urbanization
 
UCSF-Prospectus-revs.indd   55 4/22/2009   12:02:06 PM
 56  A PrOSPeC TUS On MAL ArIA eL IMInATIOn
such interventions should be conducted in a spatially targeted way that con-
centrates on previously identified foci.
Some countries have eliminated or come close to eliminating locally impor-
tant anopheline vectors as part of their malaria campaigns, but the persistence 
of suitable breeding habitats and failure of malaria vigilance systems have 
allowed vectors to reestablish and create a suitable environment for malaria to 
reemerge. In some cases, the vectors have returned decades after malaria trans-
mission was first interrupted. Countries where malaria parasites have been 
eradicated but where competent mosquito vectors remain — such as Australia,15 
France,6 Italy,5 Mauritius,16 Réunion,17 and Singapore (and nearly every elimi-
nating country shown in Figure 1.1)18 — can be said to exist in a state of “anoph-
elism without malaria.” Rather than attempt to further diminish outbreak 
risk, such countries have focused largely on ensuring that importation risk is 
minimized. Due to the proven resiliency of anopheline species, only in spe-
cial circumstances should complete elimination of the vector be considered. In 
other areas, sustainable mosquito control measures may succeed in reducing 
anopheline levels and thus decreasing outbreak risk.
3.5 |  Surveillance: From case detection to case 
investigation and response
Effective surveillance, efficient contact tracing, and aggressive response may be 
able to compensate for some weaknesses in other programs that reduce impor-
tation risk and outbreak risk. Surveillance for malaria in a region where malaria 
has been eliminated for a considerable time is somewhat facilitated by the loss 
of immunity in the population, because infections are more likely to manifest 
clinically, rather than remain asymptomatic. There is some hope of controlling 
outbreaks, even in areas with high outbreak risk, because of the length of time 
required for parasites to develop in the mosquito and in the human.
Even in the case of a country where the probability of local transmission 
is low, a strong and effective surveillance system (Figure 3.6) will be essential 
for ensuring the continued sustainability of malaria elimination, as long as 
humans and mosquitoes continue to cross borders freely:
Passive case detection Surveillance begins by examining a high fraction 
of people with suspicious fevers who show up at the clinic, either 
with microscopy or RDTs.
Active case detection Some transmission may have already occurred, 
whether or not the person in question was the index case; serological 
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sampling of individuals in the surrounding area can help define the 
history of infection, and increased testing for malaria in incident 
fevers may identify other malaria infections.
Case investigation When malaria is detected inside a country, follow-up 
procedures should be established. A history of travel should be 
taken to ascertain the source of the case — did the person travel to a 
malaria-endemic country? A travel history can also help to identify 
other places where malaria may have spread. 
Response If there is any evidence of transmission, mass spraying 
with insecticides can help to reduce the reservoir of malaria in the 
adult vector population and reduce the level of immediate risk; 
identification and focal elimination of local breeding sites may also 
prove useful. Enhanced vigilance for malaria should continue for 
several months.
Surveillance for very rare occurrences of malaria is unlikely to succeed if it 
is conducted as a vertical system. Preventing isolated malaria cases from flar-
ing into epidemics or endemic transmission requires identifying cases as they 
occur and ensuring that further transmission is prevented. In Oman, for exam-
ple, strong interaction with the community encourages reporting of malaria 
cases even among illegal immigrants who might generally fear contact with 
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F i g u r e  3 . 6   Components of the surveillance and response safety net. Most 
surveillance activities should be integrated into the public health system.
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government agencies. Those cases can then be investigated. Case investigation 
is likely to be a cornerstone of post-elimination malaria programs, since main-
taining a strong surveillance and treatment system is essential for containing 
infections before they can spark epidemics. Countries should be prepared to 
respond to imported malaria, regardless of the precautions taken to prevent it.
The MEG recommends that malaria surveillance needs to be integrated into 
the public health system for it to succeed.
It is also recommended that, until malaria is finally eradicated, every coun-
try should develop a case response plan with appropriate human capital and 
resource capacity to hold the line.
Following identification of malaria cases, screening of people in the sur-
rounding area should be paired with rapid, targeted vector control to diminish 
the probability of local transmission. Because any infected individuals must be 
treated promptly, it is essential to maintain sufficient stockpiles of effective ACTs. 
These ACT stocks must be monitored, old drugs must be replaced as they expire, 
and an appropriate mix of pediatric and adult dosages must remain on hand.
3.6 | conclusion
As long as malaria exists, countries free of transmission must be prepared to 
hold the line against reintroduction. Every country will have its own set of 
challenges to overcome in order to do so. This risk of reemergence must be 
Box 3.6 | post-elimination Surveillance in action
In the United States, around 1,000 to 1,500 cases of malaria are reported to the Centers for Disease 
Control and Prevention (CDC) annually, the great majority of which are imported cases among trav-
elers and visitors from malaria-endemic regions. Although the United States received certification 
of malaria eradication in 1969, there have been 20 cases of probable local transmission reported to 
the CDC since 1992. The CDC’s national Malaria Surveillance System collects information on cases 
reported by state health departments, laboratories, and health care providers, using a standardized 
form, and the CDC maintains a hotline to assist health departments in confirming malaria diagnoses 
with microscopy, serology, or PCr. Following identification of malaria cases in 2003, there were 
300,000 residents living in the same county as identified cases who were urged to use prevention 
measures through telephoned warnings, while other residents were warned through mailing of 
informational postcards and posting of flyers. Additionally, enhanced mosquito spraying was imple-
mented within a 3-mile radius of the homes of the malaria patients.
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weighed against a country’s surveillance and outbreak response capabilities. 
Assessing reemergence risk will require a careful assessment of importation 
risk and outbreak risk; ideally, an initial assessment should be conducted as a 
part of planning for malaria elimination. National malaria elimination pro-
grams should also develop surveillance to collect data about outbreak risk and 
importation risk, including historical patterns of endemicity and a record of 
imported malaria cases that have been investigated. Countries should weigh 
the value of reducing outbreak risk or importation risk. As a general rule, wher-
ever the intrinsic potential for transmission is high, a combination of the fol-
lowing will be required to reduce the malariogenic potential:
•	 border screening to reduce importation risk
•	 ongoing malaria control to reduce outbreak risk
•	 rapid and robust response to identified cases
As malaria control succeeds in surrounding countries, importation risk 
will decline, but the need for vigilance will remain until malaria has been 
eradicated.
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4.1 | introduction
This chapter returns to the discussion of the economics and financing of 
malaria elimination that was introduced in Chapter 1. Elimination lies at one 
end of a continuum that spans intensive control of highly endemic malaria 
and goes through sustained control of modest levels of malaria to elimination 
(and sustaining elimination) of local transmission. Control of highly endemic 
malaria can bring major health gains with modest cost and, indeed, is among 
the most cost-effective of all available health intervention areas.1 The objec-
tives of moving from sustained control to elimination include, but also go well 
beyond, further reduction of morbidity and mortality. Chapter 1 discussed this 
broader range of objectives, which include improving the climate for foreign 
direct investment and tourism, contributing to the regional and global malaria 
elimination agenda, creating a sense of national accomplishment from closing 
the books on a major health problem, and engaging in a process that will in 
all likelihood strengthen both the public health and clinical care systems of a 
country. 
In this chapter, we turn to two related and more specific issues concern-
aUniversity of California, San Francisco, USA; bOffice of the United Nations Secretary 
General’s Special Envoy for Malaria, New York, USA; c The Boston Consulting Group, 
San Francisco, USA; dThe Global Health Group, University of California, San Francisco, 
USA; eInstitute for Health Metrics and Evaluation, University of Washington, Seattle, 
USA; fThe Boston Consulting Group, Boston, USA
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ing the financing of elimination. The chapter correspondingly divides into 
two parts. The first part of the chapter explores the case where maintaining 
elimination may actually cost less than sustaining control and, therefore, be in 
some sense self-financing. The second part addresses standard issues of financ-
ing: where will the money come from, and how should particular problems 
associated with elimination, such as its long-term characteristics and frequent 
cross-border interrelations, affect the design of financial mechanisms and 
institutions?
To explore the idea that elimination may be self-financing in some cases, 
we analyzed plans for malaria elimination efforts in the Jiangsu and Hainan 
provinces of China, and in Swaziland. For these locales we estimated current 
malaria control spending, the anticipated costs of elimination, and the sav-
ings from reduced malaria control activities that are expected to accrue after 
Box 4.1 | Main Messages
•	 Countries considering elimination may wish to estimate carefully and compare the long-term 
costs of sustaining high levels of control versus eliminating. elimination costs will likely be high 
during the drive to stop transmission; they may then become substantially lower during the 
subsequent period of holding the line at zero local transmission.
•	 In some countries, perhaps in a majority, the annual cost of sustained control will exceed the 
annual cost of sustaining elimination. This chapter presents a simple approach to allow such 
countries to estimate an approximate internal rate of return (Irr) for elimination efforts. If the 
Irr exceeds 3%, elimination is almost certainly something a country should seriously consider 
independently of other benefits, which may themselves be substantial.
•	 In order to ensure sustained funding after elimination and to avoid resurgence, donors will 
need to work with endemic countries to develop innovative financing mechanisms that ensure 
long-term funding and restrict the use of these funds to malaria. endemic countries may also 
benefit from collaborating to seek funding for activities that are implemented across borders or 
regionally.
•	 A systematic evidence base on elimination economics should be developed: actual costs and 
financing should be formally documented in settings where elimination is now being under-
taken or has recently been accomplished. This will increase data for elimination planning, and 
it may identify ways to reduce elimination costs, making it more economically attractive and 
sustainable.
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elimination. The reader may reasonably question the general relevance of the 
examples from China and Swaziland. We use them in this chapter because 
they are the only detailed comparisons between the cost of elimination and 
the cost of sustained control that we have available at this time. However, simi-
lar detailed costing exercises are being worked on in a variety of other settings, 
including Mauritius, Morocco, and the Philippines. We will learn much from 
these cost comparisons, as they take place in very different epidemiological 
and ecological settings. This information will be posted on the MEG Web site 
as soon as it is available. Meanwhile, Section 4.2 presents results that we feel 
span a reasonable range of the circumstances likely to be encountered.
During an elimination campaign, when malaria transmission no longer 
poses a serious threat, donors or national treasuries may lose interest or redi-
rect their funds to other pressing issues. This reduction in support may lead to 
a significant risk of resurgent malaria. Thus, financing mechanisms to ensure 
sustainability require two key features: stability and predictability. In Section 
4.3 we explore financing mechanisms to help ensure an effective long-term 
strategy to prevent reemergence once malaria has been eliminated. Stable 
control efforts are essential to avoid backsliding, and thus to yield optimal 
health and financial dividends. The potential net savings referred to above and 
analyzed below require that malaria-elimination-related activities be sustained 
over years and decades, by definition in the absence of local malaria cases. The 
understandable tendency to redirect funds to more obvious health needs will 
need to be resisted. This challenge suggests the requirement for financial strate-
gies that effectively isolate and protect funds for maintenance of malaria elimi-
nation. We explore four potential funding mechanisms, consider evidence of 
their use from other global health funding, and describe the pros and cons 
of each for sustained malaria elimination. First, however, we explore the pos-
sibility that malaria elimination may be cost-reducing and hence potentially 
self-financing.
4.2 | when will elimination Be cost-reducing?
We review the anticipated costs of malaria control and elimination and then 
present more specific analyses of the anticipated costs and savings associated 
with malaria elimination in two provinces in China, and then in Swaziland. 
While these three case studies are unique, they highlight the sorts of analyses 
that individual countries and regions could conduct when contemplating a 
strategy of elimination.
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coStS oF Mal aria control
Roll Back Malaria’s Global Malaria Action Plan provides estimates of the long-
term costs for the control and elimination of malaria. Over the near future, 
control costs are likely to total $6 to $7 billion per year. Figure 4.1 illustrates 
the types of resources required for both control and elimination programs. 
In higher-burden countries, the bulk of spending is dedicated to commodi-
ties (health products in the figure) such as bed nets, insecticides, and drugs. 
In lower-burden settings, the balance shifts toward human resources, as 
Azerbaijan’s allocation shows. During and after elimination, surveillance and 
response costs will dominate. As discussed below, long-term costs are likely to 
decline due to decreasing need in many environments. This is because there 
will be only imported cases, a few relapsing and lingering infections, and lower 
and more-geographically-constrained risk. There may also be efficiencies asso-
ciated with integration into national health services.
1.  Includes technical assistance, procurement and supply chain costs, communication materials, monitoring and evaluation, and overhead. Program costs are not directly related to 
commodities but to general support of malaria program.  Adapted from: Global Fund applications.
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The costs of malaria elimination are less studied. Estimates from the Global 
Malaria Eradication Program in the 1950s and 1960s suggest a cost ranging 
between $0.50 and $2.00 per person per year, or $3 to $13 per person per 
year in today’s dollars. More reliable and up-to-date are the estimated costs for 
elimination in countries or regions that are currently embarked on elimination 
and have made detailed Global Fund proposals (generally 5 years in length) to 
support their costs, though it is not assured that elimination will occur within 
the period of the proposal. Six such estimates are available:
•	 For Hainan Island, China, the annual costs of elimination are 
estimated to be $0.25 per person for the whole population of 
Hainan, and $2 per person at risk.
•	 For Sao Tome and Principe, the annual costs of elimination are 
estimated to be $11 per person.
•	 For the Solomon Islands and Vanuatu, the annual costs of 
elimination are estimated to be $18 and $25 per person, respectively.
•	 For Sri Lanka, the annual costs of elimination are estimated to be $1 
per person for all Sri Lankans, and $5 per Sri Lankan at risk.
•	 For Swaziland, the annual costs of elimination are estimated to be $3 
per person for all Swazis, and $7 per person at risk.
An important caveat about these cost data is that they relate to the costs of 
achieving elimination, rather than the costs of maintaining it once achieved. 
We know very little about the latter topic, and the collection of better cost data, 
both pre-elimination and post-elimination, is a high priority for operational 
research.
Caution is also needed in interpreting elimination cost differences among 
countries, since the costing exercises do not all include the same activities. For 
example, the costs for the Solomon Islands and Vanuatu include significant 
support for the malaria component of the routine health services and external 
management and technical assistance, both provided by the Pacific Malaria 
Initiative Support Centre in Brisbane. The costs for Swaziland, by contrast, 
include neither routine health service contributions to malaria elimination nor 
technical support from partner organizations.
Costs also vary widely depending on local circumstances. The high costs in 
the Solomon Islands and Vanuatu are linked to the logistic challenges of pro-
viding sustained services to small populations on remote islands. Differences 
in cost structures, particularly in the labor markets, between the different 
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Box 4.2 |  projected cost Savings from Malaria elimination  
in Jiangsu, china
The MeG obtained data on current control and anticipated incremental elimination costs from 
Jiangsu health officials, based on ministry of health expenditures and budgets (national, provin-
cial, and local), as well as Global Fund proposals. The current and projected elimination costs are 
divided functionally, allowing us to understand spending in four broad categories that we believe 
will respond differently to successful elimination efforts: surveillance, treatment, prevention, and 
program management. The analysis explores the costs of elimination versus sustained control over 
20 years, accounting for future savings due to reduced malaria control costs. It includes an examina-
tion of the implications of imported malaria cases for potential reductions in control costs.
Jiangsu is a central province considering elimination. In 2007, there were 940 reported malaria 
cases, all Plasmodum vivax, in a population of 73 million (0.129 per 10,000). Underreporting is esti-
mated at 4.5-fold, suggesting 4,230 actual cases per year. These internal cases include those that 
are imported. Jiangsu would expect to achieve elimination by 8 years from the formal beginning of 
its program. This goal is reflected in our longitudinal analysis.
In the longitudinal analysis, we tried two approaches to estimate savings in malaria control 
costs. First, we relied on the expert opinion of officials we interviewed regarding the scale of efforts 
required to achieve sustained control in the long term. Second, we used an algorithmic approach. We 
assumed that malaria control cost savings (e.g., decreased need for prevention) reflect the reduction 
in cases and that different types of costs may be differentially sensitive to these case reductions. For 
example, a 90% reduction in cases might correspond to a 90% reduction in treatment costs. The 
model allowed us to explore the effect on results of different quantitative values for assumptions. 
The two analysis methods yield very different results for Jiangsu (although rather similar estimates 
for Hainan).
Imported malaria cases are important to overall costs and to potential savings. To explore the 
effect of imported cases, we incorporated two parameters in the analysis. First, we specified a 0-to-1 
scale that represents the severity of the border problem. In this scale, 0 designates no border cases 
and 1 designates a very severe border problem. roughly, the score reflects the proportion of current 
cases due to border crossing. Second, we specified how the border problem affects the sensitivity 
of control costs to the reduction in cases. For example, a value of 0.3 for surveillance means that a 
border problem of a severity equal to 1 results in an added 30% surveillance cost (as compared with 
the start of the elimination phase); border problems of lesser severity lead to proportionally lower 
additions to costs. The model allows the effect on results of different input values to be explored.
The over-time analysis explores how elimination might affect total malaria control costs over 20 
years. We compare current ongoing costs (i.e., ongoing sustained control) with the added costs and 
subsequent savings from elimination. This presents a more inclusive, and thus likely more realistic, 
assessment of the net costs of elimination than a shorter-term analysis.
For Jiangsu, the longitudinal result appears attractive. The reason is that the anticipated incre-
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mental cost of elimination is small in relation to current control costs. Jiangsu officials estimate $6.5 
million in annual incremental elimination costs, as compared with $9.1 million in annual sustained-
control costs (71% more).
After year 5, we assume that the sensitivity of each cost category decreases. For example, with no 
border effects, we assume that treatment costs are 100% sensitive (1.0) to case counts and that pre-
vention is fairly (80%) sensitive to case counts after 5 years once elimination is nearly achieved (0.8).
The extent of importation risk affects this sensitivity. If migrants largely originate from nonendemic 
areas, as is the case on Hainan Island, we would assume that importation risk is low at 0.05. On the 
other hand, Jiangsu is a mainland province that borders the higher-endemic province of Anhui. With 
this greater importation risk for Jiangsu, we use a value of 0.25 so the final sensitivities are lower.
The result for Jiangsu is presented in Figure 4.2. The undiscounted cumulative costs for elimina-
tion are $161 million over 20 years, versus $182 million for sustained control. The undiscounted 
cost lines cross at 14 years, a short period for reaching total cost savings. If control costs following 
elimination are $4 million, as discussed by Jiangsu officials (lower than our algorithm-based estimate 
of $6.2 million), then the lines cross after only 9.5 years.
The scale of the border problem affects the internal rate of return for Jiangsu. If we increase the 
border problem scale from 0.25 to 0.4, based on the estimate that 40% of current cases are being 
imported, the lines cross at 18 years. If we decrease the border problem scale from 0.25 to 0.05, 
based on a sharp reduction in imported cases, the lines cross at only 11 years.
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economies will also have a large effect on elimination costs. We return later to 
more detail on Hainan and Swaziland costs.
eliMination aS a potentially coSt-reducing inveStMent
While prevention and treatment costs in highly endemic areas are generally 
very cost-effective, elimination presents different economic issues. First, elim-
ination is contemplated only in situations with relatively few malaria cases. 
Thus, new strategies are likely to yield relatively few malaria cases or deaths 
averted when compared with the same strategies in high-burden settings. 
On the other hand, elimination offers the prospect of significant savings in 
future malaria control costs. Successful elimination would reduce treatment 
costs, as only imported cases would require treatment. Elimination would also 
potentially lead to a large reduction in prevention-related costs, as interven-
tion measures are confined to restricted geographic areas such as entry ports 
and border zones. In some cases, therefore, pursuing elimination may “pay 
for itself.”
We conducted a preliminary analysis of planned malaria elimination in 
Jiangsu and Hainan provinces, China, and in the southern African country 
of Swaziland. Our goal was to explore long-term costs versus savings, focusing 
on a 20-year time horizon.2 To provide a sense of the data sources available for 
these studies, and the nature of the results, Box 4.2 summarizes the MEG’s case 
study for Jiangsu, China.
the internal r ate oF return on eliMination inveStMentS
Box 4.2 provides a flavor of the complex considerations that underpin cost 
projections either of sustaining control or of moving toward elimination. A 
background paper for the Prospectus2 provides more detail on that example 
from Jiangsu, China, and on additional examples from Hainan, China, and 
Swaziland. The next step involves calculating internal rates of return (IRRs) 
to provide an argument in favor of investment in elimination when the long-
term annual costs of sustained control exceed the long-term annual costs of 
elimination.
The three cost flows and two ratios that are essential to understanding the 
financial attractiveness of elimination are shown in Table 4.1. The table also 
provides estimated values of these numbers for Hainan, Jiangsu, and Swaziland. 
The flows include the cost of maintaining the status quo (C), the cost of the 
transition to interrupted transmission (T), and the cost of maintaining elimi-
nation (E). The table defines these terms and expresses the values in millions of 
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U.S. dollars per year for the three cost streams. Two ratios that are defined give 
annual elimination costs (e) as a fraction of sustained control costs, e = T / C, and 
long-term annual cost savings (s) also as a fraction of sustained control costs, 
s = (C  – E) / C. Here e provides a sense of the cost of the elimination investment, 
and s provides a sense of its financial returns. The case of Swaziland is instruc-
tive here: the planned long-term costs of elimination exceed those of control, 
and hence s, the savings, is negative. To reiterate a point made in Chapter 1 
and earlier in this chapter, a negative s in no way suggests that elimination is 
not worthwhile. However, it does imply that the full range of benefits must be 
assessed and that the effort may not be “cost-reducing” over time.
Given e, elimination costs, and s, the savings, and then using the methods 
outlined in Box 4.3, a calculation of an internal rate of return shows an ulti-
mately cost-saving elimination investment. Figure 4.3 presents IRRs for a range 
of values of e and s. It shows, as would be expected, that IRR values will increase 
for a given cost (e) as the value of the cost savings (s) increases. The figure also 
places Hainan and Jiangsu results into the larger range of possibilities. This 
figure serves as a working tool for others to use in estimating IRRs.
In conclusion, we observe that Hainan, Jiangsu, and Swaziland span the 
continuum of possible outcomes for assessing whether elimination is self-
financing: For Swaziland, the result is clearly negative. For Jiangsu, the IRR (at 
10%) is sufficiently high to justify elimination by itself. For Hainan, elimina-
tion is ultimately cost-reducing, but the relatively low IRR of 3% suggests the 
need for careful assessment of the benefits to Hainan before a decision is made 
taBle 4 .1 | estimated costs of eliminating malaria in three locales
 
cost parameter
hainan island, 
china
Jiangsu 
province, china
 
Swaziland
C = cost of sustaining high level of control  
(U.S. $ millions per year)
2.9 9.1 0.7
T = transition cost of getting to zero  
(U.S. $ millions per year for 5 years, averaged)
5.8 13.9 2.4
E = annual cost of sustaining elimination  
(holding the line) (U.S. $ millions per year)
2.4 6.13 1.25
e = elimination cost ratio, i.e., cost of elimination 
phase as a fraction of sustaining control = T / C
2.0 1.53 3.43
s = annual cost savings as a fraction of cost of 
sustained control (cost savings ratio) = (C – e) / C
0.17 0.33 –0.79a
a(i.e., increasing by 79%)
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Box 4.3  the Simple algebra of rate of return
Investments entail giving up resources now to attain more resources later. An 
investment of $100 that yields $200 in 10 years is said to have a rate of return 
of 7.2% because $100 invested with 7.2% per year compound interest will yield 
$200 after 10 years. Alternatively phrased, the “present value” of $200 ten years 
from now at 7.2% per year is $100. The concept generalizes to circumstances 
when costs and benefits are spread over multiple years. Investing in malaria 
elimination will sometimes yield financial savings, in the sense that the annual 
costs of maintaining sustained control can exceed the annual costs of maintain-
ing elimination. During the transition period of getting local transmission to 
zero, costs will exceed those of sustained control. The present value of these 
excess costs over a period of years, assumed for purposes of this example to be 
5 years, can be viewed as an investment. If the ongoing cost of holding the line 
(maintaining elimination) falls below that of sustained control (after the 5-year 
investment period), then there will be a return on the investment that is equal to 
the difference between those numbers each year. Again, there will be a present 
value of benefits that is the sum of the present values in each year. 
The present values of costs and benefits vary with the interest rate. A com-
mon figure of merit for investments is the Irr, that is, the interest rate that 
equalizes the present value of costs and of benefits. In these calculations we 
assume that the benefits continue unchanged over an extended period. In real-
ity, because of changes in economic levels, the level of malaria in neighbors, 
or the effectiveness of available control measures, both costs and benefits will 
change with time. If the numbers are known, the change is easy to incorporate 
into the analysis. The results presented in this Prospectus, however, should be 
viewed as a first approximation, as suggestive rather than definitive. 
With this as background, the following equations yield the results we have 
used for this Prospectus. 
Let
PVC(r) = present value of costs, given an interest rate of r
PVB(r) = present value of benefits, given an interest rate of r
C = annual costs of sustained control
T = annual costs of transition to elimination
e = annual costs of maintaining elimination
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Then the present value formula gives the following:
(1) PVC(r) = Σ4t=0  (T–C)/(1+r)t
(2) PVB(r) = Σt=100t=5  (C–E)/(1+r)t
equation (1) assumes costs remain constant for the first 5 years, and equation (2) 
assumes benefits last until year 100. (The results vary little whether the assump-
tion is 100 or 60 or 40.) Table 4.1 gives values—based on planning exercises—
for T, e, and C for Hainan, Jiangsu, and Swaziland.
Given T, e, and C for a country, it is possible to calculate the Irr for the elimi-
nation investment by solving for the value of r that makes equation (1) equal 
equation (2). As discussed in the text, for example, Hainan Island’s Irr is about 
3.6%.
F i g u r e  4 . 3   Internal rates of return for investing in malaria elimination 
(from Kahn et al. background paper2) 
N OT E :  These are cost estimates prepared for planning purposes and, as such, 
do not directly reflect historical experience with costs. The background paper 
by Kahn et al.2 describes sources and makes estimates of the sensitivity of the 
results to the underlying assumptions.
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to undertake elimination. Once these analyses have been done, financing is 
the next logical need to discuss. 
4.3 | Financing Malaria elimination
introduction  —  the need For SuStained Financing
Once the costs have been established pertaining to sustained control or pursu-
ing elimination, finding sustainable funding for the long term is the next chal-
lenge. First we will look at historical patterns of country-level, international 
health financing. Then, current opportunities for regional malaria initiatives 
will be explored.
Continuing control efforts for a disease that no longer causes significant 
morbidity or mortality is a challenge in that such efforts may lead to fatigue, 
lapsed funding, and then attenuation of control efforts. In addition, the effec-
tiveness and cost of sustaining elimination within a country often depend 
on actions taken beyond its borders. These issues are essential to take into 
account when thinking about long-term and international financing. Figure 
4.4 provides concrete examples of the volatility of donor support to health, an 
essential component of malaria funding for low-income countries considering 
elimination. The volatility is perhaps more important today than during previ-
ous elimination efforts, as many of the countries that are considering elimina-
tion today are largely dependent on official development assistance (ODA) for 
health sector spending. The specific implications of this deserve further study 
and attention, as halting elimination efforts after they begin could result in 
significant rebounds in morbidity and mortality.
Successful malaria elimination programs can thus have a downside: reduced 
incidence results in diminishing awareness and, potentially, a correspond-
ing loss of funding to sustain control efforts. Ongoing, high-volume control 
efforts likewise lead to decreased political salience. Resurgence of malaria in 
previously low-transmission areas is often blamed on such factors as insecti-
cide resistance or supply shortages, yet many of these proximal causes may 
ultimately stem from decreases in funding and attention for malaria programs. 
In the past, rising donor fatigue within the international community led to 
a reduction in commitment at the same time that countries, impatient with 
lengthy elimination or eradication processes, reduced funding or shifted it 
to other programs. In many countries, indoor residual spraying (IRS) activi-
ties were the first item to be scaled back; there is a direct link found between 
donor fatigue and demise of the IRS program.3 In India, the resurgence of 
UCSF-Prospectus-revs.indd   72 4/22/2009   12:02:10 PM
  Financing Elimination  73
malaria in the late 1960s may have been the result of this deterioration of vec-
tor control.
Governments with limited health budgets also shifted funds away from 
drug supplies and surveillance activities, resulting in poor detection and treat-
ment in addition to weak program management and supervision.4 Failing 
financial support contributed to staffing shortages in India: key positions were 
left unstaffed, creating a shortage of technical and operational guidance. At 
the same time, urban municipalities endured gaps in financing, leading to an 
increase in urban cases and the creation of urban foci of transmission that 
may have paved the way for the resurgence.5 The continuation of funding and 
support might have ensured proper control and management, thereby prevent-
ing or minimizing the resurgence experienced by many countries. Large-scale 
morbidity and mortality might have been prevented.
Research support for development of new insecticides and drugs was like-
wise limited after 1963 when international funding was dwindling. This down-
ward trend discouraged young scientists from pursuing studies on malaria, 
and as a result, research and development stagnated.5 With the deterioration 
of financial support of these essential efforts in the fight against malaria, the 
momentum generated by the elimination and eradication campaigns quickly 
ground to a halt. Meeting the challenge of sustaining financing thus remains 
a priority for countries considering elimination. The lessons from the Global 
Donor commitments for health, 1997 to 2001
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Malaria Eradication Program relay the importance of sustaining financing over 
the long term to prevent the climate for a resurgence of the disease and the 
resulting morbidity and mortality.
Considering this history of fluctuating support, it is important to recognize 
that lower income countries will require external assistance for elimination that 
has a long-term and consistent commitment. This funding must be maintained 
even after malaria is eliminated and the focus moves toward preventing reintro-
duction. Yet, as we have seen, donor support can fluctuate in ways that complicate 
and even paralyze the management of a long-term intervention. This is a particu-
lar risk when working with diffuse and hypothetical benefits, as with malaria 
elimination: The risk of bounce-back is significant. Financing for elimination 
that is sustained over the long term is the only way to ensure that the benefits of 
elimination will evolve, and these methods are explored in more detail below.
Consistent financing is also important for regional elimination efforts, and 
different financing options are available to partners of this type of strategy. 
First, in a small number of cases, a country on one side of the border will be rel-
atively high-income and could, if it chose, finance cross-border control efforts 
for both countries out of its own budget. Second, neighboring countries can 
receive donor funding individually and then collaborate across their borders. A 
third option is for countries to form a regional consortium and apply together 
to the Global Fund or other sources of international financing. For example, 
the four eliminating countries in southern Africa could join forces, create links 
with their northern neighbors (the E8 countries), and write a regional applica-
tion to strengthen the necessary structures to ensure cross-country coordina-
tion and effective implementation on the border areas. Typically this would 
also include some elimination work within their borders. Whether funds are 
sought regionally or nationally, strong multi-country and cross-border col-
laboration and coordination will greatly facilitate elimination in continental 
countries with malarious neighbors. To date, it has been relatively difficult to 
find donor resources for regional or cross-border efforts, as most health ODA 
channels consider the country the basic unit of lending or granting.
Financial MechaniSMS
Financing mechanisms to ensure sustainability require two key features: a 
secure source of funds and the ability to restrict use of those funds to ongoing 
malaria control. By secure we mean stable and predictable, not subject to wide 
fluctuations. Table 4.2 summarizes several mechanisms that have the potential 
to meet these requirements. These are then further discussed below.
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Long-Term Official Development Assistance ODA can entail the prospective com-
mitment for one or more decades of foreign aid dedicated to a specific pur-
pose. This approach is similar to current health assistance efforts, and it dif-
fers fundamentally only in duration. A well-known and successful example 
is the Onchocerciasis Control Program (OCP), which was launched in 1974 
and, at its peak, covered 30 million people in 11 countries. Funding was 
planned for 20 years and was divided into 6-year phases. Continuation was 
conditional on performance.6 Another example is substantial funding by the 
Bill and Melinda Gates Foundation for the Global Alliance for Vaccines and 
Immunization (GAVI). These long-term commitments allow time for rollout of 
ambitious health initiatives and can be tailored to them. However, they may 
be more appropriate for activities with an anticipated end date than for post-
elimination malaria control of uncertain duration. They may also be subject 
to competing priorities at the funder level.
Long-term ODA may be a very suitable option for regionally implemented 
programs.
taBle 4 .2 | Four examples of long-term funding mechanisms for elimination
Mechanism (source) pros cons
very long-term external 
assistance (from standard 
donors such as bilateral 
and multilateral agencies, 
foundations)
•	 Funder	is	committed	to	specified	
purpose; funds are not lost to 
local competing priorities.
•	 Funding	is	flexible	and	can	
support cross-border efforts and 
adjust amount or structure as 
needed. 
•	 Funds	rely	on	external	funder	
(are not internally sustaining).
•	 Funder	may	face	competing	
priorities for other diseases/
countries.
•	 Funds	are	time	limited.
domestic earmarked tax 
(tapping national tax base)
•	 Funds	are	substantial	if	based	on	
large transaction base.
•	 Income	can	be	retained	in	
earmarked funds.
•	 Taxed	parties	resist.
•	 Earmarked	funds	may	be	
reassigned due to competing 
priorities.
trust fund (from standard 
donors, foundations, 
domestic taxes for middle-
income countries)
•	 Funds	are	very	substantial	if	they	
tap global capital markets.
•	 Spending	can	be	tightly	restricted	
by charter.
•	 Funds	can	support	cross-border	
efforts.
•	 If	funds	are	from	bonds,	
donors must commit to 
repayment.
•	 Funds	are	inflexible	if	
conditions change.
endowment (from private or 
public sources)
•	 Annual	funds	are	predictable	if	
endowment is stable.
•	 Spending	can	be	tightly	restricted	
by charter.
•	 Annual	spending	is	limited,	
does not tap principal.
•	 Funds	may	be	inflexible	if	
conditions change.
•	 Donor	comfort	level	with	
endowments is often low.
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Earmarked Taxes Earmarked taxes are special taxes, often levied on a single 
type of transaction, to generate funds for a designated public purpose. They are 
designed to be simple to administer in that they are added on to an existing 
tax mechanism. By being proportionally very small, they do not substantially 
distort commercial transactions, yet they are substantial in magnitude through 
application to a large transaction base. In the United States, a “black lung” tax 
on private companies funds medical care for pneumoconiosis. Another recent 
successful example is the Solidarity Tax on aircraft tickets used to support 
UNITAID, which purchases drugs for the developing world.7-10 Funds can be 
retained in special funds. Challenges include potential opposition from taxed 
parties and a fund’s vulnerability to competing priorities if earmarking does 
not fully shield it. However, general taxes used for health are typically more 
vulnerable than earmarked taxes.11
Trust Funds and Endowments Trust funds are financial reserves dedicated to a 
specific purpose, both present and future. They are funded mainly up-front 
with initial investments, rather than pay-as-you-go taxes. Funding can derive 
from taxes but can also tap into other mechanisms, such as international 
capital markets. A very successful recent example is the International Finance 
Facility for Immunisation (IFFIm). IFFIm sells bonds on capital markets, with 
the repayment obligation falling to participating European bilateral donors.12 
Bhutan provides another example of a health trust fund to which government 
and donors contribute. Ethiopia has also taken a trust fund approach, using 
a Millennium Development Goals Trust Fund to secure multi-donor commit-
ments to procure essential health commodities, including malaria control 
commodities. This mechanism permits initial investments, such as would be 
required to achieve malaria elimination, and also protects a portion of funds 
as needed for future activities. If chartered appropriately, the trust fund can 
protect funds for specific uses.
Endowments are similar to trust funds, except that annual spending is often 
limited to interest on the principal. The stock market crash of 2008, however, 
underscored the vulnerability of endowments to asset price fluctuations unless 
funds have been very conservatively invested.
Private Sector Dedicated Funds Corporate initiatives can assist with malaria elim-
ination in two separate ways. An excellent example is (PRODUCT)RED, which 
has generated over $120 million for the Global Fund through regular contribu-
tions from sales of participating products. A related philanthropic approach is 
the use of credit cards for which a small percentage of all billing is contributed 
to a public fund, as with the American Express RED card.
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Box 4.4 |  corporate Financing of Malaria control Foci in 
ghana and South africa
In low-income countries, where a domestic program budget is likely to be insufficient 
for elimination and where donor funding may prove unreliable, industries such as min-
ing and tourism provide examples of supplemental private funding sources that pro-
vide mutual benefit to a company and the local population. Two examples come from 
Ghana and South Africa.
In 2004 and 2005, malaria was considered to be the “most significant health threat” 
to the operations of AngloGold Ashanti Limited in the Obuasi gold mine in the southwest 
of Ghana.13 The workforce suffered a prevalence rate of over 20%, leading to between 
2,600 and 3,900 sick days annually. Available domestic resources were not sufficient to 
make a difference, and productivity declined. In response, AngloGold Ashanti initiated 
an integrated malaria control program in 2006 that included scientific studies as well 
as IrS, larviciding, case management, and surveillance. Costs for the first year were an 
estimated $1.7 million, with an annual budget of $1.3 million in the following years. This 
program yielded a 73% decline in less than 2 years, drastically reducing absenteeism 
and increasing productivity in the mine. AngloGold Ashanti plans to expand the malaria 
program into three other mines in the southwest of Ghana, in addition to programs in 
Guinea, Mali, and Tanzania. Their commitment to malaria provides a model for private 
sector participation when the national budget is unable to foot the bill.
The tourism industry is also directly affected by malaria. In South Africa, tourism 
brings an estimated 8.45 billion international dollars every year into the country.14 In 
the Lubombo region, a popular destination for international tourists, malaria is “identi-
fied as the primary impediment to the effective development of the high potential 
Lubombo tourism area.” In response, the Business Trust, the government of South 
Africa, the Global Fund, and other donors co-funded a regional malaria control pro-
gram, the Lubombo Spatial Development Initiative, or LSDI, in 1999.15 Seventy percent 
of funding for LSDI is from the private sector (Chapter 2).
The results of the intervention are substantial: in the 1999-2000 season, when inci-
dence reached 42,395 cases in the Kwazulu natal province alone, 89% of tourism 
operators felt that malaria was a detriment to the industry, and 53% had cancellations 
because of malaria concerns.16 In contrast, from 2002 to 2003, only 42% of operators 
believed malaria to be a detriment to their profits and 9% recorded cancellations due 
to malaria. In the interests of tourism, private companies have worked with government 
programs to control malaria, driving down transmission rates and increasing revenue 
in the region.
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A separate motivation for corporate involvement reflects the importance of 
malaria control for conducting business. Box 4.4 describes two successful cases 
of private sector involvement in implementation of control efforts, as well as 
their financing. While corporate interest offers no promise for carrying a major 
fraction of the financial burden, in some circumstances such contributions will 
be significant. Further, if corporations execute their investments efficiently, 
they can provide a useful model for other companies (Box 4.4). In this way, 
there are potential mechanisms to create long-term financial structures for 
malaria elimination. Donor support is available for low-income countries, but 
knowledge of the funding volatility over the years can make a good idea seem 
precarious. A thorough investigation and evaluation of the funding sources 
and methods to secure funding (listed above) is essential before getting down 
to the business of elimination.
4.4 | conclusions
1. Estimating three categories of costs can help inform the elimination 
decision. The categories comprise the following:
•	 annual costs of sustaining control at a high level
•	 the investment (or transition) cost of going from sustained control 
to zero local transmission
•	 the annual costs of holding the line at zero local transmission
The Prospectus presents three sets of estimates of planned costs in 
these categories, and the MEG has initiated case studies to expand the 
knowledge base.
2. For two of the three costing case studies reported in this Prospectus  — 
from Hainan and Jiangsu, China — long-term elimination costs lay 
below those of sustained control. These cases lead to the calcula-
tion of an internal rate of return of elimination as a cost-reducing 
investment. Even if long-term costs of elimination exceed those of 
sustained control, as they did for our case study from Swaziland, 
benefits may well exceed costs for elimination. The value of rate-
of-return assessments, however, lies in findings of rates of return 
sufficiently high — greater than 3%, say — to justify elimination even 
in the absence of assessed benefits.
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3. Financing elimination has two unusual challenges:
•	 The time horizon may exceed a quarter of a century, leading to 
“elimination fatigue” on the part of voters and donors.
•	 Cross-border externalities and global public good point to the 
need for coordinated multi-country financing.
4. To address these particular financing problems, several less-
 frequently used financial instruments should be considered to 
complement general revenue taxes and standard forms of foreign aid:
•	 very long-term ODA (conditional on performance)
•	 earmarked taxes
•	 trust funds
•	 endowments
5. Alongside exploring financial solutions to the elimination efforts, it 
would also be useful to concurrently explore political solutions. Most 
elimination financing is likely to come from traditional channels, 
and long-term political commitment — at donor and endemic country 
level — may be the most powerful driver of all.
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5 | underStanding Malaria
Michelle S. Hsiang,a Claire Panosian,b and Grant Dorseyc
5.1 | introduction
In the 20th century, malaria caused 150 million to 300 million deaths, account-
ing for 2% to 5% of all deaths throughout the world. Today, malaria is curable 
and preventable, yet cases still number roughly 250 million worldwide, result-
ing in at least 1 million deaths each year.1 Many wonder why so many people 
are still affected by malaria. The answer lies in the complex interplay of bio-
logical, sociological, and economic factors.
5.2 | Basic Biology
Malaria infection and illness start when a single-celled parasite of the genus 
Plasmodium invades the human bloodstream. Typically, four species of 
Plasmodium infect humans: P. falciparum, P. vivax, P. ovale, and P. malariae; in 
Southeast Asia, P. knowlesi, a simian species, has also caused human illness. P. 
falciparum, which predominates in Africa, and P. vivax, which predominates in 
Asia and the Americas, produce the largest burden of disease.
More than 70 species of female mosquitoes of the genus Anopheles trans-
mit human malaria. Of these, the greatest threat is Anopheles gambiae s.s. This 
African species is the world’s leading vector for P. falciparum because it is long-
lived and transmits with great efficiency.2 Unlike some other malaria vectors, 
aThe Global Health Group, University of California, San Francisco, USA; bDepartment of 
Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA; 
cDepartment of Medicine, University of California, San Francisco, USA
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which may seek blood from other animal hosts, A. gambiae may take 90% to 
100% of its blood meals from humans. To describe other malaria vectors is 
beyond the scope of this chapter; however, it should be stressed that detailed 
knowledge of unique characteristics (e.g., density, biting behavior, resting 
behavior, sensitivity to interventions) of local malaria vectors is necessary for 
programs to achieve and maintain malaria elimination (Chapter 9).
The survival of the malaria parasite depends on the proximity of anopheline 
mosquitoes. Figure 5.1 demonstrates the life cycle of the parasite. The infected 
female mosquito injects motile parasites, known as sporozoites, into the vic-
tim’s bloodstream while taking a blood meal. Within minutes, parasites invade 
liver cells and start to reproduce. In 1 to 2 weeks, infected liver cells rupture, 
releasing thousands of new parasites known as merozoites, which then invade 
red blood cells and undergo further cycles of asexual reproduction, during the 
course of which many erythrocytes will be ruptured. P. vivax and P. ovale can 
remain dormant in the human liver for weeks, months, or years; these dor-
mant forms are the source of relapses of illness.
A few merozoites transform into male and female (sexual) stages capable of 
infecting new mosquitoes; these stages are called gametocytes. Once ingested 
by a new mosquito during a blood meal, male and female gametes are formed 
and fuse within the insect’s gut, ultimately spawning forms that invade its 
salivary glands, from which they enter the next human host.4 Depending on 
Box 5.1 | Main Messages
•	 A basic knowledge of the biological, social, and economic factors underlying malaria is essen-
tial to understanding the road to elimination. Today’s arsenal of tools includes interventions 
targeting key stages in the malaria parasite’s life cycle in humans or mosquito vectors as well as 
strategies for case management, prevention, and surveillance. Choosing the right tools requires 
knowledge of specific social and eco-epidemiological characteristics of an elimination site.
•	 Concepts for malaria elimination build upon concepts for malaria control. The cornerstone of 
malaria control is case management and prevention. After transitioning to elimination, however, 
cases become rarer. At this point, surveillance, the identification of remaining foci of transmis-
sion, and prevention become far more important.
•	 The global burden of malaria — in terms of numbers of cases, severity of disease, geographical 
spread, and socioeconomic development — is tremendous. With today’s tools, malaria elimina-
tion is feasible in some locales. Other sites with more-challenging epidemiological and socio-
economic conditions will require new and better tools and strategies.
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the ambient temperature and parasite species, the entire sexual cycle within 
an infected mosquito takes about 14 days. Most adult Anopheles live for about 
21 days.
5.3 | individuals and populations at risk
In areas highly endemic for malaria, most notably sub-Saharan Africa, young 
children are particularly vulnerable to severe disease because they are heav-
ily exposed and lack preexisting immunity. Pregnant women also constitute a 
high-risk group because of pregnancy-associated immune suppression and an 
affinity of P. falciparum for the placenta. Adverse outcomes in infected preg-
nant women include miscarriage, stillbirth, severe anemia in the mother, and 
low birth weight in infants, which, in turn, greatly increases the risk of infant 
mortality.
In contrast, acquired semi-immunity usually is seen in older children and 
adults who have grown up and reside in areas where P. falciparum is endemic 
and stable. Although such immunity does not preclude reinfection, it greatly 
reduces the severity of the illness. In many cases, it can even render an obvious 
bloodstream infection entirely asymptomatic. Therefore, in high-transmission 
settings, control interventions are focused more heavily on children and preg-
nant women.
Sporozoites
Liver-stage
parasites
Merozoites
Ring
Trophozoite
Schizont
Rupturing
schizont
Gametocytes
In mosquito gut
Gamete zygote
oocystookinete
F i g u r e  5 .1   Life cycle of the 
malaria parasite between mosquito 
vector and human host (reprinted 
from The Lancet, 365 (2005): 1487-
1498. Greenwood, B.M., Bojang, 
K., Whitty, C.J.M., & Targett, G.A.T. 
Malaria. With permission from 
elsevier.3)
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A different pattern of disease is seen in temperate and subtropical regions 
of Asia and Latin America, where malaria transmission is more often unstable. 
Populations in these areas are more likely to suffer epidemics because their 
ongoing exposure is insufficient to induce or maintain immunity. Under these 
circumstances, residents of all ages can develop the full spectrum of disease, 
including severe complications. In fact, it is often adult men who are at highest 
risk of infection in Asia and South America because of occupational risks and 
migration. As malaria comes under control, its local epidemiology also changes 
within a given community. The proportion of clinical cases in adults increases, 
as does the community’s risk of outbreaks.
In addition, genetic and acquired conditions affect the epidemiology of 
malaria. For example, carriers of certain inherited red blood cell diseases — 
in particular, sickle cell anemia — are less likely to die of P. falciparum malaria 
than their counterparts with normal hemoglobin.5 Some genetically mediated 
protection also extends to P. vivax. This parasite invades red blood cells via a 
surface receptor called the Duffy antigen. In western and central Africa, most 
people are incapable of acquiring P. vivax infection because they lack the Duffy 
antigen. Malaria can also interact with other infections. HIV in Africa increases 
the likelihood of severe malaria in areas with unstable transmission, and in 
stable endemic areas, it increases the frequency and density of malaria infec-
tion in those with HIV as their immune suppression advances. Conversely, 
malaria transiently increases HIV viral load, thereby potentially increasing the 
likelihood of HIV transmission.6
5.4 | Socioeconomics and drugs
The majority of deaths from malaria occur among the “bottom billion,” or 
people who live on less than a dollar a day. Malaria also is primarily rural. The 
most common reasons why people die of malaria are socioeconomic and geo-
graphic. Sufferers may not have access to proper treatment because their fami-
lies cannot afford it or they lack an understanding of the disease. Or they may 
simply live too far from a health care facility to obtain adequate treatment.
Sadly, even when people understand malaria and are able to secure medica-
tion, it may prove ineffective. Counterfeit and substandard antimalarial rem-
edies are widespread. In recent studies, at least a third of medicines analyzed in 
Africa and Southeast Asia failed quality tests.7, 8
Drug resistance has contributed mightily to the world’s recent upsurge in 
P. falciparum infections. Chloroquine resistance in P. falciparum first emerged in 
the 1950s and 1960s at the Thailand-Cambodia border and in South America; 
UCSF-Prospectus-revs.indd   84 4/22/2009   12:02:12 PM
  Understanding Malaria  85
in the 1980s, it began spreading in sub-Saharan Africa at a time when effective 
vector control was sorely lacking. The rise of chloroquine resistance in Africa 
has been temporally related to increases in malaria-associated mortality.
The loss of chloroquine, which was cheap, effective, safe, and widely avail-
able as an effective drug against P. falciparum, has proved a major setback for 
malaria control efforts. Chloroquine-resistant P. vivax poses another looming 
problem. Currently, these strains have been identified in Indonesia, Myanmar, 
Papua New Guinea, South America, Turkey, and Vietnam.9
Over time, other antimalarial drugs have also lost potency against P. falciparum. 
Mefloquine resistance is present in Asia, and sulfadoxine-pyrimethamine — the 
backup to chloroquine in Africa — has become progressively less effective world-
wide. In combination with other antimalarial drugs, artemisinins (a family of 
highly effective compounds derived from the herb Artemisia annua) are the 
most potent first-line weapons remaining in the modern antimalarial arsenal 
for effective malaria control and elimination (see Section 5.6 below). However, 
recently at the Thailand-Cambodia and Thailand-Myanmar borders, some 
strains of P. falciparum have shown delayed clearance following artemisinin 
treatment.10, 11
5.5 | global disease Burden
Today, as many as 3 billion people (roughly 40% of the world’s population) risk 
exposure to malaria.1 Not surprisingly, the most endemic areas are poor and 
tropical.
An estimated 2.37 billion people live in areas of P. falciparum transmission, 
the limits of which have recently been mapped. Predictably, Africa has the 
highest transmission levels (Figure 5.2). However, in northern and southern 
Africa, several countries have substantially reduced transmission, and out-
side of Africa, roughly 1 billion people reside in areas where their chance 
of contracting P. falciparum malaria is extremely low (less than one case per 
10,000 population per year).9 These areas are the initial foci for eliminating 
P. falciparum.
The current estimate of humans at risk from P. vivax is 2.6 billion people.12,13 
South and East Asia account for 52% of the total P. vivax burden, the Eastern 
Mediterranean region accounts for 15%, and South America accounts for 13%.9 
Because P. vivax develops in mosquitoes that thrive at lower temperatures than 
P. falciparum vectors, its geographical range is much wider, extending into tem-
perate regions. The limits of P. vivax distribution are poorly defined, as our cur-
rent understanding of its transmission and epidemiology lags behind what we 
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know about P. falciparum. Attempts are being made, nevertheless, to update the 
provisional limits of P. vivax transmission (Figure 5.3), using the same methods 
that were employed for P. falciparum (Figure 5.2).14
Worldwide, malaria is the fifth leading cause of death due to infectious dis-
ease, following respiratory infection, HIV, diarrheal disease, and tuberculosis. 
In Africa, malaria’s death toll is exceeded only by HIV.15 Despite harboring only 
27% of the world’s at-risk population, Africa has 89% of the malaria deaths 
and 59% of all clinical cases of malaria (74% of P. falciparum cases alone). Not 
surprisingly, this tremendous burden of disease is reflected in a chronic drain 
on health services. In Africa’s most endemic areas, malaria accounts for 25% to 
35% of all outpatient visits and 20% to 45% of hospital admissions.16
Globally, malaria kills 1 million people every year, 90% of whom are chil-
dren under 5 years of age. In Africa, malaria is the leading cause of death in 
this age group, killing one African child every 30 seconds. There are also an 
estimated 400,000 cases of severe pregnancy-related maternal malaria per year, 
with an associated 10,000 maternal deaths.17
Beyond its devastating clinical toll, malaria thwarts productivity and eco-
nomic growth. In 2002, malaria was the sixth leading cause of life lost and 
disability-adjusted life years (DALYs).15 The majority of these occur among 
the world’s poorest quintile, fostering a vicious cycle of infection, illness, and 
stunted productivity. 
F i g u r e  5 . 2   Global distribution of P. falciparum. Areas are defined as stable 
(dark green areas, where P. falciparum annual parasite incidence, or PfAPI, ≥ 0.1/1,000 
persons per year), unstable (light green areas, where PfAPI < 0.1/1,000 persons 
per year), or no risk (light gray).  This distribution is governed to a large extent by 
temperature and aridity (from Guerra et al.14).
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In strict economic terms, malaria costs African countries an estimated U.S. 
$12 billion per year, or 4% of their shared GDP. In the worst hit countries, 
malaria slows annual economic growth by 1.3%; conversely, a 10% reduction in 
malaria has been shown to yield a 0.3% increase in annual economic growth.18
Outside of Africa, Southeast Asia is the leading at-risk region for malaria, 
accounting for 66% of the disease burden. According to the WHO World 
Malaria Report of 2008, Afghanistan, Bangladesh, Brazil, India, Indonesia, 
Myanmar, Pakistan, and Papua New Guinea are the non-African countries with 
the highest estimated malaria cases.1 Although most of these cases are nonfatal 
infections due to P. vivax, they are still responsible for significant illness and 
socioeconomic impact. Furthermore, there is growing evidence that P. vivax 
causes serious disease, especially connected to anemia in infants.9
Worldwide, an estimated 130 to 390 million P. vivax cases occur every year. 
The estimated global cost of P. vivax, including lost productivity and the cost 
of health care and transport to clinics, is between U.S. $1.4 and $4 billion per 
year.9
5.6 | Malaria control and elimination: the toolbox
Historically, malaria control has spanned many interventions targeting vec-
tors, parasites, and the human reservoir of infection. Because there is not a 
single blueprint or highly effective priority intervention such as preventative 
vaccine, modern control and elimination will require a package of interven-
tions customized to local conditions and specific programmatic goals.
F i g u r e  5 . 3   Global distribution of P. vivax (from Guerra et al.12, 13)
UCSF-Prospectus-revs.indd   87 4/22/2009   12:02:27 PM
 88  A PrOSPeC TUS On MAL ArIA eL IMInATIOn
With this caveat, modern malaria control can be divided into three broad 
categories: case management, prevention, and surveillance. Case management 
relies on prompt and effective treatment of symptomatic patients to cure dis-
ease and avert complications and death. Prevention includes everything from 
health education to vector control to prophylactic medication to vaccines. 
Surveillance refers to the systems in place for case detection as well as monitor-
ing and evaluation.
How does malaria elimination differ from control? Control is concerned with 
reduction of the risk of malaria-associated morbidity and mortality to a point 
where they are no longer considered a public health problem. Control does not 
aim to prevent all transmission from occurring. On the other hand, elimina-
tion requires identification and treatment of all infected individuals, whether 
symptomatic or asymptomatic, so that transmission is prevented. During the 
shift to elimination, cases become rarer and are commonly restricted to defined 
foci. Therefore, prevention and surveillance become far more important.
caSe ManageMent
Once a P. falciparum sufferer develops symptoms, prompt and effective treatment 
is crucial. Without it, the illness can progress to death or serious mental and 
physical impairment within hours. Before the patient receives treatment, how-
ever, a few key decisions take place. First, a patient (or patient’s parent) recognizes 
a malaria-like illness, at which point the patient may receive “self- treatment” at 
home or consult with a formal or informal health care provider. The provider, 
in turn, may treat presumptively or rely on the results of a diagnostic test. Once 
a decision to treat for malaria has been made, the choice of a treatment regimen 
has to be made. The range of options is often limited and poor.
This same decision tree has led to a modern-day dilemma around “prompt 
and effective treatment.” Presumptive therapy may reduce delays in initiating 
therapy and the risk of disease progression; however, it may also result in the 
substantial overuse of antimalarial drugs, the spread of drug resistance, treat-
ment with a drug of inferior quality, and an increase in the risk of adverse 
drug reactions. Presumptive therapy may also delay the treatment of nonma-
larial illnesses. Although treatment of laboratory-confirmed malaria has been 
increasingly advocated, many malarious communities lack diagnostic capacity. 
Even if tests are available, providers may choose to disregard negative labora-
tory test results and treat for malaria, resulting in wasted resources.
In an elimination setting where local transmission approaches zero, accu-
rate diagnostic capacity is vital. Therefore, elimination will rely on rapid and 
accurate diagnosis and treatment.
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diagnoSiS
Because malaria is a relatively nonspecific illness, diagnosis based on clinical 
grounds is unreliable. Since 1880, when Alphonse Laveran first found malaria 
parasites in human blood, a microscopic blood test has been the gold standard 
for malaria diagnosis. This test, when performed by a skilled professional, not 
only identifies malaria parasites within red blood cells, it distinguishes P. falci-
parum infection from infection with other malaria species, and it provides an 
estimate of the level of parasitemia. Disadvantages of microscopy include its 
need for trained personnel, proper equipment, and a power source.
More recently, rapid diagnostic tests (RDTs) for malaria have become avail-
able, providing an attractive alternative to microscopy. The main advantages of 
RDTs are their relative ease of use by unskilled personnel and the fact that they 
can be performed where there is no electricity. However, RDTs also carry disad-
vantages. Their average cost is U.S. $0.50 to $1.50. Also, most current RDTs are 
neither sensitive nor specific enough for P. vivax. Even with P. falciparum, RDTs 
can yield inaccurate results, requiring good quality control systems, which are 
difficult to maintain in remote, tropical settings.
Finally, RDTs cannot reliably detect gametocytes. Gametocytes do not cause 
symptoms but are necessary for transmission. When elimination is the goal, the 
ability to detect gametocytes in human blood becomes important. PCR-based 
tests that will reliably detect small numbers of both asexual and gametocyte 
stages are available; the technology is not complicated and they could soon 
be introduced routinely into central laboratory facilities. Key issues relating to 
diagnosis are discussed further in Chapters 8 and 10.
treatMent
The optimal treatment for malaria depends on the severity of disease, parasite 
species, local resistance patterns, and safety considerations. Generally, uncom-
plicated malaria is treated with oral drugs on an outpatient basis. Severe and 
complicated malaria, on the other hand, often require intravenous antimalarial 
therapy as well as other medical tests and technology found only in hospitals 
and well-equipped clinics.
Due to the spread of multi-drug-resistant parasites, the recommended treat-
ment for uncomplicated P. falciparum malaria has undergone dramatic changes 
in recent years. Previously recommended monotherapies have been replaced 
by combination antimalarial therapy, which is defined as the simultaneous 
administration of two or more drugs that work independently against blood-
stage malarial parasites (Table 5.1).
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Artemisinin and its derivatives (artesunate, artemether, dihydroartemisi-
nin) produce rapid clearance of blood parasites and resolution of symptoms. 
Combining a short, generally 3-day course of the rapidly eliminated artemisi-
nin compound with a longer-acting partner drug with a different mode of 
action is the rationale behind artemisinin-based combination therapy (ACT). 
ACTs also kill young gameocytes, thus reducing transmission and facilitating 
elimination.
Treatment options for P. vivax, P. ovale, and P. malariae infections are more 
limited. Although chloroquine remains the current treatment of choice 
for most cases, in areas of Southeast Asia and South America harboring 
 chloroquine-resistant P. vivax, ACTs are now being used for treatment. Patients 
with P. vivax and P. ovale infections also need a second drug to eliminate latent 
liver parasites. The only regimen currently licensed for this use (a 14-day course 
of primaquine) is rarely completed. Primaquine can also cause hemolysis in 
patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency, a genetic 
condition for which a point-of-care test is not widely available.
Elimination of P. vivax is further complicated by the fact that gametocytes 
are usually released into the bloodstream just as a patient becomes ill. In con-
trast, P. falciparum gametocytes are released several days after the onset of ill-
ness. This lag allows ACTs to decrease the transmission of P. falciparum, whereas 
P. vivax  – infected patients often propagate infection to others before receiving 
treatment.
taBle 5.1 |  important antimalarial drugs available for control and 
elimination efforts
drugs primary indications
Artemether + lumefantrine
ACTs recommended by WHO for 
treatment of uncomplicated malaria19
Artesunate + amodiaquine
Artesunate + mefloquine
Artesunate + sulfadoxine-
pyrimethamine
Dihydroartemisinin-piperaquine
Quinine recommended treatment for severe 
and complicated malaria (P. falciparum 
and P. vivax)Artesunate, artemether
Chloroquine Treatment for non-falciparum malaria
Primaquine Preventative against relapses and/or 
radical cure for P. vivax
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cheMoprevention
Antimalarial drugs have long been used to prevent illness and reduce trans-
mission. Chemoprevention can be divided into two categories: chemoprophy-
laxis and intermittent presumptive therapy (IPT). Chemoprophylaxis, which is 
traditionally given to nonimmune travelers to malaria-endemic areas, entails 
frequent subtherapeutic doses of an antimalarial drug to stave off infection 
for a defined period of time. Although the same strategy also could reduce 
malaria-associated morbidity in permanent (i.e., semi-immune) residents of 
malaria-endemic areas, this application of chemoprophylaxis has never gained 
wide acceptance, in large part because of cost, logistics, resistance, and con-
cerns about a “rebound” in malaria following its discontinuation. The second 
category of chemoprevention is IPT, defined as the use of full treatment doses 
of drugs given at a few pre-specified time points not linked to symptoms or 
infection. IPT is given to pregnant women and is being considered for infants 
and children in areas of high transmission where many will be infected. Since 
it is not appropriate as part of an elimination strategy in areas that have already 
greatly decreased infection rates, it is not considered further here.
5.7 | vector control
The two leading means of vector control are use of insecticide-treated bed 
nets (ITNs) and indoor residual spraying (IRS) of insecticide. Over the last two 
decades, a number of randomized controlled trials have clearly demonstrated 
that ITNs, in particular, can significantly reduce clinical disease and child mor-
tality due to malaria.20
At present, long-lasting ITNs (LLINs) are the preferred technology. These 
nets have pyrethroid insecticide directly incorporated in their fibers. A great 
challenge is to achieve universal ITN coverage and usage.21 Social marketing, 
subsidies, and provision of free ITNs are three strategies that have worked in 
program-driven initiatives, but will require further significant and sustained 
donor support for greatest effect.
Like chloroquine, the pyrethroid insecticide class will not remain effective 
forever. The recent emergence of pyrethroid-resistant Anopheles mosquitoes in 
several parts of Africa has underscored the urgent need for additional insecti-
cides suitable for application to nets and other protective materials.4
In the mid-20th century, indoor residual spraying of DDT was fundamental 
to successful malaria elimination efforts. Today, spraying with several licensed 
insecticides has attracted renewed interest, especially in sub-Saharan Africa. 
In southern African countries with unstable malaria, DDT, carbamates, and 
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pyrethroids, in concert with ACTs, have dramatically lessened the local trans-
mission of malaria.22
In parts of Asia, Africa, and South America, forest malaria presents unique 
challenges to vector control. IRS and ITNs may not provide adequate protec-
tion because forest malaria vectors mainly bite and rest outdoors.21 For many 
countries, these highly efficient vectors contribute significantly to the burden 
of disease.23
To achieve elimination of malaria, novel vector interventions that spring 
from an improved understanding of local transmission, as well as environ-
mental management, land-use, and housing innovation, will also be needed. 
Measures that kill mosquito larvae have been effective in some locales. New 
repellents, based on novel mosquito targets and genetic manipulation of natural 
vector populations, are additional strategies that hold promise for the future.
5.8 | tracking progress toward elimination
The ultimate measure of malaria transmission is its yearly toll of clinical ill-
ness and death as a result of local transmission. An elimination program must 
be technically and operationally capable of determining a progressive drop in 
morbidity and mortality due to malaria and of verifying when all local trans-
mission has stopped.
An index of cases often used is the annual parasite index (API), which is 
the number of confirmed malaria cases per 1,000 population per year. API is 
the product of the ABER, the annual blood examination rate (or percentage 
of the population examined) and SPR, the slide positivity rate, or percentage 
of blood slides or RDTs found to be positive among suspected cases (see also 
Chapter 7).
WHO guidelines consider a country ready to consider transition from con-
trol to pre-elimination when the SPR < 5%, and from pre-elimination to the 
launch of an elimination program when the API is < 1/1,000. Other experts 
support a more conservative threshold of 0.1/1,000,14 especially with respect 
to P. vivax. As stressed in Chapters 1 and 2, such policy decisions must be 
based on a range of political, economic, and organizational factors, as well as 
those measures that reflect the changing epidemiology. In addition, API can be 
very unreliable because of poor health information and underreporting, and 
it does not pick up the proportion of the population that is asymptomatic but 
still makes an important contribution to transmission. Although surveys of 
children are commonly used as a measure of parasite prevalence, as an elimina-
tion strategy proceeds, it becomes increasingly important to recognize that it 
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is the whole population, not just these children, that is the source from which 
mosquitoes become infected.
To overcome the challenge of assessing large population samples, the PCR 
diagnostic tests previously mentioned in this chapter as well as serological 
measures currently being developed for ongoing evaluation of an elimination 
program (Chapter 10) will be valuable — but they will also be costly and labor 
intensive.
5.9 | conclusion
Malaria is a complex disease. In any given setting, understanding the dynam-
ics of infection is of equal importance to making essential political, economic, 
and organizational investments in an elimination strategy. The infection char-
acteristics vary, in turn, with the local species of Plasmodium and an array of 
human and vector characteristics.
Surveillance poses a particular challenge because, for elimination, it must 
determine not just who is clinically ill with malaria but also who is infected 
and possibly asymptomatic. Finding these people is the key to getting to zero.
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6 |  learning FroM hiStory
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6.1 |  introduction to Malaria elimination:  
lessons from yesterday for today and tomorrow
Malaria has accompanied mankind since the origin of Homo sapiens. The cause 
of malaria, parasites of the genus Plasmodium, and the mechanism of transmis-
sion by mosquitoes were discovered before the end of the 19th century, fol-
lowed by the development of the armamentarium of malaria control, namely, 
methods of personal protection, advances in the discovery of therapeutic 
and prophylactic drugs, and methods of vector control directed against lar-
val breeding sites and adult mosquitoes. These developments set the scene for 
attempts to eliminate malaria through the Global Malaria Eradication Program 
(GMEP), which considered elimination feasible in countries with malaria of 
low or intermediate stability. However, after only 14 years, WHO downgraded 
the GMEP to malaria control because many countries had experienced dif-
ficulties in initiating or sustaining national programs, often because of inad-
equate national commitment. Nevertheless, several countries successfully 
eliminated malaria, demonstrating that this goal remains a feasible option for 
other malaria-endemic countries. This chapter analyzes the lessons learned 
from both successful and unsuccessful attempts to eliminate malaria, as well as 
aInstitute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, 
Austria; bMalaria Atlas Project, University of Oxford, Oxford, UK; cArmy Malaria 
Institute, Brisbane, Australia
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factors that have contributed to a constant shrinking of the malaria map from 
1955 to today.
6.2 |  chronology: development of tools for 
Malaria control
Since Plasmodium falciparum was first discovered in 1880, many important dis-
coveries have been made, and tools have been developed that enable endemic 
countries to control and/or eliminate malaria. A time line of major discoveries 
and the development of technologies in use for diagnosis of malaria and for 
parasite and vector control is given in Figure 6.1.
Drugs that today are essential for the treatment of malaria (quinine and 
artemisinins) were first used in their native form for treatment of periodic 
fevers long before the malaria parasites were discovered in the 19th and early 
20th centuries.1, 2, 3 The demonstration of the natural mode of transmission 
through anopheline mosquitoes around the same time led to the development 
of vector control measures against the larval and adult stages.4
6.3 |  history of conceptual changes: Malaria control 
to elimination
The concept of eradicating malaria was first proposed by Fredrick L. Hoffmann 
in 1916 in his “plea for malaria eradication in the Western Hemisphere.”5 At 
Development of the malaria armamentarium
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F i g u r e  6 .1   Timeline of the development of the malaria armamentarium
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that time, however, controlling malaria was the priority, and eradication was 
not yet considered a feasible goal.
New tools such as indoor residual spraying (IRS), chloroquine, amodi-
aquine, proguanil, and pyrimethamine were developed at the end of World 
War II and radically improved the prospects for intensifying malaria control. 
International attention directed toward control of malaria became stronger, 
as demonstrated by the establishment of disease control institutions such as 
the Centers for Disease Control and Prevention (CDC) in the United States in 
1946, which was founded to limit the impact of malaria and which eventually 
achieved elimination of the disease in 1952 in the 13 states where malaria was 
still endemic.
Devastating postwar malaria epidemics in southern Europe highlighted the 
need to design and implement effective malaria control programs. Cyprus, 
Greece, and Italy strengthened their health systems to cope with diagnosis and 
radical treatment of malaria, with transmission controlled by residual spraying 
of DDT. After the Greek government suspended DDT spraying, the expected 
resurgence of malaria did not occur, indicating that in similar eco-epidemio-
logical settings, P. falciparum and P. vivax can be eliminated if transmission is 
fully suppressed for 4 years for P. falciparum and 5 years for P. vivax.
Successful elimination campaigns such as those in Greece and Italy gave 
hope for a malaria-free world. The GMEP was launched at the eighth World 
Health Assembly in 1955, when the following announcement was made: “The 
World Health Organization should take the initiative, provide technical advice, 
and encourage research and coordination of resources in the implementation 
of a program having as its ultimate objective the worldwide eradication of 
malaria.”6, 7
This new strategy was heavily dependent on employing long-lasting pesti-
cides, primarily DDT, to kill adult vectors and interrupt malaria transmission. 
The countries and regions where elimination seemed feasible were initially 
targeted, which at the time included the Americas, Europe, the Mediterranean 
countries, western and eastern Asia, and the western Pacific and Australia. 
Malaria elimination in sub-Saharan Africa and New Guinea was not considered 
feasible with available tools and means, a perception that remained fundamen-
tally unchanged until recently, despite the fact that very large swaths of both 
regions experienced low endemicity.8
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6.4 |  Shrinking the Map: geographical and chronological 
progression of Malaria elimination
The geographical and chronological progression of malaria elimination between 
1900 and 2007 is shown in Figure 6.2 and summarized in Table 6.1.
Practically all malaria-endemic countries in the Americas joined the GMEP, 
and most endemic countries in Europe continued to move toward elimina-
tion. In tropical Africa, only two offshore islands declared national malaria 
eradication programs. Australia, the Solomon Islands, and Vanuatu joined the 
program, as did the majority of southern Asian countries, from Turkey in the 
west to Taiwan in the east.
In the Americas, 22 countries achieved malaria elimination from 1950 
to 1978, among them the majority of Caribbean countries. With the excep-
tion of the United States and Chile, none of the malaria-endemic continental 
countries in the Americas reached this goal. In the European region, 37 of 
the remaining 43 malarious countries became malaria free during the same 
time period. Small foci, or limited areas of continued transmission, persisted 
in Greece beyond 1970, but malaria was eliminated in the late 1970s. Australia, 
Japan, and Singapore all succeeded in eliminating malaria by 1978. Brunei, 
Israel, and Réunion followed suit soon after.
F i g u r e  6 . 2   Geographical distribution of all-cause malaria 1900, 1946, and 1965 
(modified from Hay et al.9) with the overlay of the 2007 spatial limits of P. falciparum 
malaria transmission (modified from Guerra et al.8). The 2007 bounded areas were 
defined as stable (dark gray areas, where P. falciparum annual parasite index, or PfAPI, 
≥ 0.1 per 1,000 per year) or unstable (lighter gray areas, where PfAPI < 0.1 per 1,000 
per year).
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Although mortality and morbidity from malaria decreased significantly in 
most countries during the GMEP, the initiative failed to reach the ultimate goal 
of eradication. Consequently, in 1969, the WHO General Assembly reexamined 
the strategy15 and recommended a reversion to malaria control for the coun-
tries that were clearly unable to achieve elimination within the foreseeable 
future; however, it failed to provide guidelines and recommendations for a sys-
tematic strategy to achieve control. After 1972, the malaria situation worsened 
as a result of political factors, insufficient national support, and withdrawal of 
external assistance. This was marked by a substantial increase in the number 
of autochthonous malaria cases recorded in areas under surveillance between 
1972 and 1976 (Figure 6.3).
Nevertheless, several countries continued on the path to the elimination of 
malaria, as shown in Table 6.1, and ten countries achieved elimination between 
1979 and 2009, among them six Eastern Mediterranean countries, includ-
ing Bahrain, Morocco, Oman, Syria, Tunisia, and the United Arab Emirates. 
Kazakhstan, Maldives, and Seychelles were also successful.
Remarkable success in spatially progressive elimination in large parts of 
endemic countries has been achieved in Argentina, Brazil, China, Paraguay, the 
Philippines, and Thailand. By the year 2000, an estimated 60% of the world’s 
population resided in malaria-free areas, a great increase from 20% in 1950. In 
2007, 35% of the world’s population lived in areas still endemic for malaria,8 
with about 66% of those protected by some form of organized malaria control. 
Tropical Africa and the island of New Guinea are still considered the last epi-
centers of endemic stable malaria.
The decision taken by the World Health Assembly in 1969 reflected the 
table 6.1 |  Malaria status of countries and territories 1900, 1949, 1978, and 2009 by 
who regions
parameter africa americas S.e. asia europe e. Med. w. pacific total
Total number of countries 48 45 10 58 20 27 208
Malaria free in 1900 1 2 0 3 1 13 21
Malaria free 1900-1949 0 0 0 9 0 0 9
Malaria free 1950-1978 2 22 0 37 4 4 68
Malaria free 1979-2009 1 1 1 1 6 0 10
Total malaria free 4 25 1 50 11 17 108
Sources: Wernsdorfer,10 WHO,11 Packard,12 Bruce-Chwatt and zulueta,13 and “Malaria in the Southwest Pacific”14
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opinion of three separate groups. Those groups were countries not yet able to 
embark on malaria control or elimination, those that declared the intention 
of eliminating malaria but failed to implement and sustain efficient programs, 
and several malaria-free countries that financially supported others in the 
elimination effort and intended to end these obligations.
6.5 | yesterday’s approach in Malaria elimination
In countries that successfully eliminated malaria, the disease was predomi-
nantly hypo- and mesoendemic, and transmission was of low or intermediate 
stability. Some countries, including Tunisia and the United Arab Emirates, had 
hyperendemic areas characterized by intermediate stability.
Before the adoption of WHO’s malaria eradication policy in 1955, malaria 
elimination in the United States relied on vector control to interrupt trans-
mission and reduce the malaria reservoir, organized detection and treatment 
of residual cases, and complementary focal antivectorial measures that were 
continued until complete elimination of malaria had been achieved. This 
model was subsequently adopted by the GMEP. In European countries such 
as Cyprus, Greece, and Italy, malaria was reduced to low incidence by sys-
tematic diagnosis and radical treatment of individual cases before effective 
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F i g u r e  6 . 3   number of autochthonous malaria cases (in millions) in areas under 
surveillance outside tropical Africa (solid line) and in Southeast Asia (broken line), 
1972-1976 (from Wernsdorfer10)
UCSF-Prospectus-revs.indd   100 4/22/2009   12:02:36 PM
  Learning from History  101
vector control became feasible. In Europe, the vector control measures inter-
rupted any residual malaria transmission, and case management through the 
general health system was responsible for eliminating the remaining malaria 
reservoir.
The majority of countries that established national malaria elimination pro-
grams from 1955 adopted a vertical organizational structure and followed a 
standard chronological sequence of four phases: preparatory, attack, consolida-
tion, and maintenance (Figure 6.4).16, 17
prepar atory phaSe
The preparatory phase usually lasted a year and did the following:
•	 established or improved organizational infrastructure
•	 trained personnel
•	 established physical facilities for running operations
•	 carried out geographical reconnaissance and census
•	 conducted epidemiological and entomological baseline assessment
at tack phaSe
The attack phase usually lasted 4 or more years and did the following:
•	 applied attack measures, usually antivectorial intervention
•	 regularly monitored the impact of the attack measures
•	 from the second year, established full-scale epidemiological 
surveillance
F i g u r e  6 . 4   Phases of the Global Malaria eradication Program (adapted from 
Pampana16 and Hay et al.17)
Phases of malaria eradication
Preparatory Attack Consolidation Maintenance
~ 1 year > 4 years
< 0.1/1000 incidence
Duration varies Duration varies
0 local cases for
minimum of 3 years
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•	 from the second year, conducted active and passive case detection, 
effective treatment and case follow-up, epidemiological investigation 
and follow-up of cases and foci, and application of remedial measures
conSolidation phaSe
The consolidation phase could start when the surveillance mechanisms, includ-
ing the general health care system, were functioning smoothly with complete 
coverage in space and time, and when the malaria incidence had been reduced 
to a very low level (approximately < 0.1 positive slides per 1,000 population 
per year). In this phase, antivectorial measures were usually restricted to foci 
of malaria transmission and particularly receptive areas. The duration of the 
consolidation phase varied depending on how long it took to reach the qualifi-
cation for moving into the maintenance phase (below).
Maintenance phaSe
The maintenance phase could start when no autochthonous transmission 
had occurred for a minimum of 3 years, provided there was a strong surveil-
lance system. Surveillance continued in the form of vigilance through a strong 
health system, which maintained a designated operational group to monitor 
outbreak risk and importation risk and to cope with problematic events such as 
the reintroduction of malaria.
Although the concept of the GMEP may appear rigid, it did allow considerable 
leeway in the selection of appropriate tools to be applied in the attack phase. 
Generally, this required the deployment of vector control measures, namely 
IRS and/or any of the many forms of larvicidal measures or source reduction. 
Decisions regarding the selection of intervention methods needed to be based 
on sound preoperational epidemiological and entomological stratification, 
an essential task in the preparatory phase, subject to continuous updating 
throughout the intervention phase.
Activities outlined in the consolidation and maintenance phases should have 
a firm place in any program aimed at eliminating malaria. When analyzing the 
GMEP, it is important to remember that it is useless to adhere to a national 
uniform operational plan unless the entire country shows homogeneous epi-
demiological features — a rare situation, even in tropical Africa. Malaria control 
usually requires different approaches in urban, peri-urban, and rural environ-
ments. Updated recommendations for interrupting transmission and prevent-
ing reintroduction of malaria are the subjects of Chapters 2 and 3.
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6.6 | lessons learned from past elimination programs
Although many factors that assist and enable elimination programs today have 
changed and improved on those available during earlier global and national 
programs, it is important to evaluate the lessons learned from the GMEP (Table 
6.2) in order to determine the factors that made the difference between success 
and failure.
exaMpleS FroM countrieS that SucceSSFully 
eliMinated Mal aria
Australia, 1960 Malaria was endemic in the tropical part of Australia, affect-
ing the Northern Territory and Queensland. It was predominantly hypo- and 
mesoendemic malaria, unstable or with low intermediate stability, with sev-
eral hyperendemic areas in northern Queensland. Systematic malaria control 
operations started soon after World War II, with IRS, source reduction, and 
table 6.2 | common denominators from the global Malaria eradication program
common denominators from  
successful elimination programs
common denominators from  
failed elimination programs
Political stability and absence of internal and/or 
external conflicts
Political instability, civil unrest, internal and/or 
external armed conflicts
Firm political and financial commitment to the 
elimination of malaria
Lack of or fluctuating political and financial 
commitment
Minor dependence on external financing Donor fatigue
Good organizational and technical infrastructure Poor monitoring of operational activities and the 
epidemiological situation, failure to update the 
plan of operations, insufficient understanding of 
the benefits of eliminating malaria
High quality of training and personnel Inadequate human resources; poor quality of 
training, staff, and operations; high staff turnover
Fully developed and functional general health system Weak general health system
enlightened public that understood and supported 
the program
Poor public understanding and support of the 
program
Absence of major cross-border movement from 
adjacent malarious countries
Major cross-border movement from adjacent 
malarious countries
Originally unstable or intermediately stable malaria Originally stable malaria or malaria of high 
intermediate stability
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water management in the sugar plantations as well as case detection and treat-
ment within the framework of the well-developed general health care system. 
Malaria was eliminated from continental Australia in the 1960s. In the Torres 
Strait Islands, an integral part of Australia and subject to the introduction of 
malaria from nearby Papua New Guinea, it took longer to eliminate malaria 
and to establish effective mechanisms to prevent reintroduction. Nevertheless, 
malaria was eliminated there in 1978.
Taiwan, 1965 Taiwan provides an example of an outstanding success of island 
elimination. Following a DDT spray program starting in 1952, over 20 residual 
foci of transmission were eventually eliminated with intensive IRS, and courses 
of chloroquine/primaquine were used for mass drug administration (MDA) in 
the entire population in each focus of transmission. In Taiwan, MDA was ancil-
lary to the use of insecticides.18 Finding and eliminating the residual foci was 
a massive effort of malaria surveillance involving over 5 million blood slides 
taken from July 1958 to December 1964, which identified and treated 1,023 
malaria infections. Taiwan was certified malaria free in November of 1965. The 
elimination program spanned over 20 years and involved over 7,000 staff and 
a full research institute, as well as a large logistical establishment.18
The United Arab Emirates, 2007 Until the mid-1950s, malaria was meso- or 
hyperendemic in most areas in the country, generally with low-grade interme-
diate stability and an almost equal incidence of P. falciparum and P. vivax. In 
the 1960s, the country embarked on malaria elimination, initially using source 
reduction and IRS. Case detection and treatment were introduced at an early 
stage, making full use of the strong general health care system in the public and 
private sectors. During this program, the United Arab Emirates pioneered the 
use of local larvivorous fish in the main mosquito breeding sites — Tilapia for 
deep wells, and Aphanius dispar for shallow wells, irrigation heads, and natural 
water courses. Despite the annual importation of 2,000 to 3,000 malaria cases 
from malarious countries, especially Bangladesh, India, Pakistan, and Sudan, 
transmission was completely interrupted as of 1997, and the country was certi-
fied as malaria free in 2007.
exaMpleS FroM countrieS that Failed to eliMinate Mal aria
Colombia, since the Late 1950s Malaria was originally mesoendemic with some 
hyperendemic zones and low-grade intermediate stability. After initial success 
and near elimination, the program became increasingly affected by civil strife 
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and illicit activities, thus barring access to large malarious areas. These condi-
tions continue to persist, with little likelihood of change in the near future.
Sri Lanka, Mid-1960s Malaria was originally mesoendemic with some hyperen-
demic areas and an incidence of 2.8 million cases in 1946. Malaria was gener-
ally of low-grade intermediate stability. The malaria program had well-trained, 
highly motivated, and competent staff. The program ran smoothly through the 
consolidation phase in the mid-1960s. In 1966, the number of autochthonous 
cases was reduced to 18 when parliament and government decided to disband 
the entire malaria program and to transfer its activities to the general health 
services, which were unprepared for this task. Following 3 years of moderately 
rising incidence of malaria, the country was struck by a major and widespread 
malaria epidemic, resulting in a half million cases widely distributed through-
out the island.19
Among the countries that declared a policy of malaria elimination but failed to 
implement or achieve it, the most important adverse factors have been lack of 
political will, inadequate and unsustained financial commitment, infrastruc-
tural deficiencies, insufficient availability and appreciation of epidemiologi-
cal information, and administrative rigidity. In some countries, bureaucratic 
procedures repeatedly delayed the timely allocation of public funds for malaria 
elimination, delaying the performance of seasonal IRS beyond the limits of 
usefulness. Similarly, the allocation of external financial assistance was often 
delayed, resulting in the late arrival of essential commodities, such as insecti-
cides for IRS. Also, as is occurring today, some countries declared the goal of 
malaria elimination apparently without true evaluation of their readiness or 
any serious intention of implementing such a program.
6.7 |  recommendations: eliminating Malaria today 
and tomorrow
As 39 countries pursue malaria elimination, with strong indications that many, 
if not all, will achieve their goal, it is appropriate to take note of a passage 
from the Second General Report of the Malaria Commission of the League of 
Nations, a statement that is as valid today as it was when it was issued in 1927: 
“The Commission has always insisted that the fight against malaria must be 
waged not as a separate and isolated task but as part of a general social, eco-
nomic and sanitary campaign by an enlightened public health service which is 
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able to obtain assistance from other Government departments and from unof-
ficial agencies, and to secure continuity of action and unity of purpose.”20
Observing which countries having achieved and maintained their elimina-
tion of malaria supports the Commission’s statement. Equally, it was inadver-
tent or intentional disregard of the Commission’s views that was responsible 
for failure in the countries with national malaria elimination programs that 
did not reach the elimination goal.
Whenever a country considers eliminating malaria, it should carefully 
examine the lessons learned from past successes and failures, and it should 
take preemptive remedial action to eliminate any weaknesses. For instance, it 
is futile to attempt malaria elimination if the country has an active military 
conflict on a substantial part of its territory or lacks stable political or financial 
commitment.
Retrospectively, innovative research suffered during the malaria eradica-
tion program. Moreover, the unresolved issue of malaria in tropical Africa was 
overlooked. The pharmaceutical industry was unwilling to invest in develop-
ing drugs principally to address the problems of largely insolvent economies. 
Continued research and development of innovative tools must always be a pri-
ority to sustain a program through the inevitable challenges inherent in any 
process as complex as malaria elimination.
Nevertheless, the comparison of the geographical distribution of malaria 
in the years 1900, 1946, 1965, and 2007 (Figure 6.2) indicates remarkable suc-
cess in the fight against malaria, even if the stated goal of malaria eradication 
was not achieved. Moreover, many countries have a considerable potential for 
eliminating malaria in the near future.
6.8 | conclusion
With over 3 billion people still at risk for malaria, much needs to be done to 
control and eliminate malaria from the areas still affected by the disease, and 
we are still facing the most difficult part of the campaign. As today’s spatially 
progressive elimination program continues to shrink the global malaria map, 
we must remember the many important lessons learned from the GMEP and 
past attempts to eliminate malaria, yet look forward with new hope and com-
mitment to reach a malaria-free world.
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7 |  MeaSuring Malaria For eliMination
David L. Smith,a Thomas A. Smith,b and Simon I. Hayc
7.1 |  the role of theory in Malaria epidemiology 
and control
The primary goal of this chapter is to describe the role of epidemiological theory 
and mathematical modeling in defining and updating an elimination agenda 
for malaria. Many relevant questions that come up in planning or monitoring 
malaria control begin with the words “How much . . . ?” or “What levels . . . ?” 
As an example, one question might be “How much would malaria epidemiol-
ogy change if 80% of people owned and used an insecticide-treated bed net 
(ITN)?” Although statistical answers are found by starting from data and work-
ing backward to infer cause, mathematical answers are found by starting with 
a basic description of malaria transmission and working forward. Mathematics 
thus provides a precise language for discussing malaria epidemiology in all its 
complexity, and it gives such discussions a quantitative structure.
The parasite rate (PR) is a commonly measured aspect of malaria that is highly 
useful for malaria elimination planning. Intuitively, it is known that elimina-
tion will require greater effort in places where a higher fraction of people are 
infected (i.e., there is a higher PR). Mathematical models turn the notions of 
“higher fraction,” “greater number,” and “more effort” into quantitative state-
ments. They can also draw useful comparisons about malaria control in dif-
ferent places, such as the hypothetical prediction “80% coverage with ITNs 
would reduce PR from a baseline of 20% to below 1% within 10 years, or from 
a baseline of 50% to 15% within 5 years.” Quantitative answers are rigorously 
aDepartment of Zoology, University of Florida, Gainesville, FL, USA; bSwiss Tropical 
Institute, Basel, Switzerland; cMalaria Atlas Project, University of Oxford, Oxford, UK
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testable, and they make it possible to consider the nuances of malaria transmis-
sion, such as seasonality, differences in the vectors and their biting behaviors, 
and differences in the way malaria control is implemented.
Before starting a malaria elimination program, it would be wise to ask two 
questions: “What are the goals of the program?” and “How long will it take to 
reach those goals?” Useful goals have clear criteria for success or failure, and 
it is hard to imagine answering these questions without quantitative measure-
ments, which can then be composed into a mathematical framework known as 
a mathematical model.
To be useful, mathematical analyses must describe changes in the quantities 
that are regularly measured, and they should also describe reasonable time 
frames for change. As an introduction, Box 7.1 defines the most commonly 
used measures.
the role oF theory in the gloBal Mal aria er adication 
progr aM
Ronald Ross (1857-1932) demonstrated that mosquitoes transmit malaria and 
developed the first mathematical model for malaria transmission.1 He was 
interested in the reason why the PR varied from place to place and in giv-
ing some practical quantitative advice about malaria control. Many of Ross’s 
insights guided the first four decades of malaria control, when considerable 
efforts were made to eliminate malaria with larvicides and elimination of lar-
val vector habitats.
By 1950, demonstration projects had proved that DDT spraying to kill 
resting vectors was an extremely potent tool for malaria control, but the key 
insight into why DDT was so effective came from George Macdonald’s math-
ematical analysis.2 Noting the long delay required for the parasite to complete 
sporogony in the mosquito, Macdonald showed that the longevity of mos-
quitoes is a weak link in malaria transmission. To put it another way, only 
old mosquitoes transmit malaria. DDT would shorten vector life span, and 
this would have a triple effect: It would reduce the fraction of mosquitoes 
that lived long enough to become infected with malaria, it would reduce the 
portion of infected mosquitoes that lived long enough to survive sporogony, 
and it would reduce the number of infectious bites given by an infectious 
mosquito. These three effects combined could explain why DDT spraying was 
so effective.
The Global Malaria Eradication Program (GMEP) established in the 1950s 
was based around indoor residual spraying (IRS) with DDT. After an ini-
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tial planning phase (Chapter 6), a 3-year attack phase of intensive spraying 
was envisaged, with the goal of interrupting transmission completely while 
minimizing the evolution of insecticide resistance. The 3-year time window 
was based on a mathematical model in addition to data from field trials and 
malaria therapy, which was the use of supervised clinical malaria infections to 
treat neurosyphilis before antibiotics were available. The data indicated that 
untreated infections naturally clear after approximately 200 days. A model 
showed that if transmission were interrupted, the PR would decline by about 
80% per year, and PR would fall to 1% of its starting value within 3 years.4 After 
Box 7.1 |  Measuring Malaria
Parasite Rate, or PR  The prevalence of noninfective asexual blood-stage parasites varies with age. 
In a stable malarious area, people are rarely born infected, but Pr rises with age until it reaches a 
plateau in older children. By 10 years of age, some immunity begins to develop and Pr begins to 
decline. By the age of 20, it has fallen by a third from the plateau. By the end of life, it is at two-thirds 
of the plateau.3 As immunity rises in older children and adults, parasite densities decline. Some part 
of the apparent decline in Pr is caused by the inability to detect parasites. There may also be some 
real declines in Pr because of immunity and other factors. The Pr in children older than 2 years but 
less than 10 is called the standard Pr.
Entomological Inoculation Rate, or EIR The eIr is the expected number of infectious bites per per-
son per unit time, usually over a year. The eIr is found by multiplying the sporozoite rate (i.e., the 
proportion of mosquitoes with sporozoites in their salivary glands) and the human biting rate (i.e., 
the number of bites by vectors per person per year). Human biting rates are estimated by catching 
mosquitoes as they try to land or by catching them in traps.
Force of Infection The force of infection is the rate at which humans are infected. The force of infec-
tion is closely related to the eIr, at least conceptually. Although the eIr is measured by counting 
infectious vectors, the force of infection is estimated by looking at the rate at which humans become 
infected. It is defined as the number of new infections per person per year. One way to estimate the 
force of infection is to clear parasites and then observe people until they become infected. The signs 
of infection can be detected by the lingering immune response long after infections have cleared, 
so another way of estimating the force of infection is to plot the prevalence of an immune marker 
in the blood serum, or seroprevalence, against age and to look at the slope in young children. Such 
methods provide a sensitive assay of malaria transmission in low-intensity settings.
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a successful attack, there would be a consolidation phase leading up to malaria 
elimination (Chapter 6).
Although there has been substantial disagreement about the programmatic 
implementation of GMEP as a time-limited, intensive spraying program and 
the role of mathematical models in defining that agenda, few would disagree 
with Macdonald about the value of his basic insight. Malaria transmission is 
exquisitely sensitive to the mortality rate of adult mosquitoes, and modern 
malaria elimination programs must exploit that fact by attacking the adult 
vectors.
Annual Parasite Index, or API The API is designed to measure the number of malaria fevers per year 
per 1,000 people in a defined geographical area. The proportion of the population examined is called 
the human blood or annual blood examination rate (HBer or ABer). People with suspicious fevers are 
examined for parasites, and the proportion of parasite-positive slides among suspicious fevers is called 
the slide positivity rate (SPr). API is defined as the product of the two (API = HBer × SPr) when data 
are available for the entire year. Most API data come from clinics where suspected fevers are exam-
ined for the presence of parasites, but it is often supplemented by active surveillance. When malaria 
becomes rare, it becomes increasingly difficult to detect ongoing transmission using Pr.5 Then API can 
be a reliable method for reporting new malaria infections in low-intensity settings with good report-
ing systems, especially when Pr is too low to measure reliably. API data are difficult to interpret as a 
measure of malaria intensity, and they have low value for planning for elimination in places where Pr is 
high enough to measure, but they may be the only way to measure progress toward elimination.
Vectorial Capacity Vectorial capacity is the expected number of infectious bites that will eventually 
arise from all the mosquitoes that bite a single person on a single day.6
Basic Reproductive Number, or R0 R0 is defined as the number of infected humans that would arise 
from a single infected human, or the number of infected mosquitoes that would arise from a single 
infected mosquito, after one complete generation of the parasite. It measures maximum poten-
tial transmission, so it describes populations with no immunity and no malaria control. It can be 
computed by summing vectorial capacity over the average duration of human infectiousness, but 
discounted for inefficient transmission.
Controlled Reproductive Number, or RC While R0 describes maximum potential transmission, RC 
describes maximum potential transmission in a population with malaria control. R0 measures the 
intrinsic potential for epidemics, while RC measures the potential for epidemics after taking into 
account all of the measures that have been put into place to slow transmission.
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7.2 | the context for Malaria transmission
As mentioned in Chapters 2 and 6, a common criticism was that GMEP took 
a “one size fits all” approach that made it easy to scale-up malaria control and 
coordinate activities centrally.7 The downside was program inflexibility and 
indifference to the local context for malaria transmission. A concrete example 
of how the rigid programmatic criteria may have led to an inappropriate deci-
sion comes from Pare-Taveta, a pilot program on the border between Kenya 
and Tanzania in an area where malaria was hyperendemic. The PR declined 
throughout the attack phase, but more slowly than the 80% decline stipulated 
by the programmatic criterion. After 3 ½ years, the PR was still declining; nev-
ertheless, the spraying program was stopped. It is now clear that in the high-
intensity settings more commonly found in Africa, PR will decline more slowly 
than 80% per year because of multiple infections. Such failure of GMEP argues 
for a different approach to setting programmatic criteria, one that is capable of 
being tailored to the local situation.
Malaria transmission varies regionally, and sometimes over very short dis-
tances, as a consequence of factors such as transmission intensity, which vec-
tor species are dominant, and characteristics of the human populations. At a 
global level, there are important differences between sub-Saharan Africa and 
the rest of the world. The first is that the African vector Anopheles gambiae is the 
most efficient vector of malaria and the one with the strongest preferences for 
humans. Africa has two other anopheline species, A. arabiensis and A. funestus, 
that are also very efficient vectors. All three species tend to bite indoors and at 
night, and because of these three vector species, Africa overall has very intense 
transmission. The second difference is that Plasmodium falciparum is the domi-
nant parasite in all of Africa, and P. vivax is generally absent. Outside Africa, 
there is great variety of vectors and vector behavior, and the frequencies of 
both P. falciparum and P. vivax can also vary substantially from place to place. 
Most models and discussion have focused on P. falciparum and on the African 
vectors. Clearly, P. vivax and non-African vectors will require greater modeling 
attention.
7.3 | Malaria transmission
Our understanding of malaria epidemiology and the parasite life cycle has 
increased progressively and led to successive refinements of the original Ross-
Macdonald model. Here, we discuss some of these ideas and their relevance to 
malaria elimination.
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the roSS-Macdonald Model
The Ross-Macdonald model is a basic quantitative description of the Plasmodium 
life cycle and the vector feeding cycle. The parasite enters the mosquito during 
a blood meal, and the mosquito becomes infectious 10 to 16 days later, after 
the parasite completes sporogony. In the meantime, the mosquito will have 
fed several times, and most infected mosquitoes will die before sporogony is 
complete. Mosquitoes that survive sporogony can then give several infectious 
bites before they die.
Human infections begin during the mosquito blood meal, when sporozo-
ites enter the skin. Parasites are not obvious in the blood for about 11 days. 
The human with a P. falciparum infection is not infectious until a fraction of 
the blood-stage parasites become gametocytes and then mature, 8 to 10 days 
later. Untreated or improperly treated infections last approximately 200 days 
on average, and some infections last longer than a year. As long as the blood-
stage parasites persist, some gametocytes will be produced. The number of 
mosquitoes that will become infectious depends, in part, on the number of 
mosquitoes that bite humans, the rate that parasites develop, and the longevity 
of the mosquitoes. This process is demonstrated in Figure 7.1.
One way to summarize transmission is to answer the simple question “How 
many infectious mosquitoes would be expected to come from a single infec-
tious mosquito after just one generation of the parasite?” The complex answer 
to this question is the quantity called the basic reproductive number, R0.
2 To 
answer this question, we count the number of infections by following the para-
site through its life cycle:
•	 How many times is a person bitten by vectors each day?
•	 How many human blood meals does a vector take over its lifetime?
•	 What fraction of blood meals taken by infectious mosquitoes cause 
infections in humans?
•	 How long does a person remain infectious?
•	 What fraction of mosquitoes feeding on infectious humans becomes 
infected?
•	 What fraction of mosquitoes survives sporogony?
R0 is computed by giving quantitative answers to these questions and taking 
the product.
The Ross-Macdonald model describes changes in the fraction of infected 
humans (i.e., PR) and the fraction of infectious mosquitoes (i.e., the sporozoite 
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rate) over time as infections are acquired and cleared. If R0 > 1, then a single 
infectious mosquito would tend to leave more infectious mosquitoes, and as a 
consequence PR would increase until it reached a steady state when new infec-
tions were balanced by cleared infections.
The mathematical models and the concept of R0 also describe most basic 
aspects of P. vivax transmission dynamics, but the parameters must be modi-
fied to describe the vectors and the dynamics of P. vivax infections in humans. 
There is one big difference that the Ross-Macdonald model does not accurately 
describe. Because P. vivax can lie dormant in the liver, a single infectious bite can 
result in multiple relapsing infections as new P. vivax broods emerge. Although 
this happens in only a fraction of infected people, the equations must be modi-
fied to consider dormant liver-stage infections and relapse, and R0 for P. vivax 
must add up all the mosquitoes that arise from the primary infection and from 
all of the relapsing infections.
The concept of a steady state is usually interpreted as a long-term average, 
but this requires careful interpretation in the light of malaria immunity in 
humans, seasonal mosquito population fluctuations, multiple infections, and 
the fact that some people are bitten more than others. Elaborations on the 
Ross-Macdonald model have added each one of these factors alone and in com-
F i g u r e  7.1   Measuring R0
How long does a person remain infectious?
How many times a day is a person bitten by potential vectors? 
What fraction of bites on infectious humans infect a mosquito?
What fraction of infectious bites infect a human?
What fraction of mosquitoes survive sporogony?
How many human blood meals does a vector take over its lifetime? 
p
m
– probability a mosquito survives one day
n – number of days required for sporogony
a – number of human bites, per mosquito, per day
– ratio of mosquitoes to humans
1/r
ma
c
pn
a/-lnp
b
R0=
ma2bc
r (–lnp)
pn
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bination. In each model, there is a different way of computing R0, and there 
is also a different quantitative relationship between PR and R0. Mathematical 
models can provide a good qualitative description of malaria, even where there 
is some uncertainty about the underlying quantities. Despite the uncertainty 
and quantitative differences among these models, R0 provides a unifying con-
cept. When indexed to PR or other routinely collected malariometric indexes 
in a credible way, R0 provides practical guidance about how much transmission 
would have to be reduced to eliminate malaria.
heterogeneouS Biting
Humans differ from one another in their ability to transmit malaria to mosqui-
toes, in their susceptibility to disease, in their immunological responses, and 
in many other quantitative traits. For most of these differences, R0 is propor-
tional to the population average, but heterogeneous biting is different because 
it amplifies transmission intensity. Heterogeneous biting refers to the fact that 
some people are bitten more than others. Heterogeneous biting can be sepa-
rated by three kinds of factors: how bites are distributed within households, 
among households, and among individuals over time.
The factors that determine who gets bitten within a household are compli-
cated and include body size, sex, pregnancy, and olfactory cues that have not 
yet been identified.8 Some households get more infectious bites than others, 
depending on their proximity to larval habitat, their use of ITNs or area repel-
lents, the housing design, and odors that probably attract mosquitoes from 
very long distances.8 All of these effects combine so that a few houses harbor 
the vast majority of the mosquitoes. It has been proposed that 20% of the peo-
ple get 80% of the bites.9 Not all vectors bite indoors and at night. Depending 
on the local vector present, heterogeneous exposure to malaria can have very 
different causes. When the primary vectors live in the forest, for example, the 
people who spend the most time in the forest are at greatest risk.
Heterogeneous biting amplifies malaria transmission when PR is low, and it 
hides very intense transmission when PR is high.10 Consider the contrasts of 
two populations where the PR is 10%. In a population where 10% of people are 
bitten twice a day, but 90% of the population is never bitten, R0 would be much 
higher than in a population with a PR of 10% with uniform biting rates. Thus, 
it should be obvious that when biting is extremely uneven, the prevalence of 
malaria can disguise subpopulations where biting is extremely intense. The 
message is simple. Holding PR fixed, the higher the degree of biting inequity, 
the more difficult it will be to eliminate malaria.
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eStiMating R 0
Given the importance of R0 in planning for malaria control, it is surprising 
how infrequently it is measured. Mathematical models define relationships 
between PR, R0, and other commonly measured indexes, and this provides a 
useful method for estimating R0.
11
A problem with this method is that it must take into account all of the 
factors that affect endemic malaria, such as human immunity, heterogeneous 
biting, seasonality, malaria control, and density dependence. If transmission 
is highly seasonal and focal, for example, then the value of R0 will be highly 
influenced by the time and place with the highest transmission. It is possible 
to develop a wide range of plausible models.10 Which factors matter and which 
model should be used?
One way forward is to build many different models and challenge them 
with various kinds of data and then select models that best capture both the 
underlying mechanisms and the observed patterns.12 The process of iteratively 
building models and validating them leads to refinements of the theory and 
suggests new tests of the theory. In the end, the process of building models 
allows us to make a better assessment of the potential for malaria elimination.
Using this process, one study estimated R0 in 121 African populations.
11 
Those estimates suggest that R0 ranges above 1,000, and perhaps much higher. 
This suggests that malaria will be extremely difficult to control in Africa and 
in some areas outside of Africa where transmission intensity is very high. To 
put this into a more quantitative context, it is necessary to give quantitative 
estimates of how effective malaria control can be.
7.4 | Malaria control
In the design of malaria control programs, a question often arises about how to 
set target coverage levels of malaria interventions to achieve some predefined 
goal. In order to eliminate malaria, for example, it will be necessary to reduce 
malaria transmission by a factor that exceeds R0, and to sustain this level of 
control until no parasites remain in the human or vector populations. To 
explain this better, we define the concept of an “effect size.”
A power analysis for malaria control should focus first on the likely effect 
size that can be achieved from a package of interventions and their distribu-
tion and intensity. For malaria elimination, the relevant effect size is the over-
all reduction in potential transmission. As a reminder, R0 describes potential 
transmission in the absence of control. In the presence of control, potential 
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malaria transmission is described by the controlled reproductive number, RC. 
In effect, R0 defines the maximum possible transmission in an area, while RC 
describes what would happen in light of, for example, ITN use, regular medical 
care, and the public health response to an outbreak of malaria.
Power analysis estimates the effect size, defined as the ratio RC/R0. As an 
example, if ITNs reduced vectorial capacity by 90%, the effect size would be 
RC/R0 = 10. The overall effect size for integrated malaria control is found by 
multiplying the effect sizes for reductions in vectorial capacity achieved sepa-
rately through adult vector control, larval vector control, and the reduction in 
infectiousness achieved through the use of antimalarial drugs.
integr ated Mal aria control
To understand how well malaria control will work when several different inter-
ventions are deployed simultaneously, the first step is to estimate the effect size 
of each one of the interventions separately.
Insecticides can repel or kill mosquitoes and reduce mosquito longevity, 
delay feeding, and deflect vectors so that they feed with greater frequency on 
nonhuman hosts.13 IRS works in much the same way as ITNs, but the mos-
quitoes might take a blood meal first. Clearly, ITNs and IRS reduce the risk 
of malaria for those people who use them, but at high rates of use, they also 
reduce the risk of malaria and protect people who don’t use an ITN or who 
live in unsprayed houses nearby. However, leaving some low-risk populations 
unprotected will allow malaria transmission to continue and will increase 
malaria exposure for high-risk populations. An example is the better protection 
of children that may occur when adults were provided with ITNs.14 Analyses 
of malaria transmission therefore need to consider whole populations, not just 
the high-risk groups.
Another way to reduce transmission is to control larval mosquitoes at the 
source.15 Although larval control may not be cost-effective in every situation, it 
can be extremely cost-effective in others, and it can bring about dramatic reduc-
tions in vector populations that make other forms of control more effective. 
Given the extremely high estimates of R0, it may not be possible to eliminate 
malaria with the combination of ITNs and drugs. Without new tools, larval 
control may be required to achieve elimination, although, given the diversity 
of breeding sites that A. gambiae can utilize across Africa, larval control is often 
not an option for this vector.
The effects of drugs on malaria transmission are more difficult to describe 
because of clinical immunity and the potential for reinfection. Intuitively, it 
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is clear that a drug that radically cured an infection by removing all of the 
parasites in all of the life stages would cut short the infectious period. A radical 
cure at the beginning of an infection could reduce infectiousness from several 
months, on average, to no infectiousness at all. In areas with immunity and 
frequent reinfection, many new infections tend to go untreated, and the con-
trol power of drugs is substantially diminished.
There are a few important caveats about drugs and transmission, however, 
as each drug affects the parasites at a different phase in their life cycle. The 
first-line drugs all kill at some asexual stage of the parasites; some of these 
(e.g., artemisinins and chloroquine) kill immature gametocytes, and others 
(e.g., primaquine) kill mature gametocytes. In areas of low transmission, where 
health care systems manage to treat all new infections, transmission would 
continue from people who carry only gametocytes.
Drugs also have other effects. Drugs with long half-lives would have a natural 
prophylactic effect and prevent some new infections.16 Intermittent presump-
tive treatment (IPT) of pregnant women or infants at scheduled prenatal or 
pediatric visits does provide some protection from clinical disease, and it may 
also reduce infection, for as long as the drug concentrations remain high.
The effects of reducing malaria transmission through larval control, adult 
vector control, and antimalarial drugs all complement each other. When these 
different modes of control are combined, their effect sizes are multiplica-
tive. Thus, an effect size of 10 achieved through ITNs and an effect size of 10 
achieved through drugs would be multiplicative and produce a total effect size 
of 100 (i.e., a 99% reduction in transmission intensity). Each additional mode 
of malaria control further improves the total control power. One caveat is that 
malaria control can create heterogeneity or interact with existing biting het-
erogeneity.17 Heterogeneity presents enormous modeling challenges, in light of 
variations between people in their use of health services and ITNs. If malaria 
control could focus on those who are bitten the most, the effects would be 
quite dramatic.18 Conversely, a segment of the population that was not reached 
by any form of malaria control could sustain transmission regardless of how 
intensive malaria control was applied to everyone else.
All of this raises an important question: given the arsenal of malaria con-
trol weapons, what is the optimal package of malaria control interventions, 
depending on the context for transmission? This is an important question that 
can only be answered with some modeling, combined with malaria control 
and elimination experiences in a variety of contexts.
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Mapping R 0 and R c
The map in Figure 7.2 illustrates data that are a nonlinear transformation of the 
model-based geostatistical point estimates of the annual mean PfPR2-10 for 2007 
within the stable spatial limits of P. falciparum malaria transmission, displayed 
as a continuum of light to dark green from 0 to >200 (see map legend). The rest 
of the land area was defined as unstable risk (medium gray areas, where PfAPI 
< 0.1) or no risk (light gray, where PfAPI = 0).
The spatial distribution of RC illustrated in Figure 7.3 shows areas categorized 
as the following: easy to control with simple improvements in access to health 
care and antimalarial drugs (RC = 0 to <2, lightest green); possible to control by 
achieving the equivalent of an 80% ownership with long-lasting insecticide-
treated nets (LLINs) and 80% use (RC = 2 to <10, light green); possible to control 
by dramatically improving access to health care and scaling up of LLINs as 
above (RC = 10 to <100, medium green); and difficult to control even with the 
scale-up of a complete suite of existing interventions (RC = >100, dark green). 
The rest of the land areas were defined as either unstable risk (medium gray 
areas, where PfAPI < 0.1) or no risk (light gray). It should be noted that there are 
considerable error margins in the conversion of RC to PfPR
2-10 and that places 
that have already scaled up control will find it more difficult to improve con-
trol. These estimates should thus be interpreted cautiously and used only as an 
informative guide. In addition, the time taken to achieve the interruption of 
transmission can still be considerable, on the order of decades, and is reduced 
by the margin by which the implemented control exceeds RC.
reviSed endpointS and tiMe lineS
One practical use for models is to set realistic expectations about what can be 
achieved through existing programs. The PR is a commonly measured index of 
transmission intensity that provides reliable information about R0 (or RC), so it 
forms the best evidence base for large-scale planning, although other malari-
ometric indexes improve the diagnostic ability of monitoring and evaluation. 
An important question for planners to consider is, for some fixed level of ITN 
and other intervention coverage, how much can PR be reduced and how fast 
will it change?
The logic for developing a PR-based theory is fairly simple. Given a baseline 
estimate of PR, it is possible to infer R0, albeit with some uncertainty. Given a 
specific package of interventions and specific coverage levels, it is possible to 
estimate RC. The new PR is predicted by a mathematical model using the new 
value RC. Changes in PR can, thus, be predicted for any package of interven-
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tions, as long as it is possible to estimate the control power. A simple lesson that 
comes out of this sort of analysis is that the same package of interventions will 
have different effects depending on the baseline PR, seasonality, and hetero-
geneous biting. When PR is high, the reductions will be comparatively small. 
When seasonal fluctuations or biting heterogeneity is high, the reductions will 
also be comparatively small.
The expected waiting time to reach the new PR can also be computed using 
mathematical models. The waiting times to reach the new steady state are 
longest when the packages of interventions are barely sufficient to eliminate 
malaria. The rate of decline in PR is much faster when malaria transmission is 
interrupted completely, but it is much slower than the GMEP criterion when 
the baseline PR is high (>60%).
These methods provide a way of establishing testable predictions and con-
crete advice about the coverage levels required to reach program goals. This 
same process also works when malaria control is changed from one level of 
coverage to another, so it can weigh the value of changing a package of specific 
interventions, such as increasing ITN coverage from 50% to 60%. By exten-
sion, it should also be possible to identify the control power that is required to 
reduce PR below some prescribed lower limit within a fixed time frame.
While these methods can provide some useful projections about the changes 
in PR, the entire basis for monitoring begins to break down as PR declines below 
1% and becomes harder to measure, and API may be the only measure for prog-
ress toward elimination. By extension, the factors that affect malaria control 
F i g u r e  7. 2   The spatial distribution of the estimated basic reproductive number 
of P. falciparum malaria at present levels of control (RC)
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and ongoing transmission also change. In high-intensity areas, when there is a 
commitment to elimination, the emphasis must be on reducing transmission. 
As the reservoir of malaria begins to decline and transmission is controlled, the 
emphasis may shift. Currently, transmission at low intensity has not been the 
subject of extensive modeling (Box 7.2). Low-intensity transmission in areas 
where a large fraction of clinical episodes are treated, for example, may be sus-
tained by broods of mature gametocytes. Gametocyte densities decay slowly, 
like the serum concentrations of drugs. An important consideration for P. vivax 
elimination time lines is that relapsing infections from the largely invisible 
liver-stage infections can substantially extend the waiting time to elimination. 
The relative importance of these factors for elimination awaits investigation 
using mathematical models.
outBreak riSk and iMportation riSk
For malaria eradication to succeed, it must be possible for every country to 
sustain elimination. As described in Chapters 1 and 3, two key concepts for 
describing malaria after elimination are outbreak risk and importation risk. 
Outbreak risk, also known as receptivity, is defined as the potential for malaria 
outbreaks, and importation risk, also known as vulnerability, is the risk of 
importing malaria from nearby malaria-endemic populations.
In modeling terms, outbreak risk is described by the concepts of R0 and RC. 
In areas where elimination has been achieved, it must have been true that RC 
F i g u r e  7. 3   The spatial distribution of the estimated basic reproductive number 
of P. falciparum malaria at present levels of control (RC) stratified according to the ease 
of the additional control required to interrupt P. falciparum malaria transmission
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< 1 occurred for long enough to clear parasites from all the human and vector 
hosts. This statement would not be true if elimination were achieved through 
mass drug administration, or if malaria were easier to eliminate because of high 
levels of transmission, blocking immunity in humans. An important concern 
is that the levels of control that are required to achieve elimination may not 
be sustained, especially after malaria has ceased to become a burden and when 
it competes with more-pressing public health needs. When malaria is rare, it 
is important to consider individuals and stochastic behavior. This shifts the 
emphasis to estimating R0 using baseline estimates of transmission intensity, 
and to assessing the standing capacity for malaria control. Does a country have 
the ability to rapidly and efficiently detect imported malaria and the start of an 
epidemic and then contain an outbreak?
In practical terms, importation risk can be assessed from the malaria endemic 
statuses of countries, population densities and distributions, and the rates of 
migration among countries.
Box 7.2 | Stochastic Models of Malaria epidemiology and control
There are many kinds of mathematical models. The ross-Macdonald model and most other models 
commonly used in malaria epidemiology are called “deterministic models” because nothing hap-
pens by chance. Deterministic models are useful when the law of large numbers applies, when small 
fluctuations that happen by chance can be ignored as a kind of irrelevant noise.
There is a need to develop new sorts of models that consider the consolidation phase, when 
malaria is rare, and the maintenance phase, after malaria has been eliminated. Under these condi-
tions, there are very few events, so the law of large numbers does not apply. Different sorts of 
models must be developed to consider the random fluctuations and chance events. These are called 
“stochastic models.”
Two concepts that are critical for post-elimination planning are the rate at which malaria is 
imported (i.e., importation risk) and containment of the malaria outbreaks that follow (i.e., the 
outbreak risk). The tendency for an epidemic to occur is described by RC, but the size and duration 
of an outbreak will be highly variable. Important factors include the immune status of the popula-
tion, which affects whether infected people are likely to report to health facilities, as well as micro-
heterogeneity in transmission, that is, whether imported malaria infections are likely to remain in 
localized foci or to spread widely. Stochastic malaria models have been developed, including a 
computer simulation developed by the Swiss Tropical Institute.19 There is an urgent need to extend 
such analyses to low-transmission settings, with the modeling of surveillance systems as a priority.
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To put these concepts into a metaphor that is more readily understood, con-
sider an analogy to forest fires. Outbreak risk describes aspects of a forest that 
leave it susceptible to fires, such as large amounts of standing timber, the den-
sity of dead trees, and the moisture content of living trees. Importation risk is 
analogous to the risk of lightning strikes and human activities that spark the 
fire.
7.5 | Before and after elimination
The ability to sustain elimination once it has been achieved depends on the 
methods used to control malaria and achieve elimination in the first place. In 
areas with low importation risk where elimination was achieved by combin-
ing intensive vector control with effective surveillance and prompt effective 
treatment with antimalarial drugs, it may be possible to relax the level of vec-
tor control and shift some of those resources to detect and control outbreaks 
(Box 7.3).
It is probably easier to keep malaria out of a place than to eliminate it. When 
malaria is rare, antimalarial drugs can be extremely effective tools for con-
trolling transmission and stopping outbreaks, but drugs are much less effec-
tive where malaria is endemic. The reason is that ongoing infection maintains 
clinical immunity so that some infections go untreated and individuals remain 
infectious for months, thus making it easier for malaria to keep up a chain of 
asymptomatic infection. Since an individual with an infection that was cured 
radically ceases to become infectious, an outbreak could be stopped immedi-
ately by treating every person. When malaria is rare and every new case of clin-
ical malaria is detected and promptly and radically cured, malaria transmission 
never gets started. In the same place, malaria transmission can continue until 
clinical immunity wanes sufficiently.
The conditions that allow outbreak control to work are extremely effective 
surveillance combined with prompt treatment to achieve a radical cure. It is 
intuitive that having effective contact tracing and aggressive outbreak control 
focused around confirmed cases will make outbreak control more effective. 
The long delay between infection and the point when a person presents at the 
clinic, the waiting time for gametocytes to mature, and the delay for sporogony 
all open a window of opportunity for malaria outbreak control to contain epi-
demics in the post-elimination state.
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Box 7.3 | is elimination a “Sticky State”?
To achieve global malaria eradication, each country that achieves malaria elimination must 
sustain it. Mathematical models generally suggest that this will be quite difficult, especially 
in places where R0 is very high.
11 Transmission models suggest that the Pr tends to a long-
term average, depending on RC. The relationship is like the temperature in a room and the 
set point of a thermostat. Vector control, such as ITns or IrS, lowers RC and changes the set 
point, and Pr drops until it reaches the new set point. If vector control were relaxed, the 
set point would change, and Pr would increase. In other words, these models suggest that 
intensive malaria control must be sustained for decades to keep the set point at zero.
Some recent theories suggest that this metaphor may not be entirely correct.20 After 
malaria control brings the incidence of malaria near zero, there may be other changes that 
make malaria elimination easier to sustain. Increases in wealth and housing quality can per-
manently reduce R0, change the market forces for health care, and change people’s attitudes 
toward malaria. After a prolonged reduction in transmission, adults can lose their immunity, 
but this is a double-edged sword. On one hand, an uncontrolled epidemic in a nonimmune 
population would probably cause massive mortality. On the other hand, after the loss of 
malaria immunity, malaria transmission would be obvious because every person who got 
infected would also get sick, and this could make malaria easier to control. Contact trac-
ing could be very effective. Measures that are generally impractical or ineffective against 
endemic malaria, such as mass spraying with insecticides and mass drug administration, 
could become much more effective because of the smaller scale of the problem. As attitudes 
change, a small outbreak of malaria can cause a huge outcry for action. If attitudes about 
malaria, wealth, and health infrastructure change enough, the outbreaks can be prevented.
Mathematical theory suggests that the same place can have two set points. One set point 
corresponds to endemic malaria and well-developed immunity, and the other set point cor-
responds to no malaria and no immunity. These set points are only possible if the response 
to clinical malaria, such as prompt effective treatment with antimalarial drugs and effec-
tive outbreak response, is very effective. To put it another way, if malaria elimination is sus-
tained for long enough, and if the health systems and outbreak response are good enough, 
the absence of malaria can be “sticky.” The success of global malaria eradication is greatly 
enhanced if malaria transmission dynamics are sticky, because it becomes easier to hold the 
ground that has been won.
This possibility is conditional on having strong health care systems and effective surveil-
lance in place to be able to identify a high proportion of clinical malaria episodes. This helps 
to explain how some countries have managed to stay malaria free, despite having a history 
of endemic malaria, healthy vector populations, and frequently introduced malaria.
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the inForMation needed For eliMination
Strategic planning at the regional and global levels will require a consider-
able evidence base, including information on human population distribution, 
outbreak risk, and importation risk. Some of these databases are already being 
assembled on a global scale. As mentioned previously, the parasite rate is com-
monly measured, and it provides a useful index of malaria transmission inten-
sity. Maps of malaria endemicity (i.e., PR) provide a basic estimate of outbreak 
risk. When combined with population distribution maps and other informa-
tion, they can also be used to estimate importation risk. The ability to move 
the modeling agenda into an explicitly spatial context is a luxury that was not 
available to the former GMEP. Although considerable effort will be required 
to quantify the uncertainty in predictions, global maps of malaria endemicity 
not only provide a platform to help inform strategic planning through scenario 
analyses but also provide a mechanism to monitor change and evaluate inter-
vention effects.21
7.6 | conclusion
Mathematical modeling is one of many tools that can be used to plan for and 
carry out elimination. In forming a strategic plan, it is not enough to set vague 
goals. The elimination program, like any program, will need plans with defined 
time limits and concrete targets with well-defined parasitological, entomologi-
cal, and epidemiological endpoints, such as 80% coverage within 5 years to 
reduce PR to less than 1%. There is little benefit to making a goal that is not 
realistic and cannot possibly be met. Mathematical models can help to estab-
lish realistic goals and time lines based on existing tools, they can help to 
inform the monitoring and evaluation and make course corrections, and they 
can also help to describe the big picture for malaria elimination in quantitative 
terms. As we have stated, mathematical models are nothing more than think-
ing carefully and quantitatively about malaria.
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8 |  killing the paraSite
John C. reeder,a Geoffrey A. Targett,b G. Dennis Shanks,c 
and Brian M. Greenwoodb
8.1 | introduction
The pattern of malaria transmission around the world is highly variable and 
covers a broad spectrum of epidemiological situations ranging from areas with 
a high population at risk, high mortality, and high transmission (predomi-
nantly Plasmodium falciparum malaria) to the other extreme of low population 
at risk, low mortality, and low mixed-species transmission. As we have seen, a 
very different approach is needed to achieve elimination of the parasite from 
low-transmission settings than is required for the attack on disease in high-
transmission settings. A conceptual and operational shift must be made, from 
prevention and treatment of disease in individuals across entire or broad areas 
of the country, to community-focused strategies aimed at ending transmission 
and eliminating residual foci of infection. Strategies for elimination must be 
based on accurate case reporting and precise assessments of the epidemiol-
ogy and the populations at risk (Chapter 2). It will be necessary for an elimi-
nation program to constantly monitor the shifting character of malaria and 
adapt intervention strategies appropriately to these changes as they occur, as 
an aggressive intervention program will change the pattern of malaria over 
time.
aMacfarlane Burnet Institute for Medical Research and Public Health, Melbourne, 
Australia; bLondon School of Hygiene & Tropical Medicine, London, UK; cArmy Malaria 
Institute, Brisbane, Australia
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8.2 | non-Falciparum Malaria: a challenge to elimination
Pl asmodium vivax
The focus of malaria control programs has, to date, been largely on P. falci-
parum because this parasite is the major cause of mortality and severe clinical 
malaria, especially in tropical Africa, although there is recent evidence that 
the burden of P. falciparum infection in Southeast Asia may have been under-
estimated.1,2 However, once elimination becomes the target, P. vivax needs to 
Box 8 .1 | Main Messages
•	 Strategies developed for malaria elimination should be planned to detect all infections and not 
just those that are responsible for clinical malaria.
•	 The progress of a malaria elimination initiative should be monitored regularly, as the epidemi-
ology will change and measures used for parasite killing (and vector control) may need to be 
modified. It is important to obtain accurate estimates of the numbers of infections persisting in 
the community.
•	 Clinical diagnosis is inappropriate for an elimination program and should be replaced by 
malaria-parasite-specific diagnosis, by either rapid diagnostic tests (rDTs) or microscopy of 
blood films. reference facilities, with personnel to provide quality assurance for microscopy and 
rDTs, are needed.
•	 Diagnostic measures should assume that all Plasmodium species can persist as both subclinical 
and mixed infections.
•	 Trials of drug combinations that include a drug capable of killing gametocytes (or stages devel-
oping in the mosquito) should be undertaken for both treatment and mass drug administration 
(MDA). Safety should be a priority, particularly when drugs are likely to be given to a large 
number of people who are not infected.
•	 An assessment should be made of the appropriateness of using either MDA or mass screening 
and treatment (MST) in order to find and kill the last parasites.
•	 There needs to be greater focus on P. vivax, as the number of infections and the severity of the 
disease are commonly underestimated.
•	 P. vivax and P. ovale present particularly challenging problems because they can persist unde-
tected in the liver for 3 to 5 years. A detection and treatment strategy should assume that new 
blood infections can occur in an individual over several years without exposure to infectious 
mosquito bites.
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be given much more attention. As discussed in Chapter 5, the proportion of 
the 3.6 billion people who were living at risk of malaria in 2005 was higher 
for P. vivax than for P. falciparum.3 As many as 250 million infections may be 
due to P. vivax each year.4 In many places outside Africa, such as in some coun-
tries of Central and South America, P. vivax is the dominant malaria problem.5 
As shown in Figure 8.1, P. vivax and P. falciparum coexist in many countries 
around the world.
Issues such as underdiagnosis, relapse from dormant liver stages, a poor 
understanding of mechanisms of acquisition of immunity, and interspecies 
interaction complicate any malaria control intervention in areas where P. vivax 
infection predominates and will block achievement of the goal of eradication 
unless taken into account.6
The low priority given to P. vivax infections by policy makers, funders, and 
researchers stems in part from the historical under-recognition of the scale 
of the problem, an issue which is now being acknowledged. Even more of an 
obstacle has been the definition of P. vivax malaria as “benign” malaria, imply-
ing that it does not present as serious an infection and can be ignored until the 
P. falciparum malaria problem is controlled. This perception is being seriously 
Comoros
Zanzibar
Vanuatu
Solomon Islands
Cape Verde
Sao Tome & 
Principe 
>90% P. falciparum
>90% P. vivax
P. falciparum and P. vivax
F i g u r e  8 .1   The distribution of P. falciparum and P. vivax by country
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challenged by a growing number of case studies that indicate that P. vivax can 
cause severe malaria.7 Two recent studies on the island of New Guinea, from 
both the Papua, Indonesian, side and the Papua New Guinean (PNG) side, have 
shown that P. vivax can cause severe disease.8, 9 In the PNG study of almost 
10,000 children, mainly under 5 years old, the proportion of cases with a WHO 
definition of severe malaria caused by P. falciparum was 11.7%, while P. vivax 
followed closely behind at a substantial 8.8%.
Although there is increasing recognition that P. vivax contributes signifi-
cantly to the global malaria burden, the number of infections persisting in 
the community is probably still being massively underestimated. This has sig-
nificant implications for those countries where P. vivax malaria is endemic and 
that are already setting an elimination goal, for example, Vanuatu and the 
Solomon Islands. The extent of this underestimation has been revealed by the 
use of sensitive methods based on polymerase chain reaction (PCR) for diagno-
sis of blood-stage infections in large community studies in areas of PNG where 
the four human malaria species are co-transmitted.10, 11 Increases in the esti-
mated prevalence of P. vivax by 2- to 3.5-fold were observed, and even greater 
increases in the prevalence of P. malariae and P. ovale were seen.12 The number 
of estimated mixed infections increased by orders of magnitude when these 
sensitive detection methods were used. We should note that the same problem 
of underestimation of prevalence can occur with P. falciparum in apparently 
low-endemicity areas, unless the sensitive diagnostic methods are employed.13
One of the big obstacles to stopping transmission of P. vivax, and one of its 
major distinctions from P. falciparum, is the ability of P. vivax to relapse after 
cure of the original bloodstream infection. A proportion of sporozoites remain 
dormant as hypnozoites for periods as short as a few weeks or as long as 5 
years before emerging to cause a clinical, blood-stage infection (Chapter 5). 
The dormant stages are not detectable, and the ability to relapse will hinder 
elimination of this parasite. In order to interrupt transmission completely, it 
will be necessary to kill the hypnozoites.
Mixed inFectionS
PCR studies such as those discussed above have shown that there is a much 
larger pool of mixed infections than suspected, which raises another difficulty 
for elimination. In areas where transmission of more than one malaria species 
is common, a malaria-infected person is very likely to be co-infected with more 
than one species of Plasmodium. In such circumstances, there may be inter-
species interactions that are modified by interventions that alter the balance 
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between species, as has been seen in the highlands of Papua New Guinea.14, 15 
The question remains open as to whether the simultaneous presence of non-
 falciparum malaria can reduce the clinical impact of infection with P. falciparum. 
Good examples can be found in the literature arguing either way, although a 
recent meta-analysis of all available studies fell on the side of a significant nega-
tive association between mixed infection and clinical disease.16 Most of these 
earlier studies are, however, colored by the underestimation inherent in the 
use of non-PCR-based techniques for diagnosis, and more research is needed to 
determine how the pattern of malaria might be altered in areas where infection 
with multiple species is common as a program moves toward elimination.
8.3 | Malaria immunity and elimination
People who live in malaria-endemic areas show an age-structured burden of 
clinical disease, with older children and adults having resistance to severe mor-
bidity and death due to the acquisition of natural immunity, although the 
nature of the immunological changes that are involved is still not fully under-
stood.17 Once control programs have reached the stage at which elimination 
in a particular community is a possibility, it is likely that there will have been 
a reduction in the level of naturally acquired immunity in that community, 
though it may be a number of years before there is a substantial loss in the 
community as a whole. This progressive change may have a significant impact 
on the final attempts to achieve elimination. Some examples of the changes 
that may be encountered are considered below.
Reduction in naturally acquired immunity in a community may result in a 
change in the age pattern of the few clinical infections that continue to occur, 
with more cases being seen, first in older children and then in adults, than 
had been the case previously. This necessitates a change in treatment programs 
with, for example, an increased focus on older schoolchildren.
There is strong evidence that in malaria-endemic areas where some level of 
drug resistance is present, treatment success is often enhanced by naturally 
acquired immunity. As control improves and elimination becomes a feasible 
target, highly effective drug combinations will be needed that can achieve cure 
without any help from naturally acquired immunity.
Reduction in the community level of acquired immunity as a result of suc-
cessful control programs over a period of years will also increase the risk of an 
epidemic resurgence of the infection, as seen in the highlands of Madagascar18 
and on the island of Mauritius (Chapter 10) when control programs failed after 
a lengthy period of success. Much still needs to be understood about the impor-
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tant and dynamic interplay between immunity and exposure before we can be 
confident in predicting the effect of interventions and can formulate strategies 
to minimize adverse impact.
8.4 | Finding and killing the last parasites
In an elimination program, treatment of a sufficient number of infected sub-
jects in a community, whether they are symptomatic or asymptomatic, to 
interrupt transmission becomes the primary goal. Two possible approaches to 
this objective can be adopted — detection and treatment of infected individuals 
capable of transmitting the infection, or MDA given to as large a proportion of 
the population as possible on the grounds that this will cover a high propor-
tion of those infected. As naturally acquired immunity wanes, the proportion 
of symptomatic individuals increases, making it easier to detect them as they 
are more likely to seek treatment. However, as we have seen, even in areas of 
relatively low transmission, asymptomatic individuals are still detected, and 
they need to be treated in order to interrupt transmission. The availability of a 
sensitive method for diagnosing malaria is essential for this strategy of malaria 
elimination.
diagnoSiS oF Mal aria inFection
When killing the last remaining parasites becomes the goal, an ability to iden-
tify all parasites becomes increasingly important. Good-quality microscopy 
conducted by skilled technicians with capacity to manage appropriate quality 
control, and currently available RDTs, whose effective use requires less train-
ing than microscopy, are generally adequate for diagnosis in persons who are 
acutely ill with malaria. However, there are particular issues to be addressed 
with both procedures. Ensuring the quality of microscopy used for routine 
diagnosis has often proved difficult, as the sensitivity and specificity of routine 
microscopy is significantly lower when compared with that of qualified micros-
copists based in central reference laboratories. This underlines the need for 
good training in microscopy for staff in primary health centers, coupled with 
the provision of reliable, well-maintained equipment and regular monitoring 
and quality control (Chapter 2).
There is a wide range of commercially available RDTs. Each one incorporates 
a monoclonal antibody that detects one of three well-characterized proteins 
of the malaria parasites. Though cost is a problem, they are becoming widely 
used. Among the many tests being manufactured, there is considerable vari-
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ability in quality, however, so it is important to establish quality assurance 
programs for quality of manufacture, plus measures of their stability and per-
formance over time.19, 20 Some RDTs detect only P. falciparum, but others can 
distinguish between falciparum and non-falciparum malarias, although RDTs 
are generally less sensitive at detecting non-falciparum infections.21
When compared against each other, microscopy and RDTs detect a similar 
minimum threshold density of parasites (about 50 parasites per microliter of 
blood). Thus, the choice for routine use is this: use microscopy, which is tech-
nically more difficult but is better for species identification (especially non-
falciparum species) and for estimating parasite densities, or diagnose with the 
user-friendly RDT, which gives a positive or negative result (but not a measure 
of the density of parasites) and is not as good for detecting P. vivax and the 
other non-falciparum parasites.
Since most elimination efforts will need to deal with both low-density para-
sitemias and non-falciparum species, diagnosis becomes a major challenge for 
elimination programs. More-sensitive methods of diagnosis than microscopy 
and RDTs are likely to be needed, including those that can detect small num-
bers of gametocytes. Although the propensity of a gametocyte carrier to trans-
mit infection is related to the density of gametocytemia, individuals with very 
low gametocyte numbers can still transmit infection and can be an important 
part of the reservoir of infection. Thus, if an elimination program is to be based 
on detection and treatment of all potential transmitters of infection, much 
more sensitive detection tests will be needed.
PCR assays provide the sensitivity needed to detect low parasitemias, includ-
ing low-level gametocyte infections. Studies in Kenya and Tanzania using the 
QT-NASBA real time PCR assay have shown that this increases the number 
of gametocyte carriers detected in the population 40-fold over the number 
detected by microscopy. LAMP assays may prove to be equally sensitive.22 
Developing tests with the sensitivity of these assays that can be employed in 
field situations is a key priority for the operational research agenda (Chapter 
10) in elimination.
Serology, which employs relatively crude assays such as the measurement 
of antibodies against the whole parasite by fluorescence, was occasionally used 
during previous eradication programs to monitor their impact, but serology has, 
until recently, been a largely neglected aspect of malaria research. In China, 
immunofluorescence assays are being used in schools at the end of malaria 
transmission seasons to measure how much P. vivax transmission has occurred, 
and it is used as a guide to whether any control interventions are needed. New 
studies using antibody assays to defined malaria antigens, particularly MSP-1, 
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have shown that serology can play an important role in assessing malaria ende-
micity, and it could therefore make an important contribution to elimination 
programs. It is unlikely to be used to detect infection in individual subjects, but 
it may prove to be very useful in monitoring the progress of elimination efforts 
and for detecting foci where transmission is still continuing, and where extra 
control efforts are needed.
drugS to kill the l aSt par aSiteS
Treatment of malaria in the context of elimination necessitates achieving a 
complete parasitological cure, including killing of the parasites in their sexual 
stages, either in the blood of the infected subject or in the midgut of any vector 
mosquito that ingests them. Artemisinin-based combination therapies (ACTs), 
now the first-line treatment for P. falciparum malaria in nearly all countries, 
have an advantage over many other antimalarials used for treatment — they 
have some effect on gametocytes, thus reducing the potential for transmission. 
The introduction of ACTs may have contributed to the marked reduction in 
the incidence of P. falciparum malaria seen on the Thai/Myanmar border23 and, 
more recently, in some countries in Africa, such as South Africa24 and Zanzibar. 
However, the effect of artemisinins on gametocytes of P. falciparum is not com-
plete, and patients treated with artemisinins can still transmit malaria infec-
tion.25 In fact, the mature gametocytes of P. falciparum are resistant to most of 
the antimalarial drugs that affect the asexual stages, and they develop much 
more slowly than gametocytes of the other three species. Currently, the only 
licensed drug that can ensure complete killing of P. falciparum gametocytes 
is the 8-aminoquinoline drug primaquine, which is very effective at prevent-
ing transmission when given as a single treatment. Thus, in the context of 
elimination, any patient treated for P. falciparum malaria should also receive 
primaquine in addition to the primary treatment unless he or she is glucose-
6-phosphate dehydrogenase (G6PD) deficient and thus at risk from hemoly-
sis.26 Within the context of an active case detection program, the inclusion of 
screening for G6PD deficiency is recommended, but the tests available are not 
readily applicable, and testing becomes increasingly difficult for mass treat-
ment programs. Development of simple, cheap, field-friendly tests for G6PD 
deficiency (Chapter 10) would greatly facilitate the elimination agenda, par-
ticularly because there are different forms of G6PD deficiency, some of them 
relatively mild and therefore perhaps not presenting such a serious risk to the 
treated patient.
There are many factors that can lead to an increase in the number of game-
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tocytes of P. falciparum circulating in the blood and hence capable of increasing 
transmission to vector mosquitoes. Most of these are not well defined, but the 
numbers can increase during the course of a long infection (being higher at 
the end of a season of transmission than at the beginning), when the patient is 
anemic, and as a consequence of the development of drug resistance. This last 
effect is particularly important as the increased transmissibility contributes to 
the spread of resistance. Increase in gametocyte numbers has been identified 
as the first indication that a drug is beginning to fail and emphasizes the need 
for treatment to include drugs that will kill the sexual stages — what has been 
called “prevention by treatment.”19, 27
Gametocytes of P. vivax, P. ovale, and P. malariae appear in the circulation at 
the same time as the asexual stages and, unlike the gametocytes of P. falciparum, 
are killed by the antimalarial drugs that are effective against the asexual blood 
stages. P. vivax transmits well at very low parasite densities, so transmission can 
already have occurred before a patient has become symptomatic and sought 
treatment.19
Obtaining a complete cure of vivax or ovale malaria is a more complex pro-
cedure than is the case for P. falciparum infections, as it involves not only killing 
sexual and asexual blood-stage parasites but also eliminating residual inactive 
parasites in the liver (hypnozoites). Currently, primaquine is the only licensed 
drug that can do this.28 As mentioned above, primaquine can cause hemolysis 
when given to subjects who are G6PD deficient, and this complication is more 
likely to occur when the drug is used to eliminate hypnozoites, as opposed to 
killing gametocytes, as a much more prolonged course of treatment is needed — 
for example, a 14-day course.26 Tafenoquine is a new 8-aminoquinoline under 
development that has the advantage over primaquine that a much shorter course 
of treatment is needed.29 However, it still has a propensity to cause hemolysis 
in G6PD-deficient subjects, and development of a safer treatment for killing 
P. vivax hypnozoites is a high research priority that is now being addressed by 
organizations such as the Medicines for Malaria Venture (MMV).
8.5 | Mass drug administration and elimination
MDA has a mixed reputation and is not recommended by WHO. Part of the 
antagonism comes from a form of MDA that involved use of salt fortified with 
chloroquine or pyrimethamine (the Pinotti method) that, predictably, led to the 
rapid development of resistance. However, other forms of targeted MDA have 
been much more successful, for example, intermittent preventive treatment 
(IPT) in infants and children30 (though IPT is not appropriate in low-endemic 
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settings). Many large community-based studies of MDA, such as those under-
taken in Nicaragua and Garki, Nigeria, have shown that community-based 
MDA can be highly effective in reducing parasite prevalence to a very low level 
but that parasitemia soon rebounds to its previous level once MDA is stopped.31 
Thus, this form of MDA has no role in disease control programs, except dur-
ing epidemics. However, MDA could play a key role in the final stages of an 
elimination program as an alternative to an active case detection program, 
once the level of infection has been reduced to a low level.27 Although a dif-
ficult and labor-intensive process, MDA may be easier and more effective than 
mass screening and treatment, and previous studies have shown that a high 
level of coverage can be achieved for a limited number of treatment rounds, 
provided there is full involvement of the community. MDA probably played 
an important role in the elimination of P. falciparum and P. vivax malaria from 
Aneityum, Vanuatu.32
Drugs used for MDA should ideally be active against sexual-stage parasites 
(and hypnozoites, if used in an area where P. vivax or P. ovale infections are pres-
ent), and they must be very safe, as a high proportion of the subjects treated are 
likely to be uninfected. Any serious adverse event that could clearly be linked 
to the medication would end a community’s participation, no matter what 
the long-term risk-benefit equation indicated. Whether it would be safe to use 
primaquine for MDA in large populations where G6PD deficiency prevalence 
is high without screening is uncertain; a safer drug, or drug combination, for 
MDA is urgently needed.28
8.6 | vaccines 
The Prospectus focuses on the tools available to eliminate malaria today and/
or in the near future, and it therefore pays little attention to malaria vaccines. 
This is because it is unlikely that a malaria vaccine that is effective enough 
to play a significant role in malaria elimination will become available in the 
next few years. However, in the longer term, malaria vaccines may have a very 
important role to play in malaria elimination programs, especially in areas 
where the infection is otherwise difficult to control.
Any malaria vaccine that is highly effective at preventing infection, regard-
less of whether it acts at the pre-erythrocytic or erythrocytic stage of parasite 
development, will have an impact on transmission. However, in areas of mod-
erate or high transmission, modeling indicates that for a significant effect to be 
achieved, efficacy will need to be very high, probably as high as 95%. 
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Thus, as elimination becomes an increasingly realistic prospect, there has 
been renewed interest in the development of vaccines which are targeted spe-
cifically at preventing transmission either by inducing an immune response 
that destroys gametocytes or interferes with the development of the parasite in 
the mosquito. A move to elimination has raised the development of transmis-
sion blocking vaccines higher up the malaria research agenda than in the past 
and a number of candidates are now reaching the stage of early clinical trials.33 
For transmission blocking vaccines to be most effective they will need to be 
given to as large a proportion of the population as possible, and probably deliv-
ered through mass campaigns in a manner analogous to that used to deliver 
drugs in MDA programs.
8.7 | conclusion
Elimination of malaria involves a paradigm shift away from treating patients 
with malaria toward killing the last few malaria parasites. Relapsing malaria 
such as P. vivax will become increasingly important as current measures limit 
transmission of P. falciparum malaria. Improved means to detect asymptomatic 
persons with low parasitemia will be crucial to malaria elimination. Effective 
chemotherapy is and will remain a primary means of achieving malaria con-
trol and eventually elimination. Mass screening (active case detection) and 
MDA are alternative approaches toward this goal, but both are hindered by 
the lack of a safe and effective drug that is highly effective at killing both the 
sexual stages of all the main human malaria parasites and the resting stages of 
the relapsing malaria infections.
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9 |  SuppreSSing the vector
Ahmadali enayati,a,d Jo Lines,b rajendra Maharaj,c and 
Janet Hemingwayd
9.1 | introduction
Vector control is the main attack weapon for reducing malaria transmission.1 
It is a lead intervention in the Roll Back Malaria (RBM) Global Malaria Action 
Plan. It is the only tool that is capable of bringing intense or moderate trans-
mission down to the low levels where elimination is within reach. It can also 
play an important role in knocking out the last foci of transmission in the 
later stages of elimination. In this chapter, we provide an overview of available 
vector control tools and a summary of the essential characteristics of the vari-
ous methods. We then consider how these methods fit within an elimination 
context and their respective roles at each stage of the process. Finally, we con-
sider a few examples of operational issues in implementation and some critical 
constraints to the effectiveness of vector control.
9.2 | introduction to the anopheles vector Species
Malaria is transmitted by female mosquitoes of the genus Anopheles. About 
70 species of Anopheles transmit human malaria, but only about 30 of these 
are of major importance as vectors. In any given area, just a few Anopheles 
species will be responsible for most malaria transmission. Individual species 
aSchool of Public Health and Environmental Health Research Centre, Mazandaran 
University of Medical Sciences, Sari, Iran; bLondon School of Hygiene & Tropical 
Medicine, London, UK; cMalaria Research Program, Medical Research Council, Durban, 
South Africa; dLiverpool School of Tropical Medicine, Liverpool, UK
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vary widely in their breeding and biting behavior. The main characteristics 
that determine whether an Anopheles mosquito is a major vector of malaria are 
its blood feeding preferences (predominantly animal or human) and longev-
ity. The range and type of breeding place can be highly variable for different 
mosquito species.
Anopheles mosquitoes occur throughout the world, with the exception of 
the Polynesian and Micronesian islands of the Pacific Ocean and most arc-
tic regions. Following is a list of some examples of biological and behavioral 
differences.
in aFrica
The principal vectors in sub-Saharan Africa belong to the A. gambiae or A. 
funestus groups of species. The vector species within these groups feed and rest 
indoors at night (i.e., are endophagic and endophilic), so insecticide-treated 
nets (ITNs) and indoor residual spraying (IRS) are effective against them.
The relative efficiency of these African species as vectors, compared with 
Box 9.1 | Main Messages
•	 Vector control is a vital attack weapon of elimination. It is the only intervention capable of 
reducing transmission in the early stages of elimination.
•	 In the later stages of elimination, the role of vector control is to knock out the remaining foci of 
transmission; post-elimination, its role is reducing outbreak risk and as a defense against reinvasion.
•	 The deployment of vector control must be carefully adapted both to the biology of the local 
species of vector mosquitoes and to the local epidemiology of malaria.
•	 Although some countries have kept up intensive and successful vector control operations for 
several decades, many others have encountered serious technical and operational obstacles to 
sustainability, including insecticide resistance in the mosquitoes and gradual declines in both 
the technical quality of spraying operations and acceptance by target communities.
•	 If transmission is suppressed by vector control for a long period and this suppression is then 
withdrawn suddenly, rapid resurgence of malaria can sometimes lead to catastrophic epidemics 
with substantial loss of life.
•	 Without a substantial expansion in training, the scarcity of specialized expertise in vector 
control will be a growing practical constraint on the delivery and effectiveness of vector control 
programs.
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their equivalents in other continents, is one of the main reasons that 90% of 
the world’s malaria mortality occurs in Africa.
These species do not breed well in man-made containers or in water with 
organic pollution, so they tend to be excluded by the process of urbanization; 
for this reason, the intensity of transmission in Africa tends to be much lower 
in urban areas.
in india
Conversely, India is the only part of the world where malaria transmission 
is often more intense in town than in the surrounding countryside. This is 
because one of the main Indian vectors, A. stephensi, is the only important 
malaria vector that is adapted to breeding in man-made containers, such as 
rooftop water tanks. Transmission in the rural areas is sustained by members of 
the A. culicifacies complex, another very effective vector.
in SoutheaSt aSia
The most efficient vectors in Southeast Asia, A. dirus and A. minimus, are 
strongly associated with forests. Hence, malaria transmission tends to be most 
intense in forested areas, many of which are in remote mountainous regions, 
often on the borders between countries.
The African and Indian vectors tend to bite and rest indoors and so are well 
controlled by indoor spraying. By contrast, the forest vectors of Southeast Asia, 
and the equivalent species in the Amazon basin, such as A. darlingi, are all 
much less likely to rest indoors and so are less well controlled by spraying.
9.3 | the vector control Menu
irS  —  indoor reSidual Spr aying
In terms of its immediate impact, IRS remains the most powerful vector con-
trol technology to reduce and interrupt malaria transmission.2 This reflects 
two critical aspects of the biology of the vector. The first concerns the biting 
habits of anopheline mosquitoes. Tropical Anopheles mosquitoes feed repeat-
edly, every 2 or 3 days, and most of the important vector species tend to bite 
humans indoors and then rest on the walls of the bedrooms. This means that 
they risk being killed every time they feed indoors. The other key biological 
fact is that it takes malaria parasites approximately 11 to 14 days to mature 
inside the mosquito before they are ready to be passed on to the next human 
host, and in the tropics, only a small minority of Anopheles females live that 
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long. The critical advantage of IRS is that it not only reduces the abundance 
of mosquitoes but, more importantly, reduces their lifespan. This makes a big 
difference; even a marginal reduction in longevity will produce a dramatic 
reduction in transmission.3
The advent of house spraying in the 1950s made effective malaria preven-
tion feasible for the first time in scattered rural populations. The impressive 
initial achievements of large-scale IRS led to the creation of the first global 
malaria eradication campaign, and the eventual failure of this campaign was 
also attributable in part to vector control problems that were anticipated but 
underestimated. First, a long series of pilot IRS trials failed to demonstrate that 
the highly intense transmission in tropical Africa could be interrupted, even 
by careful deployment of a combination of the most powerful malaria con-
trol weapons.4, 5 Meanwhile, in much of Asia, progress had slowed down or 
stalled because of problems related to logistics, reduced compliance from target 
populations, insecticide resistance, and vector behavior.6 Eventually, the world 
reluctantly concluded that global eradication was “technically unfeasible.”
The same caveats that applied to the first eradication campaign can be 
applied to elimination campaigns today. IRS is a logistically demanding inter-
vention: it is easy to do badly and is then ineffective. Proper infrastructure 
that can sustain coverage in a targeted area must be in place, including a sys-
tem for selecting the right insecticide, adequate supervision of the program, 
enforced safety measures for sprayers, reliable and up-to-date spray equipment, 
frequent monitoring of progress, and careful evaluations of the program. The 
local epidemiological, entomological, and transmission patterns of the targeted 
areas must be understood and carefully monitored throughout the program. 
Furthermore, as IRS must be deployed on the insides of homes, community 
acceptance of IRS must be obtained to ensure that targeted populations under-
stand and will consent to the spray program.
For elimination, IRS may have to be intense, thorough, and prolonged; the 
problem is that this may also intensify selection for resistance. The speed at 
which resistance is selected is unpredictable. The crucial point is that there are 
only four classes of insecticide recommended for IRS, so running out of effec-
tive compounds is possible. This means that there may be a limit to the period 
over which very intensive IRS can be sustained.
Insecticide choice may be further constrained by available formulations. 
Current IRS insecticide formulations last from 2 to 6 months, and this is a major 
constraint on its effectiveness. Formulations have improved recently, but with 
the exception of DDT, which is intrinsically stable, most IRS formulations last 
less than 4 months, so there is room for considerable further improvement.
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itns  —  inSecticide-treated netS
Insecticide-treated nets have become the most widely used form of vector 
control, not because they are more powerful than IRS, but because they are 
usually less demanding logistically and coverage is easier to sustain. Ordinary 
ITNs need to be retreated every year or so, but this is not so with long-lasting 
insecticide nets (LLINs), which are designed so that the insecticide lasts as 
long as the net. ITNs work in two ways: first, they protect the individual user 
against biting, and second, they can kill some of the mosquitoes that try to 
bite. Like IRS, use of ITNs can produce a community-wide reduction in trans-
mission.7 Untreated nets give valuable protection against malaria, and their 
public health utility should not be underestimated, but the addition of the 
insecticide approximately doubles this protection.
ITNs (including LLINs) can be distributed in large-scale campaigns or 
through routine health contacts such as antenatal care and childhood immu-
nization services. When the aim is disease control in high-transmission set-
tings, they may be targeted to young children and pregnant women. In an 
elimination program, they should be provided to every sleeping place, as a 
means of general transmission control.
Community acceptance of ITNs, as with IRS, is essential if the targeted 
population is to use the nets properly. For example, some communities have 
a long tradition of net use, with well-established preferences for shape, size, 
color, and fabric. In places with a lot of nighttime nuisance biting by mos-
quitoes, most people who are not otherwise protected are happy to use a net, 
but it is often important to emphasize the need to use ITNs even when levels 
of nuisance biting are low. Engaging the community in the decision-making 
Box 9.2 |  is a combination of Both itns and irS More 
effective than either alone?
So far, there is insufficient operational data to answer this question, which 
is important for the purposes of elimination at the geographical margins of 
malaria. From the point of view of disease control, however, we must not 
forget that the majority of children in Africa (who suffer about 85% of the 
global burden of disease) so far have no access to either of these interven-
tions. For the moment, therefore, the public health priority at the regional 
level must be to extend coverage with either IrS or ITns, whichever is more 
convenient locally.
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process is important, as are information, education, and communication (IEC) 
campaigns.
at tackS on Breeding SiteS  —  Source reduction, 
environMental control, and l arviciding
Before the advent of DDT, destroying the larvae of mosquitoes was the only 
available form of vector control.8 However, if the aim is to interrupt disease 
transmission, attacking the larvae tends to be less effective and efficient than 
attacking the adults. Larval control is not effective unless it is extremely thor-
ough, and this is difficult to achieve. Most malaria vector Anopheles species pre-
fer breeding sites that are small, numerous, scattered, and shifting. The critical 
obstacle is not how to kill the larvae in the known breeding sites but how to 
find and routinely treat all the sites. Each species has its own idiosyncratic pref-
erences, so detailed knowledge of the specific kinds of water exploited by the 
local vectors is needed: some vectors breed in freshly formed puddles, others 
in rice fields or in established pools or marshland. The larval control has to be 
deployed and constantly sustained over a large area; tropical malaria vectors 
take only a week to complete their larval development and can easily fly 4 or 
5 kilometers. For all these reasons, effective larval control requires highly spe-
cialized expertise, substantial investment, and constant effort.
There are opportunities for effective larval control when breeding sites are 
few, fixed, and easy to identify. Most of the famous examples of successful lar-
val control have occurred in circumstances where, for one reason or another, 
breeding sites were clearly identifiable and confined to locations that were well 
defined and fixed.9 Such situations are not common, but experience shows 
that when they occur, there are sometimes opportunities to knock out all the 
sites with just one economical intervention. The key rule is “don’t make things 
worse.” In many places, a substantial proportion of the local breeding sites are 
man-made, typically as an inadvertent side effect of some otherwise beneficial 
activity. Often these problems are a consequence of ignorance and misinforma-
tion about mosquitoes and how they breed.
9.4 |  comparing the impact of alternative vector control 
Methods on transmission
Eliminating the vector is not possible; our current methods of vector control 
are not normally capable of reducing vector numbers to zero over a large area. 
As we have seen, some methods of vector control (such as attacks on breed-
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ing sites) act simply by reducing mosquito numbers and 
reduce transmission in simple direct proportion to their 
effect on vector population size. Other methods (such as 
IRS) have a larger impact on transmission by reducing 
not only the size of the vector population but also its 
capacity to transmit malaria.
The intensity of malaria transmission varies across 
a remarkably large range. For example, in areas with 
moderately intense transmission, people are typically 
exposed to an average of 10 to 100 bites from infectious 
mosquitoes per person per year. At the other end of 
the scale are locations that have reached the threshold 
between the pre-elimination and the elimination phases of the process, a point 
that is defined by the World Health Organization in terms of an observed inci-
dence of 0.1 cases per 1,000 persons per year. A difference of about 100,000-fold 
separates these two situations. Converting any given location from the former 
condition into the latter is beyond the capacity of control methods that reduce 
mosquito population size but have no other effect on vectorial capacity. In 
the future, this might become feasible if researchers succeed in developing 
methods, almost certainly involving genetic modification of the mosquitoes, 
that can eliminate the ability of local vector populations to transmit malaria 
altogether. At present, this essential first giant step in the elimination process 
can only be done with methods such as IRS and ITNs, which work by reducing 
vector longevity as well as vector population size.
9.5 |  how the role of vector control evolves through 
phases of elimination
Because of the characteristics reviewed above, the relative roles of these dif-
ferent forms of vector control evolve — before, during, and after elimination is 
achieved. These changes are summarized in Table 9.1. Various terms have been 
suggested for the successive stages of the elimination process (Chapter 3); here 
we use our own functional classification, which focuses on the role of different 
vector control methods during each phase. 
prepar atory phaSe
Planning is the key to effective vector control.10, 11 Accurate information is 
needed on the biology and behavior of the vector mosquito species and on the 
geography and epidemiology of the malaria foci to be attacked. This informa-
Box 9.3 | genetic control
At present, the use of genetically mod-
ified mosquitoes is an area of intense 
research. Such methods might even-
tually be useful for elimination pur-
poses, but there is no genetic control 
technology that is likely to be prac-
tical for application against malaria 
vectors in the next few years.
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taBle 9.1 |  allocation of malaria suppression measures to different phases of an 
elimination program
 
 
 
attack phase
elimination 
stages
 
consolidation
 
Maintenance
rationale and 
role
•	 General	reduction	in	
transmission
•	 Maximum	
intensity and 
complete coverage 
throughout, with 
aim to interrupt 
transmission 
completely
•	 Intensive	attacks	
on remaining 
foci (predictable) 
and outbreaks 
(unpredictable)
•	 Maximum	
targeting and 
responsiveness as 
malaria becomes 
increasingly 
unstable, with 
essential vector 
control and drugs 
•	 Rapid	(fire	brigade)	
emergency 
responses around 
cases
•	 Long-term	
background 
measures to reduce 
outbreak risk
•	 Background	
long-term 
measures 
to reduce 
outbreak risk, 
perhaps now 
with reduced 
scale and 
intensity
weapons •	 IRS	and	100%	
coverage with 
ITns (LLIns) for 
maximum impact 
•	 Good	
epidemiology, key 
for targeting, and 
IrS for shifting 
targets
•	 Nets	(including	
untreated) for 
outbreak risk, and 
IrS (and ITns) for 
fire brigade
•	 Nets,	with	
environmental 
measures 
in selected 
places
vulnerabilities, 
threats, 
possible 
reasons for 
failure
•	 Very	high-intensity	
transmission in 
equatorial Africa
•	 Mobile	populations,	
open houses, 
exophilic vectors, 
and inaccessible 
shifting foci of forest 
malaria in Southeast 
Asia and Amazon 
•	 Insecticide	resistance
•	 Conflict	and	
complex 
emergencies 
•	 Failing	to	follow	
the shifting target
•	 Conflict	and	
complex 
emergencies
•	 Sluggish	or	
ineffective 
emergency response
•	 Neglect	of	
background 
measures
•	 Conflict	and	
complex 
emergencies
•	 Complacency
•	 Conflict	and	
complex 
emergencies
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tion should be used to formulate a plan of action for vector control activities 
within the malaria elimination strategy. Another important technical aspect of 
the preparatory phase is mapping of the main sources of infection in the coun-
try in order to allow targeting of interventions at individual malaria foci.12
at tack phaSe
The aim of the attack phase is to interrupt transmission completely for a period 
long enough to allow the reservoir of infection to die out, or else to suppress the 
transmission to such low levels that drug-based interventions can finish the job. 
The attack phase starts with the selection of vector control measures and then 
formulation and implementation of a plan of action, which must consider the 
following criteria: efficacy, cost, ecological acceptability, acceptability by the 
local population, operational feasibility, and administrative suitability, includ-
ing availability of infrastructure, trained personnel, financing, transportation, 
legislative support, technical direction, public information, and community 
participation and sustainability. For present purposes, we should stress that 
these issues must not be underestimated; they require investment in human, 
operational, and technical resources, and meticulous attention to detail.
eliMination StageS  —  rooting out the l aSt Foci oF local 
tr anSMiSSion
Sooner or later, as the general suppression of transmission proceeds, it will 
become clear that local transmission is no longer occurring in many places 
but still continues in a few remaining foci. When the target locations have 
been identified, vector control must be directed with great intensity, and since 
the targets are likely to be shifting from year to year, vector control must be 
capable of tracking this moving target. There are three key operational issues 
to evaluate:
1. How can we find and track the moving target as the foci of transmis-
sion shift and recede? This requires an excellent surveillance system, 
one that is active and effective even in places where other parts of 
the health system are weak. Creating or reinforcing such a system is 
a critical preparation for this phase, and its importance must not be 
underestimated.
2. Having detected the foci, intensive vector control must be deployed, 
much as in the attack phase, but there is little evidence to guide the 
difficult operational decisions about the extent and manner of this 
deployment.
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3. We need to know if there is a particular reason why transmission is 
persisting in some places but not others. Sometimes these remnant 
foci reflect operational or other problems in the deployment or 
public acceptance of vector control, resulting in less-effective cover-
age in these areas. In other cases, there may be a different vector 
(with different behavior or with insecticide resistance) or differences 
in human behavior (e.g., migration patterns), so an alternative or 
supplementary method of vector control (e.g., adding ITNs to IRS) 
may be needed.
conSolidation phaSe
This is a lengthy endgame in which vigilance against reintroduction of malaria 
is required. At the start of this phase, the program must anticipate the possibil-
ity of reinvasion outbreaks and possible epidemics. This means remaining vigi-
lant and being ready to respond, even after a long period of zero local cases. A 
robust surveillance system is needed, covering the whole population, especially 
the hardest-to-reach areas where outbreaks are most likely (Chapter 3). When 
an outbreak is detected, the response must be rapid, determined, and thorough. 
This is classical epidemic control, and the necessary systems and methods are 
essentially similar to those used to control unstable and epidemic malaria. For 
this purpose, IRS has particular advantages that ITNs do not share.13
Maintenance phaSe
During this phase, the desirable characteristics of vector control activities are 
low intensity, with high long-term coverage, and low cost. The key concept 
is outbreak risk reduction. For example, the routine use of untreated nets is 
to be greatly encouraged: It is already a social norm in much of Southeast 
Asia, the Americas, Madagascar, and large areas of West Africa, and such nets 
give approximately half the protection of a treated net.14 Other effective means 
of personal protection, such as the use of window screening, should also be 
encouraged. Vector control interventions that are too weak to be useful in the 
attack phase, such as larviciding and environmental management and espe-
cially avoidance of the creation of man-made mosquito breeding sites, may be 
useful to reduce the risk of reinvasion.
Perhaps the most powerful and neglected factors influencing outbreak risk 
are the social, economic, and environmental developments that have indirect 
and unintended effects on malaria transmission. For example, recent decades 
have seen a massive transformation in housing materials in Africa. Twenty 
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years ago in northern Tanzania, almost all rural houses were thatched, and 
corrugated iron was a luxury; now metal is becoming as common as thatch in 
many areas. This has a profound impact on mosquito entry and biting num-
bers in houses.17, 18 The same is likely to apply to other house construction fea-
tures that are spreading rapidly (e.g., ceiling boards, window shutters, concrete 
brick walls, cement flooring). More effort is needed to study the impact of 
these changes on malaria risk at the household level, and their contribution to 
observed trends in malaria statistics at the population level.
9.6 |  operational and technical constraints on vector 
control
This is a selective list of issues that are either frequently encountered or strategi-
cally important and limit the present and future usefulness of vector control.
procureMent
The procurement of insecticides for IRS or the bulk purchase of LLINs is not 
complicated, but it is time-consuming. In the case of IRS, the amount of 
Box 9.4 |  how quickly will Malaria return if elimination is not 
Successful and vector control Stops?
The answer to this question depends on background vectorial capacity, the period for which trans-
mission has been suppressed, the quality and capacity of the surveillance and response program, 
and the immune status of the human population. In Africa, where background vectorial capacity is 
high, the withdrawal of spraying after 3 to 5 years of intensive control led to different results in dif-
ferent places. In the Pare-Taveta project, malaria came back over several years, eventually reaching 
the original levels of endemicity, but without any excess of disease.15 This may have been because 
the spraying was with the insecticide dieldrin, which has a very long active life span. After another 
spray trial in Kisumu, Kenya, which used the very short-acting insecticide fenitrothion, malaria is 
said to have returned much more quickly, with abnormally high levels of morbidity and mortality 
in the young children who had grown up in the sprayed area and had little immunity. A human 
population that has been unexposed to malaria for a substantial number of years will have little or 
no immunity to malaria, and reinvasion can then produce sudden epidemics that are explosive and 
catastrophic. This is not just a theoretical threat: Disastrous epidemics, sometimes causing hundreds 
of thousands of deaths, occurred after various intervals following the withdrawal of spraying in 
ethiopia, Madagascar, and Sri Lanka.16
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insecticide needed can be calculated based on previous years’ consumption, 
with a small percentage increase to take into account new structures that may 
have been built. The tendering process involves a great deal of decision mak-
ing and needs to be started early. Timing is critical: IRS must be performed 
at or just before the onset of the transmission season, and any delay greatly 
reduces its effectiveness. The manufacturers only start making the product 
after the order has been placed, and this means that lead times can be very 
long. Underestimation of the need to plan well in advance and order early is a 
common source of problems in practical vector control programs.
coMMunity reSiStance
Community involvement and acceptance of vector control measures, particu-
larly IRS, have been cited as very important. Sometimes they are difficult to 
obtain, and the response may depend on the insecticide that is used. Modern 
house construction may offer protection against transmission, but their inhab-
itants often have the most resistance to spraying, especially of DDT.
ForeSt Mal aria
In large forested areas of Southeast Asia, Africa, and South America, vector con-
trol is less effective than elsewhere. This is partly because of vector behavior: 
Vectors of forest malaria mainly rest outdoors and not in houses protected by 
IRS. Some tend to bite outdoors, or early in the evening, reducing the effective-
ness of ITNs. Human behavior is also an important part of the challenge; often 
forest communities are mobile, practice shifting cultivation, move to stay in 
distant farms during part of the rainy season, and may be wary of outreach 
efforts. In many areas, the people live in houses with incomplete walls and 
sleep in hammocks, not beds. Forests also attract many temporary visitors. All 
this makes it very difficult to deliver vector control in a way that is effective.19
inSecticide reSiStance  —  eSpecially, pyrethroid reSiStance
Insecticide resistance is often a key constraint limiting the sustainability of 
intensive insecticide-based vector control operations.20 Experience in the 1960s 
and 1970s, in the first malaria eradication campaign, showed that resistance is 
not the most frequently encountered obstacle to effective vector control, but it 
is one of the most difficult to overcome.1
Resistance is a particularly urgent and decisive threat for ITNs because, so 
far, we have only one class of insecticides, the pyrethroids, that combine a 
safety profile suitable for use on fabric next to the skin with a rapid mode of 
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action that kills or repels the insect before the person sleeping under the net 
is bitten. One form of a pyrethroid-resistant gene, kdr, is already widespread 
in West African vectors and present to a lesser extent in East Africa.21,22 Some 
studies have claimed that ITNs and even IRS can still be effective despite high 
frequencies of this resistance gene in the local vectors,23 but the gene is spread-
ing rapidly and hence must confer some advantage on the insects that carry 
it. Even more worrying is the evidence that more-powerful metabolic mecha-
nisms have appeared in some localities in South and West Africa.24, 25, 26 It is 
hard to overestimate the strategic implications of a resistance gene that can 
undermine or eliminate the effectiveness of IRS and ITNs.
There are only four classes of insecticide suitable for IRS. Resistance manage-
ment can be practiced using rotations or mosaics of insecticides, but a basic 
understanding of the underlying resistance mechanisms and the cross-resis-
tances they produce is necessary.27, 28 Theoretical models suggest that the most 
effective form of resistance management would be the use of combinations of 
insecticides for IRS, but this would require a great deal of development research 
(Chapter 10), as well as a policy change as great as that needed to establish 
combination drug therapies as the standard for treatment of malaria.
None of this can be managed properly without better monitoring of resis-
tance. There has been a great deal of technical progress developing simplified 
methods for monitoring resistance, but these are not used nearly as widely as 
they should be.20
huMan reSourceS
It was said that the Global Malaria Eradication Program “failed to eradicate 
malaria, but nearly succeeded in eradicating malariologists,” and this is espe-
cially true for malaria entomologists. The facts are simple: global expenditure 
on malaria vector control is at an all-time high, but the supply of people with 
knowledge and skills in vector biology and control has declined steadily for 
the past 25 years. This has happened at all levels, from the most advanced 
experts to the most basic field-workers and technicians. The knowledge and 
skills needed for effective vector control are not especially difficult or demand-
ing, but they are specialized, and they are no longer included in most modern 
courses in epidemiology, infectious disease, or tropical public health. The scar-
city of these skills has emerged as one of the most important constraints on 
current efforts to scale up vector control, and unless the problem is tackled, it 
will remain a key constraint on efforts at elimination.
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9.7 | conclusion
Vector control is indispensable for getting to zero transmission. Although vec-
tor control is the make-or-break intervention, there is still much to be done to 
maximize its effectiveness. Many forms of vector control are especially sensi-
tive to coverage; there can be a great deal of difference between the effective-
ness of 70% and 95% coverage. For elimination, the target is zero transmission, 
and completeness is therefore even more important than in a control setting. 
For the moment at least, effective technologies and the finances to pay for 
them are available, and the critical limiting factors are often infrastructural 
weakness, inadequate organizational capacity, and a scarcity of the skilled per-
sonnel needed to use these resources most effectively. The issues highlighted 
in this chapter illustrate the need for detailed analysis of the technical and 
operational obstacles to 100% coverage and effectiveness of available vector 
control interventions. In the longer term, there remain critical threats to the 
sustainability of vector control that are not yet being adequately addressed.
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10 |   identiFying the gapS  —  
what we need to know
Geoffrey A. Targett,a Shunmay Yeung,a and Marcel 
Tannerb
10.1 | introduction
The preceding chapters have set a detailed agenda for countries considering 
or pursuing an elimination goal, and they discuss the multiple components 
of the decision-making process that leads from a state of improved control 
to the new strategy of elimination. The process by which countries assess 
elimination of malaria as a strategy will have a complex, challenging, and, for 
some, long-term agenda requiring the resolution of a substantial number of 
unknowns. Country or regional resolution of these unknowns will be key to 
the success of the programs. There is no single strategy for countries to follow. 
This immediately requires them to adopt an integrated approach that evalu-
ates and investigates the operational requirements of health systems structures 
and functions. They must consider stakeholders (public, private, nongovern-
ment organizations, and charity), program management, financial feasibility, 
and related issues, plus assessment of technical needs, to determine what is 
going to be the most effective way forward.
The Roll Back Malaria (RBM) Global Malaria Action Plan1 calls for research 
of three kinds to help lead us toward the eventual goal of global malaria 
eradication:
aLondon School of Hygiene & Tropical Medicine, London, UK; bSwiss Tropical Institute, 
Basel, Switzerland
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•	 research and development for new tools, including vaccines, better 
drugs, more vector control options, and more effective diagnostics
•	 research to inform policy, both international and national
•	 operational and implementation research, to better guide detailed 
strategies and action plans in individual countries and ensure the 
optimal use of the correct set of interventions and tools
MalERA (the Malaria Eradication Research Agenda) has been established by 
the Bill and Melinda Gates Foundation to elaborate an agreed research and 
development (R&D) agenda related to successful malaria elimination and erad-
ication. This complements the Global Malaria Action Plan by detailing R&D 
needs for each step. This work is a short-term activity leading to a long-term 
R&D enterprise of the utmost importance. Specifying the need for a better 
drug or a better diagnostic tool needs to be done now, although the products of 
R&D that result will probably not be available for widespread use for another 
10 years. This gestation time could be even longer, for example, with vaccine 
development.
The operational research agenda that the MEG is interested in for elimina-
tion is primarily focused on the second and third areas of research defined by 
the Global Malaria Action Plan. In other words, it is research that is directed 
towards policy and operations and which has a short-term time horizon. The 
MEG is particularly interested in operational research that can help the blue 
elimination countries (Figure 1.1) improve their work and reach elimination 
within the next 5 to 10 years.
The purpose of this chapter is to highlight these more pragmatic operational 
research needs in order to assist countries to move on to an elimination strategy 
in the short term or to sustain their ongoing elimination programs. In addition 
to the chapter’s three authors, others have contributed content in their areas of 
expertise. These include Scott Barrett, Chris Drakeley, Erin Eckert, Michelle S. 
Hsiang, Oliver Sabot, David L. Smith, and Jim Tulloch.
The chapter is organized as a series of key questions leading to research 
priorities. The questions are arranged in a tabular form that is intended to 
guide planning of operational research investigations relevant to getting to 
zero and holding the line. It is not possible here to do more than highlight 
important research areas and admit that in some of these areas, very major 
questions have to be addressed in a progressive manner. They are of funda-
mental importance to consideration, adoption, and achievement of an elimi-
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nation strategy. Predictive modeling of the complex questions may assist in 
decision making.
10.2 | case Studies
There is a diverse literature on the history of malaria elimination from the 
countries where it was achieved. Outlines of two of the successful programs, 
Mauritius and Morocco, are presented.
However, details of activities that were the core of elimination programs are 
often not available. A selection of the key questions that need to be asked about 
each program is set out below to serve as a guide to countries embarking on or 
contemplating elimination. Some of these are very substantial questions:
•	 How was the decision to pursue elimination made?
•	 What intervention strategies were used, and why were they selected?
•	 How was the effectiveness of interventions measured?
•	 How long was it necessary to employ each of the interventions?
•	 What were the financial and economic costs of each activity?
•	 How was the national elimination budget managed?
•	 How was the program financed?
•	 If outside funding was required, how was long-term and dependable 
financing ensured?
•	 What human resources were required to pursue elimination?
•	 How did the government program interact with nongovernmental 
and private sector stakeholders?
•	 What are the annual costs of preventing reintroduction of infection?
•	 How did personnel priorities change as transmission decreased?
•	 How are vigilant, trained staff retained to deal with outbreaks?
•	 Was there a political and legal framework that enabled elimination 
and prevention of reimportation?
•	 What were the major challenges of the elimination program, and 
how were these overcome?
The MEG will investigate case studies of countries that achieved elimination 
or came close to doing so, and these will be made available on the MEG Web 
site.
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10.3 | checklist for health Systems
This section is based on the health systems structure and functions as pro-
posed by WHO.4 Health systems as defined here include both public and pri-
vate stakeholders. Those from within the private sector may include private-
for-profit, NGO, and charity stakeholders.
acceSS to diagnoSiS and treatMent
Accepting that malaria elimination requires an integrated and systemic 
approach, the key questions are around determinants of different health system 
functioning that need to be addressed. This entails understanding (1) which 
comparative analyses are required to evaluate health systems performance in 
Box 10.1 | elimination case Study: Mauritius
Mauritius was originally malaria free.2 The first malaria case was detected in 1864 after anopheline 
vectors were imported through shipping. In 1948, with the support of the British colonial authori-
ties, the malaria eradication program was initiated. Mandated DDT spraying resulted in decreased 
transmission and the elimination of Anopheles funestus. In 1960, WHO assisted in setting up an active 
malaria detection system, and 6 years later targeted DDT spraying replaced the previous strategy.3
Mauritius was certified malaria free in 1973. However, after a cyclone event led to an outbreak 
of malaria in 1982, Mauritius established a plan of action with support from WHO.3 Household 
spraying with DDT was reinstituted in all active foci for a 3-year period, in addition to large-scale 
environmental sanitation work, fogging and larviciding, and the implementation of a malaria detec-
tion system. Blood slides and treatment of all malaria cases began, and staff training was increased. 
During this time, funding was primarily used to purchase spray, fogging equipment, entomology 
and laboratory equipment, insecticide, and drugs.
By 1998 the country was once again considered malaria free. Since then, there has been key 
political support for malaria activities, and government services now carry out most preventive mea-
sures. The port and airport unit disinfects airplanes, screens incoming passengers, registers those 
originating from or transiting malarious areas, and refers them to regional offices for follow-up blood 
slides. early diagnosis through microscopy, including through the private sector, and free treatment 
and follow-up are provided for all cases. A government laboratory tests all blood slides and cross-
checks private laboratory slides. Protocols are established for each of these activities. entomological 
surveillance is ongoing, and vector control requires port and airport DDT spraying every 6 months, 
larviciding, and health education to eliminate breeding areas. Free malaria prophylaxis is provided 
for nationals traveling abroad.
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the delivery of diagnosis and treatment, (2) which health system factors are 
most important to ensure access to preventative interventions and cure, and (3) 
what are the basic requirements for individual and community diagnosis and 
the diagnostic tools/strategies that will enhance health systems performance.
Key linked questions include the following:
•	 How do you improve the reliability of supply of good-quality 
diagnostics and treatment through public sector delivery channels?
•	 How do you ensure that access is assured across the whole health 
system, including public and private (private-for-profit, NGO, 
charity) providers?
Box 10.2 | elimination case Study: Morocco5
By the mid-1990s, Morocco had made substantial progress in reducing 
malaria transmission. This was brought about by classifying geographical 
areas according to their degree of risk of transmission. Once a risk area was 
classified, an appropriate surveillance and control strategy was implemented 
to target its specific needs.
In 1999, Morocco implemented the Autochthonous Malaria elimination 
Strategy (AMeS) with a goal to eliminate malaria by 2002. The program 
included case detection and treatment, vector control, entomological sur-
veillance, and larval control.
AMeS was followed by a 5-year consolidation phase to prevent the reintro-
duction of malaria. To sustain the elimination effort, training and retraining 
of essential staff (such as microscopists and entomology technicians) specific 
to the program was implemented and fully supported. Information and edu-
cation campaigns were conducted throughout Morocco to raise awareness 
about the elimination process. To reduce the number of imported cases of 
malaria, border health control staff were also retrained, and travel agency 
and airline executives were engaged to help promote more understanding 
among persons traveling to or from malaria-endemic countries. Morocco 
reported zero locally acquired cases of malaria.
Through these various elimination efforts and continued vigilance to pre-
vent reintroduction of malaria, Morocco provides an excellent example for 
many other lower-middle-income countries that wish to be malaria free.
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•	 How can diagnosis reach the remotest and poorest populations, who 
often have the residue of infection?
•	 What is required to integrate public and private sector access to 
ensure effective treatment in an equitable and economic way?
•	 How can poor treatment practices, including use of poor-quality 
drugs and monotherapies, be eliminated?
•	 How do you ensure adequate detection and treatment of P. vivax (and 
P. ovale) where this is relevant?
•	 How can vertical antimalarial diagnostic and treatment programs be 
integrated within the existing health care systems?
•	 How can new and introduced cases be diagnosed and treated within 
existing health care systems?
•	 Are there novel, effective, and equitable strategies to deliver 
treatment and prevention in a given sociocultural, economic, and 
political setting?
•	 In which circumstances is syndromic treatment (e.g., home or 
community-based management) appropriate and effective?
•	 What systems of training, incentives, regulation, and consumer 
education will ensure a good outcome, especially regarding the 
informal and private sector system?
organiZing the MaJor nonclinical FunctionS in 
Mal aria eliMination
In what ways (roles, responsibilities, and contractual relationships) can NGOs 
contribute to elimination programs at national and subnational levels, specifi-
cally the following:
•	 indoor residual spraying (IRS) implementation and/or promotion 
and distribution of insecticide-treated nets (ITNs) in relation to the 
stages of expansion and maintenance of coverage
•	 maintaining community involvement in malaria elimination, 
including the promotion of early diagnosis and treatment, such as 
use of mass media
•	 linking with private facilities
•	 training the required human resources
•	 integrating malaria vector control into a broader vector-borne disease 
program following elimination
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the rel ationShip Bet ween the national Mal aria control 
progr aM and the reSt oF the MiniStry oF health and other 
governMental departMentS
•	 How can the necessary focus and vigilance in preventing the 
reintroduction and resurgence of malaria be ensured?
•	 How do we ensure that the investments and scale-up necessary to 
achieve and maintain malaria elimination are of maximum benefit 
for the overall health system?
•	 How do we make the best use of strengthened monitoring and 
evaluation (M&E), surveillance, and laboratory systems to bring 
broad benefits to the health system?
•	 What are the key determinants to move from pilot studies to 
nationwide or regional initiatives?
•	 What structures and processes are required to ensure coordination 
and cooperation between different governmental and 
nongovernmental partners?
10.4 | checklist for Finance and economics
An elimination strategy presents financial and economic challenges at 
least equal to the technical issues that have to be resolved.6 Elimination 
of malaria will require substantial financial investment. The effectiveness 
and sustainability of different financing mechanisms need to be explored 
(Chapter 4).
coSt coMpariSonS
A fundamentally important question is the cost of an elimination program 
and how this might compare with the counterfactual of sustained control. 
Requirements include the following:
•	 a standardized analytical approach to compare costs and cost 
structure between different countries and settings
•	 direct and recurrent costs of interventions, costs of support at the 
district level, and costs of necessary health system strengthening
•	 a monitoring system to obtain standardized comparative 
information on the coverage required and on the intervention mix 
needed
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coSt BeneFitS
Comparisons of the strategies of elimination and sustained control should 
address the benefits that can accrue to the people and the economy:
•	 Costs and benefits of elimination should be compared with those 
of sustained control, specifically the incremental cost and benefits 
derived from moving from low-level malaria to no malaria.
•	 Costs of elimination and control should be calculated for a period of 
20 to 25 years. If elimination is cost-reducing, further calculation of 
the cost benefits of elimination is not essential.
•	 Where elimination costs do not come out lower, a full cost-benefit 
analysis is necessary.
•	 Benefits to be costed will include the following:
•	 labor supply, productivity, and agricultural output through 
reduction in malaria-related morbidity and mortality
•	 reduced treatment and other health sector costs
•	 improved foreign investment
•	 increased tourism
•	 long-term cost reductions
•	 Assigning a monetary value to these benefits and comparison with 
costs of elimination provides a cost-benefit ratio.
•	 Decisions are required on how to deal with benefits that cannot be 
given monetary values, for example, educational attainment and 
natural satisfaction.
•	 New approaches should be explored to health planning at national 
and subnational levels for the elimination strategy. Such approaches 
should be based on both burden of infection and cost benefit.
•	 Regional benefits, which should be regionally financed, and 
internationally financed global benefits should be considered.
•	 Who benefits most from elimination (relative to control)?
coSt-eFFectiveneSS
Consideration of cost effectiveness should be based on technical efficiency and 
can be assessed by cost-effectiveness analysis (CEA) of the health returns of 
different elimination strategies and interventions.
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The CEA technical efficiency measures are relevant for a diverse range of 
interventions, such as the following:
•	 selection of diagnostic procedures to be used peripherally and 
centrally
•	 combinations of interventions — additive or synergistic
•	 interventions used as transmission changes over time
•	 active case detection
•	 extending the reach of malaria interventions, especially to isolated, 
lowest-quintile populations
10.5 | checklist for Surveillance
The single objective of a surveillance program is to prevent transmission. 
Countries need to consider individually and regionally what procedures are 
required to reduce transmission to zero, how to prevent importation of infec-
tions, and if there is transmission, how to detect cases rapidly in order to stop 
an outbreak.
Foci oF inFection
As transmission is driven down to very low levels, it is likely to become restricted 
to small foci.
The key questions are these:
•	 What determines the heterogenicity of transmission?
•	 How much local transmission is there, and can intense local control 
eliminate it?
•	 What strategies and practical procedures have to be established for 
dealing with new foci of infection?
Finding all par aSiteS
Elimination is only achievable if all infections are detected and treated. The 
challenge is to develop and integrate strategies, both passive and active, that 
will achieve this. As transmission reaches low levels, infections that do occur 
are more likely to be symptomatic, but even in low-transmission settings, there 
remains a significant number of carriers of asymptomatic infections.7
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There is an equally urgent need to ensure that only those with a confirmed 
malaria infection are treated.8 It is necessary to devise means of finding the 
individuals who generally have little or no contact with the public health sec-
tor and assess the effectiveness of different types of surveillance and diagnostic 
procedures to cover these under operational conditions.
Key questions include the following:
•	 What surveillance systems are required, particularly for subpopula-
tions at special risk?
•	 How can robust malaria surveillance be effectively conducted within 
a weak health system, including through use of new technology?
•	 What system of active case detection is required to detect, treat, and 
investigate all new cases and to contain new foci of infection?
•	 What is the cost-effectiveness of varying approaches to active case 
detection?
•	 In which settings is mass treatment or mass screening and treatment 
effective for removing remaining cases of infection?
•	 What approaches and systems are needed to find asymptomatic 
infections?
•	 How can malaria infections be identified best among those with 
acute febrile illness?
•	 What systems are needed for reporting and integrating data on 
malaria detected outside the public health system?
•	 What central and peripheral routine systems are most effective for 
detection and prevention of cross-border importation of infections?
coMMunity involveMent
•	 How can advocacy campaigns and community-led initiatives be 
developed, used, and sustained in a given health and social system?
•	 Can village health workers be used for frontline surveillance?
•	 What incentives are required to maintain community involvement?
•	 How can IT (including GPRS or cell phones) best be used for 
community and public health reporting of infections?
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10.6 | Monitoring and evaluation
A strategy of the scope and duration required for elimination needs an M&E 
plan to identify the steps necessary to achieve the endpoint over a given time 
frame and then to maintain it.
The procedures required to deal with small numbers of cases that remain to 
be detected and treated in the process of getting to zero are similar to those that 
must be employed, or in readiness, to prevent importation and an outbreak.
get ting to Zero
Once transmission has been reduced to a point where elimination can be 
planned, specific changes in emphasis and capacity must be made before pur-
suit of complete elimination. The M&E research areas to be addressed include 
the following:
•	 How is parasite (including gametocyte) prevalence monitored in 
at-risk populations?
•	 How is the quality of clinical and laboratory services monitored?
•	 How is the accuracy of diagnosis and response systems to ensure 
effective use of resources monitored and evaluated?
•	 How can equity of access to prevention and cure be monitored?
•	 How is the effectiveness of vector control interventions evaluated?
•	 What systems are needed for monitoring drug quality and drug and 
insecticide resistance?
•	 How can all monitoring systems permit effective reporting and near-
real-time analysis?
holding the line
The key M&E issues to research are the following:
•	 effective detection and response to outbreaks, including determina-
tion of the species and origins of the parasites (imported or local)
•	 comparison of the position and role of the centralized laboratory 
facilities used for confirmation of diagnosis and determination of 
origin of parasites, versus the role and responsibility of the peripheral 
facilities, including reporting systems
•	 monitoring of vector control measures used in focal areas and 
assessing development of resistance to insecticides or larvicides
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MeaSureS oF expoSure
Antibodies are produced in response to a first infection, and a memory 
response can be induced that can persist for decades. The likelihood of being 
antibody positive depends on the age of the individual and the frequency 
with which he or she is exposed to infection. Simple antibody prevalence 
rates can be used to define malaria endemicity, and a more detailed examina-
tion of age-specific antibody positive rates can be used to monitor changes in 
transmission.
Developments using standardized recombinant antigens of different immu-
nogenicities, from both P. falciparum and P. vivax (and potentially other spe-
cies), allow a detailed assessment of malaria exposure.9 Analytical and model-
ing advances will allow antibody levels, in addition to prevalence, to be used to 
monitor the progress of an elimination program. Antibodies can be detected in 
blood from a small finger prick, and samples can be assayed in large numbers 
quickly, making this approach readily accessible and suitable for monitoring 
elimination efforts.
The key question is this:
•	 How can existing and new sero-epidemiological strategies be used 
to measure success in elimination of transmission or, conversely, to 
obtain evidence of reexposure?
popul ation MoveMentS/Migr ation
What are the technical and systems needs for monitoring population move-
ments within a country to prevent reintroduction of infections into a malaria-
free area? Specific questions include the following:
•	 How can we capture the heterogeneity of moving populations with 
regard to finding the clusters of infected people (imported cases)?
•	 How can reintroduction of malaria by cross-border population 
movement best be prevented?
indicatorS
The key issue for impact is monitoring of rapid completion of case reports and 
immediate reporting to a local rather than a central response network
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The key issue for impact is monitoring of rapid completion of case reports 
and immediate reporting to a local rather than a central response network. 
The key issue for outcome and output is to ensure local responsibility for 
achieving high coverage, with systems to track diagnosis, ensure prompt, effec-
tive treatment, and monitor drug efficacy. 
The key issue for outcome and output is to ensure local responsibility for 
achieving high coverage, with systems to track diagnosis, ensure prompt, effec-
tive treatment, and monitor drug efficacy. 
10.7 | checklist for diagnosis
Making the best use of currently available diagnostic tests and advancing the 
introduction of new highly sensitive and specific tests are crucial to the success 
of an elimination strategy.
Clinical diagnosis of malaria is widely used as the basis for treatment in 
areas of moderate to high transmission, but it is not appropriate for an elimi-
nation strategy8 (or for sustained control). The preferred alternatives available 
are rapid diagnostic tests (RDTs) that detect parasite-specific antigen in the 
blood.10 Currently available RDTs have the improved benefits of ease of use and 
of speed, detect the majority of malaria cases (P. falciparum more effectively 
than P. vivax), and are specific enough to guide treatment. RDTs should be 
widely deployed in order to identify malaria infections within the context of 
management of fevers.11 Medical staff and the community as a whole need to 
be educated to accept the results of diagnosis (particularly negative results).12 
This requires that malaria diagnosis should be an integral part of a health facil-
ity capable of managing the major causes of fever.
There are increasing reports that all species of Plasmodium can persist as sub-
patent blood-stage infections mostly below the level of detection possible by 
microscopy or RDTs. Progress is being made in the development and applica-
tion of more-sensitive PCR-based diagnostic tests. There is no way of detecting 
hypnozoites of P. vivax or P. ovale until they give rise to blood-stage forms.
Mixed infections are not uncommon,13 and where two, three, or four species 
occur together, it is important to target all of them for elimination (Chapter 8).
The key questions are the following:
•	 How can the use of RDTs or microscopy be optimized to avoid fever 
mismanagement and overdiagnosis of malaria?
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•	 What system of quality assurance of RDTs is required?
•	 How should more-sensitive diagnostic techniques (PCR and related 
tests) be tested and introduced for point-of-care, screening of sub-
patent infections, and/or regional reference center diagnosis?
•	 How can long-term persistence of P. vivax, P. ovale, and P. malariae be 
monitored?
•	 What strategies are needed to improve acceptance of diagnostic tests 
and their results by health workers and patients?
10.8 | checklist for drugs
There are some very substantial operational questions to be addressed regard-
ing use of the drugs that are currently available. Maintaining fully effective 
drugs for treatment is a very high priority for both control and elimination pro-
grams. The approach identified as “prevention by treatment”14 requires use of 
drug combinations that prevent transmission through effects on gametocytes 
or mosquito stages (Chapter 8).
drugS For treatMent
•	 What drug combinations should be used for treatment in an 
elimination strategy?
•	 Can rotating first-line treatment be used to delay the evolution of 
drug resistance?
•	 How is the access to drugs ensured in a given elimination program?
•	 What systems for rapid deployment of treatment are needed?
gaMetocyticidal drugS
Gametocytes of P. vivax, P. malariae, and P. ovale are generally sensitive to the 
drugs that kill the asexual forms,15 but the effectiveness of currently avail-
able drug combinations, especially artemisinin-based combination therapies 
(ACTs), needs to be established, as they are likely to be used more frequently 
once chloroquine ceases to be effective against P. vivax.
•	 Can primaquine (or other 8-aminoquinolines) be deployed in 
combination with ACTs?
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MaSS drug adMiniStr ation or MaSS Screening and 
treatMent
Mass drug administration (MDA) could be considered for elimination (Chapter 
8), for example, for removal of small residual foci of infection or reintroduced 
foci. For MDA, the general guidelines would be to use drugs in combination, 
but not those required as first- or second-line treatment, to include a drug effec-
tive against gametocytes or mosquito stages of the parasite, and to ensure that 
the drugs are safe to use.
An alternative to MDA for clearing residual foci and, more appropriately, for 
dealing with the reintroduction of infections is mass screening and treatment 
(MST). Operational questions that must be considered in comparing the two 
approaches are the following:
•	 Which approach is more appropriate, and which drugs should be 
used?
•	 What pilot study designs are required?
•	 What level of coverage is needed?
•	 How might these interventions be sustained and for what period?
•	 How cost-effective are these interventions?
Hemolytic episodes in patients with glucose-6-phosphate dehydrogenase 
(G6PD) deficiency is a risk factor when they are treated with primaquine. There 
are many different forms of this deficiency, many of them mild, and it is likely 
that a single dose of primaquine combined with ACT treatment would be suf-
ficient to reduce substantially the numbers of circulating gametocytes. Trials of 
the ACT-primaquine combinations (and with ACT plus a single dose of tafeno-
quine) are needed.
Key questions include the following:
•	 What are the tests to use to identify G6PD deficiency in 
MDA programs and allow the use of primaquine (or other 
8-aminoquinolines) in MDA or MST?
•	 Is there an effective dosage or delivery system for primaquine (and 
possibly tafenoquine) that can be given safely and easily to large 
populations without screening for G6PD deficiency? For example, 
a skin patch designed to deliver a graduated amount of drug slowly 
over a week or month could lessen the likelihood of hemolytic events 
by avoiding the peak blood concentration seen after oral use.
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P. vivax  and P. ovale  hypnoZoiteS
The only licensed treatment capable of radical cure of P. vivax, by killing hyp-
nozoites, is a 14-day regime with primaquine. The safety concerns in G6PD-
deficient patients are more serious with this long treatment schedule. Without 
this radical cure, relapses can occur for 3 to 5 years without exposure to any 
additional mosquito bites. A 14-day regimen would not be feasible for MDA in 
most settings.
Other long-acting 8-aminoquinolines such as tafenoquine also induce the 
same hemolytic episodes but require fewer doses than primaquine16 and should 
be investigated further as an alternative. The key question is how primaquine 
(or other 8-aminoquinolines) can be used safely and effectively?
Monitoring For reSiStance
The development of antimalarial resistance needs to be monitored carefully, as 
it can have a marked effect on transmissibility as well as reducing the clinical 
impact of treatment. A reduction in drug efficacy is marked by an increase in 
gametocytemia (Chapter 8) and therefore infectivity of the population. The 
failure of treatment will increase the likelihood of recrudescence and gameto-
cyte carriage with resistant infections. Recent evidence of tolerance to artemisi-
nin has emerged from the Thai-Cambodia border where decreased efficacy of 
artemisinins is manifesting as prolonged parasite clearance times.17 This is a 
global crisis, as the worsening and spread of artemisinin resistance threatens 
the efficacy of most of the ACTs on which treatment of malaria depends. The 
capacity for monitoring drug resistance needs to be strengthened. Particular 
focus should be paid to monitoring the efficacy of artemisinins. A network for 
collecting, analyzing, and sharing data is currently being established under the 
umbrella of the World Antimalarial Resistance Network.
•	 What strategies are needed to contain or eliminate the spread of 
artemisinin-resistant infections through alleviating drug pressure 
and isolating and removing foci of resistant infections?
10.9 | checklist for vector control
Vector control, or more precisely the reduction in the ability of mosquitoes 
to acquire, incubate, and transmit malaria parasites, is an essential part of an 
elimination strategy (Chapter 9). Elimination of the mosquito vector of malaria 
is only rarely optional for elimination.
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Foci oF inFection
Mosquitoes in particular determine the outbreak risk, and the breeding hab-
its and behavioral characteristics of different Anopheles species determine the 
range of measures that can be used to reduce or prevent malaria transmission.
There may be human behavioral factors that include, on the one hand, cre-
ation of breeding sites for the mosquitoes and, on the other, a reluctance to accept 
ongoing vector control measures such as IRS. The persistence of foci and the 
factors that make such foci receptive to reintroduction of transmission depend 
on vectorial capacity. This in turn depends on mosquito species and density, 
biting habits, the egg-laying cycle, survival, and duration of development of 
parasites within the mosquito. Other factors are included below, and once the 
characteristics of a focus of infection have been established, an intensive and 
appropriate package of vector control measures must be implemented.
Special transmission settings are of particular importance. Forest malaria 
is maintained by communities living within the forest areas and may make 
up a high proportion of malaria cases. Forest malaria is difficult to control, 
especially because vectors are outdoor-resting early biters that are largely unaf-
fected by IRS and ITNs. These are populations where alternative vector control 
measures such as use of repellents should be investigated. Malaria within the 
fringe areas may be dramatically changed by activities such as deforestation, 
which can change the whole vector ecology and the mosquito species trans-
mitting infections.
Key questions include the following:
•	 What are the specific entomological and epidemiological features of 
foci of transmission?
•	 What vector control interventions are most effective?
•	 How do vector-specific characteristics determine outbreak risks?
•	 How can importation from forest to nonforest areas be monitored 
and managed?
•	 How does changing ecology affect transmission?
inSecticide reSiStance
Insecticide resistance poses some difficult questions. On the one hand, a range 
of mechanisms of resistance to the different classes of insecticides being used 
has been identified, and resistance could therefore reduce the efficacy of the 
insecticides (Chapter 9).18 However, the operational impact that different resis-
tance mechanisms have is far from clear. Further investigation is required, in 
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the context of what insecticides are used and the resistance status of regional 
anopheline species.
Key questions include the following:
•	 How can insecticide resistance be monitored routinely?
•	 What strategy can increase and sustain IRS or ITN effectiveness, and 
to what extent are rotation and mosaic use of insecticides important 
in a given epidemiological setting?
repellentS
Many mosquito vectors are exophilic (outdoor resting), dawn or dusk bit-
ing, exophagic (outdoor feeding), and not exclusively or even predominantly 
anthropophilic (human blood feeding). Consequently, ITNs and/or IRS may 
be of limited effectiveness, and supplementary or alternative methods may be 
required. Combining repellents with ITN use has been shown to be highly 
effective,19 and cluster randomized trials of this combination should be consid-
ered. Issues will include effectiveness, safety, acceptability, and sustainability.
The key question is this:
•	 How can repellents be used beneficially either alone or in 
combination with ITNs or IRS?
Breeding SiteS
Larval control is generally less effective than attacking adult mosquitoes, and 
there must be good coverage when it is used. Many species of Anopheles (nota-
bly A. gambiae) have breeding sites that are difficult to identify because they 
are not fixed bodies of water. However, finding sites, especially those linked to 
foci of infection, along with intensive vector control (Chapter 9) that includes 
antilarval measures can be effective. Many of the identifiable breeding sites are 
man-made, and investigations into mosquito source reduction should include 
environmental management and community involvement to prevent creation 
of such sites.
Key questions include the following:
•	 Which are the epidemiological settings where larval control is 
feasible and has a high potential effectiveness? In epidemiologically 
suitable sites, how can transmission be contained by reducing 
natural and man-made mosquito breeding sites?
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•	 How and under what circumstances can community involvement be 
used to prevent creation of man-made breeding sites for vectors?
•	 Can larval control be scaled up in a cost-effective way for vector 
species that are not adequately controlled by use of IRS and ITNs 
because of their resting and biting habits?
coMBining vector control interventionS
Interventions need to be combined as packages. Research into the best ways 
to deliver existing tools should be continued. In many countries, scaling up 
provision of ITNs, and especially LLINs (long-lasting ITNs), is a high priority. 
Other interventions will be required, and trials must be designed to assess the 
incremental effect of adding any intervention against the background of high 
use of nets in different epidemiological settings.
There are a few examples of where the benefits of combining different vector 
control measures have been investigated, but much more needs to be known 
about the value of using combined interventions.
Integrated vector management (IVM) is defined as “a rational decision-
making process for the optimal use of resources for vector control,” and it is 
recommended for national malaria control programs especially as they elect to 
move from sustained control to elimination. IVM goes beyond vector control 
measures alone because IVM is employed as part of intersectoral collabora-
tion and incorporates social mobilization, advocacy, legislation, and capacity 
development.20
All interventions should be reviewed in an ongoing way to ensure that they 
remain fully effective and cost-effective. This is particularly important when 
the elimination strategy is well advanced or when maintenance of a malaria-
free state is the objective. For example, IRS is a very demanding vector con-
trol measure, requires repeated application, is costly to maintain, and often 
becomes progressively more unpopular with the populations required to accept 
it. It also leads to insecticide resistance.
Key questions include the following:
•	 What are the additive or synergistic benefits of combining different 
antivector measures?
•	 When would it be appropriate to consider withdrawing or replacing a 
vector control intervention tool within the course of an elimination 
program?
•	 What is required for integrated vector management?
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10.10 | conclusion
The much broader R&D agenda that embraces both basic research needs and 
the multidisciplinary global agenda needed to make the long-term goal of erad-
ication feasible is not addressed here but is the remit of the recently established 
MalERA project. This consists of an intensive 12-month program of consul-
tation and definition culminating in the production of an agenda (or white 
paper) designed to strengthen the links between different research areas and 
to gain consensus among research institutions and sponsors on directions for 
malaria R&D toward the ultimate long-term goal of eradication.
This chapter is intended to flag the issues that need to be considered for 
the planning and implementation of malaria elimination programs in order 
to make them feasible and effective. The checklists presented point to both 
operational and operational research areas.
Consequently, any national plan aiming at elimination may find these 
checklists helpful when completing their operational plans, identifying where 
in a given setting specific operational research is required, and/or identifying 
where the program could draw from evidence generated in comparable set-
tings. We feel that this approach will assist countries and regions to establish 
a relevant operational research agenda that can be presented to national and 
international partners for support and implementation.
Finally, the research agenda outlined in this chapter can be improved and 
more fully adapted to the various epidemiological settings in which elimina-
tion programs are undertaken by an interactive process between national/
regional programs, WHO, and other technical experts and MEG members. In 
this way, questions can be refined and/or adapted to specific settings and stages 
of elimination. We particularly welcome input based on practical experience 
from areas that have already moved into implementation of an elimination 
program or are holding the line.
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gloSSary
The following definitions apply specifically to malaria.
active case detection Proactive screening of a defined portion of the 
population for malaria parasites. 
acquired immunity Immunity acquired over time in people residing in 
malaria-endemic areas through continued exposure to malaria parasites.  
Although full immunity is not obtained, and low-level parasite infections 
may still occur, it does generally protect against severe malaria.
administrative feasibility The possibility of creating a national 
administrative infrastructure that can carry out a malaria elimination 
program with a strong long-term governmental commitment and a 
conducive legal environment for elimination.
annual blood examination rate (aBer) The number of blood slides 
examined for malaria parasites as a proportion of the total population in 
areas at risk of transmission.
annual parasite index (api) A measure of the number of confirmed malaria 
cases per year per thousand people in a defined geographical area.
autochthonous (indigenous, local) Transmission acquired locally in an area 
where malaria regularly occurs.
Basic reproductive number (R0) The number of potentially infected 
humans that would arise from a single infected human, or the number 
of potentially infected mosquitoes that would arise from a single infected 
mosquito, after one complete generation of the parasite. It measures 
maximum potential transmission, so it describes populations with no 
immunity and no malaria control.
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case, imported A case whose origin can be traced to a known malarious 
area outside the area in which the case was diagnosed.
case, indigenous A malaria case likely to have occurred through local 
transmission.
controlled reproductive number (Rc)  The same as the basic reproductive 
number (RO) but takes into account all of the malaria control measures 
that have been put into place to slow transmission.  It is also a measure of 
potential for outbreaks.  
cost-benefit Ratio of costs to benefits, considering the financial value of a 
wide range of health benefits,  economic benefits, and social benefits.
cost-effectiveness Ratio of the net cost divided by the number of disability-
adjusted life years (DALY) averted, or some other metric of morbidity or 
mortality averted.
elimination The interruption of local mosquito-borne malaria transmission 
in a defined geographical area, creating a zero incidence of locally 
contracted cases.
endemic Applies to a malarious area when a sustained measurable incidence 
of cases and mosquito-borne transmission occur over a succession of 
years.
entomological inoculation rate (eir) The expected number of infectious 
bites per person per year.
epidemic Occurrence of many cases of infection that substantially exceeds 
the expected number in a given place and time period.
eradication The permanent reduction to zero of the worldwide incidence 
of malaria infection. Intervention measures are no longer needed once 
eradication has been achieved.
Financial feasibility The ability to establish and sustain the necessary 
funding to achieve and maintain elimination on a long-term and reliable 
basis from domestic and international sources, given other demands on 
health sector expenditure.
Focus (foci) A defined and circumscribed locality situated in a current 
or former malarious area that contains the continuous or intermittent 
epidemiological factors necessary for malaria transmission. 
Force of infection Rate per year at which susceptible individuals become 
infected by malaria.
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gametocyte The sexual stage of malaria parasites, present in the host red 
blood cells, that are infective to the anopheline vector mosquito.
gametocyte carrier Person who has malaria gametocytes in his or her 
peripheral blood, making the person a potential source of infection.
holoendemic Permanent intense transmission with a high parasite rate 
among infants and a well-developed immunity in older children and 
adults.
horizontal program An effort to provide the population with access to all 
health services and interventions through an integrated health delivery 
system.
human biting rate The number of mosquito bites per person per year.
hyperendemic An area with high transmission, frequently seasonal, with 
infants being the most susceptible.  
hypoendemic An area with little malaria incidence and a parasite rate of less 
than 10% in children aged 2-9 years. 
importation risk (also known as vulnerability) The probability of malaria 
reintroduction based on an area’s proximity to other malarious areas and 
the movement of infected humans or infected Anopheles mosquitoes.
internal rate of return (irr) The percentage rate of interest that represents 
the economic return on an investment in malaria elimination; it is 
calculated from the incremental annual costs of an elimination strategy 
over the baseline costs of a strategy of sustained control over time.  
Malariogenic potential Combination of a region’s outbreak risk and 
importation risk.
Mass drug administration (Mda) Presumptive treatment of a defined 
population with a therapeutic dose of an antimalarial drug or drugs.
Merozoites Parasites released into the host bloodstream when a hepatic or 
erthrocytic schizont bursts, initiating a new cycle of development within 
the red blood cells.
Mesoendemic An area of intermediate malaria incidence and a parasite rate 
of up to 50% in children aged 2-9 years.
operational feasibility The ability to establish and sustain the systems and 
capacity to effectively implement all the activities needed to achieve and 
maintain elimination.
outbreak A case or number of cases of locally transmitted infection greater 
than would be expected at a particular time and place.  
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outbreak risk (also known as receptivity) A measure of the potential of an 
area or focus to allow transmission to occur, or once elimination has been 
achieved, the propensity for reintroduced malaria to give rise to malaria 
outbreaks.
parasite rate (pr) Prevalence of asexual blood-stage parasites.
parasitemia Percentage of malaria infected red blood cells.
passive case detection Detection of malaria cases among patients who on 
their own initiative went to a health post to get treatment, usually for a 
febrile disease.
positive predictive value (pv+) The probability that infection is truly 
present, given a positive diagnostic test result.
pre-elimination phase Malaria control program reorientation during the 
period between sustained-control and elimination, in which emphasis on 
surveillance, reporting, and information systems increases.
private sector All health facilities outside of the government’s health system, 
and all potential malaria contributors that are outside government.
reintroduction risk The risk following elimination that endemic malaria 
will be reestablished once surveillance shows a reduction to zero of all 
locally acquired cases (i.e., not including imported cases), when malaria 
can be reintroduced to the local environment. 
Sensitivity (of a test) The percentage of true positives correctly identified by 
diagnostic test results.
Serology The diagnostic identification of immunoglobulins/antibodies in 
the serum.
Slide positivity rate (Spr) The proportion of slides found positive among all 
slides examined.
Spatial analysis A general ability to manipulate spatial data (e.g., maps) into 
different forms and extract additional meaning (e.g., high-risk areas) as a 
result.
Specificity (of a test) The percentage of true negatives correctly identified by 
diagnostic test results.
Sporozoite rate The proportion of mosquitoes with sporozoites in their 
salivary glands.
Surveillance The part of the program aimed at the discovery, investigation, 
and elimination of continuing transmission; the prevention and cure of 
infections, and the substantiation of claimed elimination.
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Sustained control Period during which malaria control measures 
are stabilized and universal coverage is maintained by continued 
strengthening of health systems.
technical feasibility The probability that malaria transmission can be 
reduced to zero in a given area and that zero transmission can be 
maintained in that area once elimination has been achieved using 
currently available control tools.
transmission foci Areas in which malaria transmission is concentrated. 
transmission, stable Constant, year-round malaria transmission that is 
relatively insensitive to environmental changes.
transmission, unstable Malaria transmission with marked fluctuations in 
intensity due to changing environmental conditions.
vectorial capacity The expected number of infectious bites that will arise 
from all the mosquitoes that bite a single person in one day.
vertical program A nonintegrated (e.g., stand-alone) health program, often 
aimed at a single disease, group of diseases, or target population.
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aBBreviationS and acronyMS
aBer annual blood examination rate
act artemisinin-based combination therapy
api annual parasite index
cdc Centers for Disease Control and Prevention
daly disability-adjusted life year
dna deoxyribonucleic acid
eir entomological inoculation rate
e8 Elimination 8 (Angola, Botswana, Mozambique, Namibia, 
South Africa, Swaziland, Zambia, Zimbabwe)
giS geographic information system
gMap Global Malaria Action Plan
gMep Global Malaria Eradication Program
g6pd glucose-6-phosphate dehydrogenase
hBer human blood examination rate
iec information, education, and communication
itns insecticide-treated nets
ipt intermittent presumptive treatment
irr internal rate of return
irS indoor residual spraying
laMp loop-mediated isothermal PCR
llins long-lasting insecticide-treated nets
lSdi Lubombo Spatial Development Initiative
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M&e monitoring and evaluation
Mda mass drug administration
Meg Malaria Elimination Group
MSp-1 merozoite surface protein 1
MSt mass screening and treatment
ngo nongovernmental organization
nMcp National Malaria Control Program
oda official development assistance
pcr polymerase chain reaction
pr parasite rate
pv+ positive predictive value
qt-naSBa quantitative nucleic acid sequence-based assay
rBM Roll Back Malaria
Rc controlled reproductive number
rdt rapid diagnostic test
R0 basic reproductive number
r&d research and development
Sadc Southern African Development Community
Spr slide positivity rate
wha World Health Assembly
who World Health Organization
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annex 1:  MeMBerShip oF the Malaria 
eliMination group (Meg)
Dr. rabindra abeyasinghe Project Director
national Malaria Control Program
Ministry of Healthcare and nutrition 
Sri Lanka
Mr. Abdullah ali Program Manager
zanzibar Malaria Control Program
Ministry of Health and Social Welfare
zanzibar
Dr. Mario S. Baquilod Medical Officer 
national Center for Disease Prevention and Control
Department of Health
Philippines 
Mr. Suprotik Basu Advisor 
Secretary General’s Special envoy for Malaria
United nations
USA
Mr. Colin Boyle Partner and Managing Director
The Boston Consulting Group
USA
Dr. David Brandling-Bennett Deputy Director, Malaria
Infectious Diseases Development Division
Bill and Melinda Gates Foundation
USA
Dr. Carlos C. (Kent) campbell Director
Malaria Control Program 
PATH 
USA
Mr. ray chambers Secretary General’s Special envoy for Malaria
United nations
USA
Dr. John Paul clark Senior Technical Specialist
Booster Program for Malaria Control in Africa
The World Bank
USA
Dr. Grant dorsey Associate Professor
Division of Infectious Diseases, School of Medicine
University of California, San Francisco
USA
Dr. richard Feachem Director 
The Global Health Group, Global Health Sciences
University of California, San Francisco
USA
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Dr. Brian greenwood Manson Professor of Tropical Medicine
London School of Hygiene & Tropical Medicine 
UK
Dr. Simon hay reader of Infectious Disease epidemiology
Malaria Atlas Project, Department of zoology
University of Oxford
UK
Dr. Janet hemingway Director
Liverpool School of Tropical Medicine
UK
Dr. Michelle hsiang research Associate, Malaria elimination Initiative
The Global Health Group, Global Health Sciences 
University of California, San Francisco
USA
Dr. Dean Jamison Professor
Institute for Health Metrics and evaluation, and  
Department of Global Health 
University of Washington
USA
Dr. Simon kunene Program Manager
national Malaria Control Program
Ministry of Health
Swaziland
Ms. Lebogang lebese Technical Advisor for Health
Southern African Development Community
Botswana
Dr. Klaus M. leisinger President and executive Director 
novartis Foundation for Sustainable Development
Switzerland
Dr. Jo lines reader
Malaria Control and Vector Biology
London School of Hygiene & Tropical Medicine 
UK
Dr. rajendra Maharaj Director
Malaria research Program
Medical research Council
South Africa
Dr. George Malefoasi Under-Secretary of Health
Ministry of Health
Solomon 
Islands
Dr. Carol Medlin Senior Program Officer
Global Health Policy and Advocacy
Bill and Melinda Gates Foundation
USA
Dr. Devanand (Patrick) 
Moonasar
Malaria Technical Advisor
Southern Africa Malaria elimination Support Team
Global Health Group, Global Health Sciences
University of California, San Francisco, and Clinton Foundation
South Africa
Dr. Bruno Moonen regional Malaria Manager
Malaria Program 
Clinton Foundation
Kenya
Dr. Kaka Mudambo regional Coordinator
Military Malaria Control Program
SADC Military Health Services
zimbabwe
Dr. Bernard nahlen Deputy Coordinator
President’s Malaria Initiative
USA
Ms. Allison phillips Program Manager, Malaria elimination Initiative
The Global Health Group, Global Health Sciences
University of California, San Francisco
USA
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Dr. Steven phillips Medical Director
Global Issues and Projects
exxon Mobil Corporation
USA
Dr. John reeder Director
Centre for Population Health
Macfarlane Burnet Institute for Medical research and  
Public Health
Australia
Dr. Mario Henry rodriguez Director General 
Instituto nacional de Salud Pública
Mexico
Mr. Oliver Sabot Director
Malaria Control Team 
Clinton Foundation
USA
Dr. Dennis Shanks Director
Australian Army Malaria Institute
Australia
Dr. Laurence Slutsker Chief
Malaria Branch
Centers for Disease Control and Prevention
USA
Dr. David Smith Associate Professor
Department of Biology, and emerging Pathogens Institute
University of Florida
USA
Dr. richard Steketee Science Director
Malaria Control Program and MACePA
PATH
France
Mr. George taleo Manager
Malaria and Vector Borne Diseases Control
Ministry of Health
Vanuatu
Dr. Linhua tang Director
national Institute of Parasitic Diseases
Chinese Center for Disease Control and Prevention
China
Dr. Marcel tanner Director
Swiss Tropical Institute
Switzerland
Dr. Geoffrey targett Professor emeritus
London School of Hygiene & Tropical Medicine
UK
Dr. Awash teklehaimanot Director
Malaria and neglected Tropical Diseases
earth Institute, Columbia University 
USA
Dr. Jim tulloch Principal Health Adviser
AusAID
Australia
Dr. Andrew vallely Director 
Pacific Malaria Initiative Support Centre
University of Queensland
Australia
Dr. Walther wernsdorfer Professor
Institute of Specific Prophylaxis and Tropical Medicine 
Medical University of Vienna
Austria
Dr. Shunmay yeung Senior Lecturer
London School of Hygiene & Tropical Medicine
UK
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The Global Health Group
Global Health Sciences
University of California, San Francisco
50 Beale Street, Suite 1200
San Francisco, CA 94105 
www.globalhealthsciences.ucsf.edu/ghg
Shrinking the Malaria Map:
A Prospectus on Malaria Elimination
is available online at: www.malariaeliminationgroup.org
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